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Abstract 
Effect of Identity and Number of Chiral Microemulsion Components in Chiral 
Microemulsion Electrokinetic Chromatography 
Kimberly Ann Kahle 
Dr. Joe P. Foley 
 
 
 
The field of microemulsion electrokinetic chromatography (MEEKC) is one of the newer 
subsets of electrokinetic chromatography (EKC) in which microemulsion droplets 
(consisting of three components:  surfactant, cosurfactant, and oil) aid in analyte 
separation.  The benefits to utilizing this methodology include short analysis times, high 
efficiencies, multiple parameters to fine-tune, ability to solubilize hydrophobic 
compounds, and minute consumption of both mobile phase and sample.  This research 
area continues to expand as additional microemulsion formulations are examined for the 
analysis of more diverse and complex samples.  In particular, the composition of the 
nanodroplets has a major impact on the separation characteristics.  Therefore, the effect 
of each individual microemulsion constituent depends on the identity of the other 
components.  It was the aim of this work to examine the impact of cosurfactant and oil 
identity and stereochemistry in dodecoxycarbonylvaline (DDCV)-based chiral 
microemulsion formulations for chiral MEEKC. 
 
In Chapter 3, the preparation of novel dual-chirality microemulsions is described wherein 
the chiral surfactant DDCV, in each of its stereochemical configurations, is combined 
with the chiral cosurfactant S-2-hexanol for the separation of two pairs of enantiomers.  
Additionally, results with racemic 2-hexanol were obtained and compared to previously 
published data using 1-butanol as the cosurfactant. 
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The focus of Chapter 4 is the effect of achiral cosurfactant identity in which seven 
different achiral alcohols are examined for their influence on chromatographic figures of 
merit.  Both the alkyl chain length and the hydroxyl group position caused distinct 
changes in the separation characteristics. 
 
Chapters 5 through 7 describe several novel multi-chirality microemulsion formulations.  
Combinations of a chiral surfactant (DDCV) and a chiral oil are evaluated with two 
different chiral oils:  dibutyl tartrate in Chapter 5 and diethyl tartrate in Chapter 6.  
Finally, in Chapter 7, novel triple-chirality microemulsions containing DDCV, S-2-
hexanol, and diethyl tartrate are used for the analysis of six pairs of chiral enantiomers. 
 
The findings of these studies demonstrate that both the identity and stereochemistry of 
the individual microemulsion components affect efficiency, enantioselectivity, and 
resolution.  Importantly, the incorporation of additional chiral reagents to a 
microemulsion formulation provides a unique method of improving chiral separations. 
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Chapter 1:  Chiral Electrokinetic Chromatography Fundamentals and Applications 
 
 
 
1.1 Brief History and Advantages of Capillary Electrophoresis and Chiral 
Electrokinetic Chromatography  
 
Capillary electrophoresis (CE) as a separation technique has experienced widespread 
growth since its introduction in 1967 by Hjertén [1].  Since then, many advancements in 
instrumentation and additives have led to its industrial and academic acceptance.  In the 
1980s, several key developments were made including [2]:  usage of small inner diameter 
glass capillaries (75 µm) by Jorgenson et al. in 1981 [3], the advent of electrokinetic 
chromatography (EKC) by Terabe et al. in 1984 (micellar electrokinetic chromatography, 
MEKC) [4], the first chiral CE separation by Zare et al. in 1985 [5], the first commercial 
instrumentation in 1988, and the first CE use of cyclodextrins (CDs) by Guttman et al. in 
1988 [6].  The characteristics of CE that make it so appealing have been frequently noted 
[2, 7-10] and include:  high efficiencies, high resolving power, short equilibration times, 
short analysis times, ease of additive use, and low consumption of analytical reagents and 
samples.   
 
One area in which CE has been shown to be particularly useful is chiral separations.  The 
multitude of chiral reagents that can simply be added to the electrolyte solution continues 
to increase and allows many types of chiral analytes to be resolved.  Some examples of 
chiral selectors are surfactant aggregates, cyclodextrins, crown ethers, and glycopeptides.  
Due to the extensive exploration in this field, numerous reviews detailing fundamentals 
and applications can be found in the literature prior to 2005 [11-16] and over the past 2 
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years [17-20]. Reviews have also covered methods developed specifically for 
pharmaceutical compounds [21-27], biological compounds [28], chiral LC-MS/CE-MS 
[29], pesticides [30], pollutants [31], and food additives [32, 33]. 
 
1.2 Electrokinetic Chromatography Fundamentals  
Electrokinetic chromatography (EKC) is one of several important subdisciplines within 
capillary electrophoresis (CE) in which a pseudostationary phase (PSP) is added to the 
buffer to selectively retard (slow down) the migration of charged and neutral analytes, 
thus achieving their separation.  Because EKC has the same hardware requirements and 
utilizes the same underlying principles, it is appropriate to begin with an overview of CE. 
 
1.2.1 Capillary Electrophoresis Basics 
All separation techniques require separative transport that may or may not be coupled 
with bulk transport.  Most analytical-scale, liquid-phase separation techniques such as CE 
and high performance liquid chromatography (HPLC) employ both forms of transport to 
accomplish their goal.  After introduction of the sample, the analytes must travel through 
a capillary or column in which separation occurs via differential migration (with the aid 
of a mobile phase in chromatography) and be detected.  Capillary electrophoresis (CE) 
differs from other liquid separation methods in two main aspects:  bulk flow profile and 
mechanism of separation.  In CE, an electrical potential difference (voltage) is the driving 
force behind the generation of mobile phase movement (termed electroosmotic flow or 
EOF) and results in an almost perfectly flat flow profile, see Figure 1.1.  This is in 
contrast to high performance liquid chromatography (HPLC) where the mobile phase is 
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Figure 1.1.  Bulk flow profiles for a.) pressure-driven and b.) voltage-driven systems 
[34].
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pumped through the separation column (pressure-driven flow), thereby creating a 
hyperbolic or laminar flow profile as shown in Figure 1.1.  In practice, this difference in 
bulk flow translates to decreased band broadening in electrophoretic separations and thus 
sharper, more efficient peaks.   
 
The main components of CE instrumentation are shown in Figure 1.2:  inlet/outlet buffer 
vials (labeled as source and destination vials in Figure 1.2), a capillary column, a high 
voltage source, and a detector.  The column utilized in CE is an open tube typically 
composed of polyimide-coated fused silica with an internal diameter on the order of 12 to 
100 micrometers.  The coating imparts flexibility and protects the column from breakage.  
It is the ionizable silanols on the interior surface of the capillary that are responsible for 
the generation of EOF.  As pH is increased, the ionization of these groups also increases.  
In the presence of a buffer solution, cations are attracted to the negative silanols, creating 
an electrical double layer (EDL, see Figure 1.3) analogous to that near the surface of a 
negatively-polarized electrode; such EDLs have been well-described by Stern who 
combined previous models proposed by Gouy, Chapman, and Helmholtz [2, 35, 36].  The 
layer of the EDL closest to the capillary wall is composed of cations; due to the strong 
ionic attraction between the cations and the negatively charged silanols, an immobile 
layer (also termed the compact, Helmholtz, or Stern layer [36]) is created.  Beyond the 
compact layer, a diffuse layer (also termed Gouy layer) exists [35] where a mostly 
cationic region is found adjacent to the immobile layer and a neutral region is located 
near the center of the capillary.  According to the Stern model, the electrical potential 
decreases linearly in the compact layer and exponentially in the diffuse layer as 
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Figure 1.2.  Schematic of capillary electrophoresis instrument [37]. 
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Figure 1.3.  Interior surface of fused silica capillary [38].
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a function of the distance from the capillary wall [2].  Once a voltage is applied 
longitudinally across the capillary, the cations in the diffuse region of the double layer 
migrate toward the cathode, pulling the bulk solution with them via viscous forces and 
creating the EOF.  Thus, in CE analyses the bulk flow can be increased by working with 
higher pH buffers or practically suppressed by using buffers at a pH below 2.5.  The 
electroosmotic velocity (bulk flow), veo, depends on electroosmotic mobility (µeo) and the 
electric field (E), as shown in the first part of equation 1.1.   
! 
v
eo
= µ
eo
E =
"#
4$%
dl
E        (1.1) 
The electroosmotic mobility can alternatively be expressed in terms of the dielectric 
constant of the buffer (ε), buffer viscosity in the double layer (ηdl), and the zeta potential 
(ζ, the charge on the surface of the capillary), as shown in the second part of equation 
1.1.  Organic modifiers also affect the magnitude of the EOF by altering the buffer 
dielectric constant and viscosity.  In practice, the electroosmotic mobility (µeo) is 
determined using a neutral compound, such as methanol, to mark the passage of the 
solvent front through the detector window and the following equation: 
! 
µeo =
LtotLeff
t
0
V
         (1.2) 
where Ltot is the total length of the capillary (cm), Leff is the capillary length from the inlet 
to the detector window (cm), t0 is the migration time for the EOF marker (s), and V is the 
applied voltage (Volts).  An important factor to consider is the Joule heating, the heat 
created by the electrophoretic movement of ions through neutral solvent molecules.  If 
this heat is not adequately dissipated via the instrument cooling device (typically air or 
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liquid cooling of the capillary), temperature gradients can form in the capillary, which 
increase dispersion and degrade peak efficiency.  In extreme cases, autothermal runaway 
can occur where the buffer solution inside the capillary actually boils, breaking the circuit 
and causing a loss of current.  A general guideline is to maintain a Joule heating level in 
the linear range of an Ohm’s law plot (current versus voltage), whose upper limit is 
typically 1.5 W/m.   
 
Charged analytes can be separated in capillary zone electrophoresis (CZE) based on their 
charge and frictional drag.  Comparatively, HPLC separations rely on an interaction 
between the compound of interest and the column packing (stationary phase).  It is 
important to note that the CZE mode of CE will not separate neutral species because they 
do not contain an ionizable group, and thus will elute as one peak with the EOF.  
Depending on the particular buffers employed and the analytes to be tested, experimental 
conditions for CE can be set up such that bulk flow (EOF) is from anode to cathode 
(termed normal polarity) or cathode to anode (termed reverse polarity), where the main 
difference is the elution order for cations and anions.  In normal polarity, the most highly 
charged, most compact cations will elute first followed by cations with lower charges or 
more frictional drag.  Anions will elute later with the lowest charged, least compact 
anions migrating before the higher charged, more compact ones, see Figures 1.4 and 1.5.  
The opposite is observed in reversed polarity.  The electrophoretic mobility of each 
analyte relates the analyte’s electrophoretic velocity to the applied electric field 
(vep=µepE) and can also be expressed using Stoke’s equation:
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Figure 1.4.  Schematic of the cation and anion movement in capillary electrophoresis 
[39].
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Figure 1.5.  CE separation schematic depicting the influence of charge and frictional drag 
[40].
  
11 
! 
µep =
q
6"#r
         (1.3) 
where q is the charge, η is the solution viscosity, and r is the hydrated radius of the 
analyte.  In practice, a form of equation 1.2, where t0 is replaced with the analyte 
migration time (tR), is used to measure the (net) mobility of an ion, and the 
electrophoretic mobility (µep) is calculated from µnet - µeo. 
 
A fundamental equation that expresses resolution in terms of efficiency and 
electrophoretic mobility for CZE is: 
! 
Rs =
N
4
"µ
µep+ µeo
# 
$ 
% 
% 
% 
& 
' 
( 
( 
( 
        (1.4) 
where Rs is resolution, N is the average efficiency (number of theoretical plates), Δµ is 
the mobility difference between a pair of analytes, 
! 
µep  is the average electrophoretic 
mobility of the analyte pair, and µeo is the electroosmotic mobility or EOF.  In order for 
two compounds to be resolved, they must have unequal electrophoretic mobilities, and as 
this difference increases, resolution improves.  Assuming that the only zone-broadening 
phenomenon is longitudinal diffusion, equation 1.4 can be further delineated with respect 
to efficiency to give: 
! 
Rs =
1
4 2
" 
# 
$ 
% 
& 
' 
(µ
µep + µeo
VLeff
DLtot
      (1.5) 
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where D is the average diffusion coefficient of the analytes.  Thus, further enhancement 
in resolution can be achieved with the application of higher voltages provided, that Joule 
heating is adequately dissipated. 
 
The remaining instrumental parameters/components are the injection method, the 
inlet/outlet buffer vials, the high voltage source, and the detector.  There are two options 
for sample injection that are frequently employed:  hydrodynamic and electrokinetic, 
equivalent to applying pressure or voltage, respectively.  When the sample contains 
analytes with different charges and frictional drags, the latter is not preferred because it 
can introduce a sampling bias.  The inlet and outlet buffer vials are filled with buffer 
solution; care must be taken to achieve identical liquid levels in each to reduce possible 
siphoning effects.  In commercial instrumentation, the maximum voltage that can be 
applied is 30 kV.  Lastly, the detector in standard CE equipment is a variable wavelength 
or diode array UV detector, in which a detector window is created by burning a small 
section of polyimide coating off the capillary.  Alternative methods of detection include 
conductivity, fluorescence, and mass spectrometry. 
 
1.2.2 Electrokinetic Chromatography (EKC) Basics 
As mentioned previously, electrokinetic chromatography (EKC) is a subdiscipline of CE 
in which a pseudostationary phase (PSP) or interaction agent is added to the buffer. There 
are two types of separation mechanisms occurring in this form of CE:  electrophoretic 
and chromatographic.  Neutral compounds can be differentiated by this technique due to 
their association with the buffer additive.  Interaction with the buffer additive is not 
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restricted to uncharged compounds, both charged and uncharged species of interest can 
interact with the PSP.  Thus, analytes spend differing amounts of time associated with the 
selector and in the mobile phase, resulting in a separation.  As is discussed in subsequent 
sections for chiral separations, a wide variety of selectors can be employed to improve 
analyte resolution.  The most commonly used of these are cyclodextrins (CDs) and 
micelles, see Figures 1.6 and 1.7 for respective separation schematics.  Selectors that 
migrate in a direction opposite that of the EOF are considered to be PSPs because their 
movement toward the detector is quite small but will occur provided the EOF is greater 
than the PSP velocity.  In contrast to CZE, where the elution window (time available for 
separation) is essentially infinite, the elution window in EKC is determined by the 
mobility of the selector, see Figure 1.8.  Therefore, in order to effectively separate the 
target compounds, they must elute between the EOF marker and the additive.    
 
1.2.3 Electrokinetic Chromatography Theory 
Equations related to EKC are more complex than those of CZE due to the presence of the 
second separation mechanism (chromatographic).  The fundamental resolution equation 
in EKC contains four factors versus the two needed in CZE (equation 1.4): 
! 
Rs =
N
4
" #1
"
$ 
% 
& 
' 
( 
) 
k
2
1+ kavg
$ 
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& & 
' 
( 
) ) 
1+ µr # t0 / tPSP
1+ µr + t0 / tPSP( )kavg
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% 
& & 
' 
( 
) )     (1.6) 
where N is the efficiency (previously defined), α is the selectivity (ratio of retention 
factors, k2/k1), k2 is the retention factor of the second compound, kavg is the average 
retention factor for the pair of analytes, µr is the analyte relative electrophoretic mobility 
(µep/µeo), tPSP is the migration time of the PSP, and t0 was previously defined.  As  
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Figure 1.6.  Schematic of neutral analyte separation using CDs [41].
  
15 
 
 
 
Figure 1.7.  Schematic of the EKC separation mechanism with micelles [42].
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Figure 1.8.  Depiction of a micellar EKC (MEKC) separation, where µMC, µep,MC, and tMC 
represent the micelle’s net mobility, electrophoretic mobility, and retention time, 
respectively [43].   
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demonstrated by equation 1.6, the impact of efficiency is reduced due to its square root 
dependence but still plays a role in resolution.  The main elements of the last three terms 
of the fundamental resolution equation are selectivity, retention factors, and elution range 
(tPSP/t0), respectively.  Improving selectivity, i.e., increasing the distance between adjacent 
peaks for a given retention factor (kavg), will obviously result in enhanced resolution and 
can be accomplished by adjustment of the PSP identity.  When the compounds being 
analyzed are chiral, the selectivity is termed enantioselectivity (αenant) and provides a 
measure of the PSP’s ability to discriminate between enantiomers.  Retention factors are 
calculated via equation 1.7: 
! 
k =
tR 1+ µep /µeo( ) " t0
t
0
" 1+ µep,PSP /µeo( )tR
       (1.7) 
 
Due to the finite elution window in EKC, an optimal retention factor between 1 and 5 
exists for each analyte and is calculated using equation 1.8 [44, 45]: 
kopt =
tPSP
t
0
1+
µep
µeo
!
"
#
$
%
& =
µeo
µme
1+
µep
µeo
!
"
#
$
%
&      (1.8) 
When retention factors are near the optimal value (kavg/kopt near unity), the resolution 
achieved will approach the maximum obtainable value.  Thus, if analytes experience too 
little or too much retention, resolution will suffer, see Figure 1.9.  Lastly, the elution 
range affects resolution in that small ranges effectively diminish the separation time for 
each compound, reducing migration time differences between compounds and negatively 
impacting resolution.  Larger elution ranges are therefore desired but excessively large 
values will lengthen the analysis time markedly, see Figure 1.10.  EKC resolution  
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Figure 1.9.  Influence of retention factors on resolution [43].  In this simulated MEKC 
example, βrel is the quotient of the nth retention factor (n=1-10) for the given simulation 
and the nth retention factor employed in the reference chromatogram (βrel=1).  Retention 
factors employed in the reference chromatogram:  0.25, 1.25, 2.25, 3.25, 4.25, 5.25, 6.25, 
7.25, and 8.25 for peaks 1 through 9; corresponding to selectivities (α) of 5.00, 1.80, 
1.44, 1.31, 1.24, 1.19, 1.16, and 1.14.  Peak 10 is a marker for tpsp (k=∞).  The elution 
range was estimated to be 4.0.  
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Figure 1.10.  Effect of elution range (tMC/t0) on resolution [43].  The simulated micelle 
mobility and retention time are represented by µep and tMC, respectively. Retention factors 
employed in the simulation for the reference chromatogram are the same as those in 
Figure 1.9.
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optimization can be improved via several parameters, but a fine balance of the four 
factors is required to avoid detrimental effects.  One final measure frequently employed 
in EKC is methylene selectivity (αmeth), which provides a measure of the PSP’s ability to 
distinguish between analytes differing only in the number of methylene groups (CH2).  
Typically, a series of homologs is utilized with data analysis performed by graphing the 
natural log or log of retention factor (ln k or log k) versus carbon number (n), see Figure 
1.11.  The PSP migration time used to calculate homolog retention factors is optimized in 
an iterative fashion and the antilogarithm of the slope of ln k (or log k) vs. n gives αmeth. 
 
1.3 Chiral Separation Mechanisms in EKC 
There are two main approaches to chiral separations, indirect and direct.  Indirect relies 
on derivatization of enantiomers to form diastereomers that can then be separated without 
chiral selectors, and as such does not fall into the separation category of chiral EKC.  The 
direct approach is the strategy employed in EKC where a temporary diastereomeric 
interaction occurs between the enantiomers and the chiral selectand.  The two 
enantiomers can be separated when either their binding constants with the chiral agent or 
the mobilities of their diastereomeric complexes are different.  In cases where one chiral 
selector is unable to provide sufficient enantioresolution, a second chiral agent can be 
added.  Assuming that neither chiral selectand is inert with respect to the chiral analytes, 
the two selectands will either work constructively or destructively to improve or worsen 
the overall resolution.  It is generally recognized that a three-point-interaction must take 
place for chiral discrimination [46].  The nature of these interactions can be electrostatic,  
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Figure 1.11.  Graph of the log of retention factor (log (
! 
k'
~
)) versus carbon number [43].  
The calculation of tPSP is performed iteratively until a convergence is reached, with the 
iteration number represented with the letter i.
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hydrogen bonding, steric hindrance, π-π, ion-dipole, dipole-dipole, dipole-induced 
dipole, or van der Waals (in order of decreasing strength). 
 
Efforts to simplify chiral method development have focused on theoretical model 
development and spectroscopic mechanism elucidation.  Mathematical models for 
optimizing chiral selector conditions with CDs have been developed by Wren and 
Rowe [47-50].  Kafri and Lancet examined chromatographic data and proposed the string 
model for enantiorecognition (SMED) [51].  Their goal was to provide guidelines for 
selection of a chiral agent to reduce the screening process.  NMR is a popular approach 
for defining specific interactions leading to chiral recognition, typically for CD-analyte 
complexes [52, 53] but also for micellar studies [54].   
 
One last aspect to note in chiral CE is the importance of elution order.  Many separation 
methods are quantitative; to improve quantitation, it is beneficial to have a minor peak 
elute prior to the major peak.  This can be accomplished with chiral surfactant aggregates 
by switching to the opposite selector enantiomer, if available.  However, the situation is 
not as straightforward with other types of selectands such as CDs.  A recent review by 
Chankvetadze discussed this special consideration [55]. 
 
1.4 Complex Forming Selectors 
A wide variety of chiral selectors that do not form aggregate structures have been 
employed for the difficult task of enantioseparation.  In general, these types of selectands 
form complexes with the analytes.  A separation is obtained when the binding affinity for 
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one enantiomer is higher than the other or when the complexes have different mobilities.  
The literature is dominated by cyclodextrin (CD) usage, see [56-58] for recent reviews.  
In many cases, CDs are combined with other PSPs to either produce or improve 
resolution. 
 
1.4.1 Charged Cyclodextrins 
Native cyclodextrins, which are neutral, are available in three “flavors” that differ in 
cavity size: α, β, and γ, having 6, 7, and 8 glucopyranose units, respectively.  Their UV 
transparency is one characteristic of CDs that has popularized their use.  In order to 
enhance solubility and alter selectivity, many derivatized CD forms have been 
synthesized, creating a wide variety of neutral and charged options.  The utilization of 
such charged CDs for pharmaceutical enantiomeric separations was reviewed by de Boer 
et al. in 2000 [59].  A distinction in the literature has been made in which separations 
obtained using neutral and charged CDs are classified as CD-CZE and CD-EKC, 
respectively [60].   
 
In the preparation of modified CDs, the nature and size of the derivatizing group have a 
dramatic impact on selectivity: large groups can make access to the cavity more difficult 
and charged groups add an opportunity for electrostatic interactions.  An important aspect 
of charged CD use is that the BGE ionic strength increases with addition of this chiral 
selector, thereby increasing Joule heating.  In some instances, problems can arise from 
inclusion of BGE additives in the CD cavity, which decreases enantioselectivity.  One 
approach to fine-tuning chiral selectivity has been the simultaneous use of neutral and 
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charged CDs.  Fillet et al. reviewed this literature in 2000 [61].  The mechanism of chiral 
recognition with CDs has been studied using NMR, indicating that a host-guest complex 
is typically formed via interactions within the CD cavity and with the outer rim.  
 
1.4.1.1 Anionic Cyclodextrins 
 Negatively charged CDs have been produced using either carboxyalkyl- or sulfur-
containing groups.  Derivatives containing a sulfated group are permanently charged, 
whereas the ionization of carboxyalkyl-CDs varies with pH.  More recently, single 
isomer CDs have experienced increased interest due to reductions in batch-to-batch 
variability.  Chiral separations that have been performed with anionic CDs during the 
specified review period are listed in Table 1.1.  The bulk of the literature contains method 
optimization steps focusing on buffer identity, buffer pH, buffer concentration, CD 
identity, CD concentration, applied voltage, and/or temperature.  In many cases, a wide 
spectrum of selectors was screened with anionic CDs outperforming neutral CDs because 
of the former’s countermigration property and ability to electrostatically interact with 
positive enantiomers.  One exception was the negatively charged enantiomers of 
etodolac, where a series of eight neutral CDs and five anionic CDs were studied with 
only HP-β-CD and γ-CD showing promise [62].  A method was subsequently optimized 
and validated with HP-β-CD. 
 
1.4.1.2    Cationic Cyclodextrins 
In dramatic contrast to the plethora of CD publications with anionic selectors, cationic 
CDs have yet to be frequently utilized, as demonstrated by Table 1.2.  Typically, some 
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Table 1.1.  Chiral EKC applications utilizing anionic cyclodextrinsa).  
 
 
 
Cyclodextrin(s) Sample Other CDs Screened and/or 
Comments 
Reference 
CDsuc6 Catecholamines Novel anionic CD [63] 
Carboxyethyl-CDs 
CE-β-CD Pheniramine Native CDs, S-β-CD, and IMA-β-
CD also evaluated 
[64] 
CE-β-CD Antihistiminic 
pharmaceuticals 
Coupled CITP-CE [65] 
Carboxymethyl-CDs 
CM-β-CD Glucopyranosyl-based 
enantiomers 
β-CD and HP-β-CD also tested  [66] 
 
CM-β-CD and 
HP-γ-CD 
4 isomers of a 
benzoaxathiepin 
derivative 
Dual-CD system 
HP-β-CD, S-β-CD, and DM-β-
CD also examined 
[67] 
 
CM-γ-CD Citalopram β-CD, γ-CD, M-β-CD, DM-β-
CD, HP-β-CD, bile salts, and 
SDS were screened 
[68] 
 
CM-β-CD Basic pharmaceuticals General chiral method 
development strategy with 10 
CDs (neutral and charged) 
[69]  
CM-β-CD  8 Chiral pesticides CM-γ-CD, S-β-CD, and Succ-β-
CD also tested 
[70]  
CM-β-CD and 
α-CD 
3-(4-
Methylbenzylidene)-
camphor 
Dual-CD system 
 
[71]  
CM-β-CD, HP-
β-CD, DM-β-
CD, and HS-β-
CD 
Basic and neutral 
enantiomers, including 
three aminoalcohols 
Temperature study  [72] 
 
CM-γ-CD Citalopram and 
metabolites 
Entangled polymer solution also 
used 
Several selectors employed in 
preliminary studies 
[73] 
 
CM-β-CD Thalidomide Unified equation development for 
reaction mechanism and rate 
information 
[74] 
 
CM-β-CD Bevantolol 
enantiomers 
HPLC method also developed [75] 
Highly Sulfated CDs 
HS-β-CD, S-β-
CD, and HpS-β-
CD 
Five pharmaceutical 
enantiomers 
Different types of sulfated CDs 
used.  Compared to HPLC 
method 
[76] 
 
HS-γ-CD Moxifloxacin 
hydrochloride 
 [77] 
 
HS-γ-CD Butorphanol tartrate 
and cycloamine 
enantiomers 
α-CD, β-CD, and γ-CD tested [78] 
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Table 1.1 (continued) 
 
 
Cyclodextrin(s) Sample Other CDs Screened and/or 
Comments 
Reference 
HS-α-CD and/or 
HS-β-CD 
γ-amino butyric acid, 
baclofen, phaclofen, 
saclofen, and 
hydroxysaclofen 
HS-γ-CD also screened [79] 
 
HS-α-CD, HS-β-
CD, and HS-γ-
CD 
Benzothiazolinone and 
benzoxazolinone 
derivatives 
Chiral recognition described [80] 
 
HS-β-CD Ketamine and 
norketamine 
enantiomers 
Equine plasma analysis [81] 
 
HS-β-CD Baclofen enantiomers LIF detection 
HS-α-CD and HS-γ-CD also 
evaluated 
[82] 
 
HS-γ-CD Amphetamine and 
related compounds 
Analysis time reduction study [83] 
 
HS-γ-CD Tramadol enantiomers HS-α-CD and HS-β-CD also 
provided resolution 
[84] 
 
HS-β-CD Phenylalanine 
enantiomers and 
synthesis byproducts 
HS-α-CD and HS-γ-CD also 
screened 
[85] 
 
HS-γ-CD Amphetamine 
derivatives, 
methadone, and 
tramadol 
CE-MS [86] 
 
HS-γ-CD Methamphetamine 
derivatives, 
precursors, and 
impurities 
 [87] 
 
HS-γ-CD Tolterodine and two 
developmental basic 
pharmaceuticals 
γ-CD, HP-γ-CD, S-β-CD, HpS-β-
CD, HS-α-CD, HS-β-CD, 
HDAS-β-CD, and HDMS-β-CD 
also screened 
[88] 
HS-β-CD Sumanirole Original CE method used neutral 
CD, but was replaced with HS-β-
CD 
[89] 
HS-β-CD Rivastigmine  [90] 
HS-α-CD, HS-β-
CD, and HS-γ-
CD 
Propranolol, atenolol, 
chlorpheniramine, 
tryptophan 
CD choice varied with analyte 
identity 
[91] 
 
HS-β-CD Cis and Trans 
Nucleosides 
HPLC method gave better 
performance 
HS-α-CD and HS-γ-CD also 
evaluated 
[92] 
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Table 1.1 (continued) 
 
 
 
Cyclodextrin(s) Sample Other CDs Screened and/or 
Comments 
Reference 
Sulfated CDs 
S-β-CD and α-
CD 
Substituted 2,3-
dihydro[1,4]dioxinol[2
,3-b]pyridine 
derivatives and 
intermediates 
Dual-CD system [93] 
S-β-CD and HP-
β-CD 
Ephedrine and 
pseudoephedrine 
enantiomers 
Dual-CD system 
Methods with HP-β-CD and DM-
β-CD also described 
[94] 
 
S-β-CD Aziridine α-CD, β-CD, γ-CD, HDMS-β-
CD, and DM-β-CD also 
examined 
[95] 
 
S-β-CD Cetirizine α-CD, β-CD, HP-β-CD, CE-β-
CD, 1MA-β-CD also screened 
[96] 
 
S-β-CD Tamsulosin 
hydrochloride 
β-CD, CM-β-CD, DM-β-CD, and 
HP-β-CD also tested 
[97] 
 
S-β-CD Tamsulosin 
hydrochloride 
α-CD, β-CD, γ-CD, DM-β-CD, 
HP-β-CD, and CM-β-CD also 
tested 
[98] 
 
S-β-CD Basic pharmaceuticals 50 analytes examined [99] 
S-β-CD and/or 
HP-β-CD, β-CD, 
or γ-CD 
Five Phenothiazines Single and Dual-CD [100] 
 
SI-S-β-CD and 
β-CD 
Hydrobenzoin and 
related enantiomers 
Dual-CD system with single 
isomer anionic CD 
Randomly substituted S-β-CD 
also analyzed 
[101] 
 
S-β-CD Biperiden β-CD, γ-CD, CM-β-CD, and 
sulfobutyl-β-CD also tested 
[102] 
 
S-β-CD and HP-
β-CD 
Hydroxychloroquine 
and metabolites 
Dual-CD 
DM-β-CD, TM-β-CD, CM-β-CD, 
and maltodextrin also examined 
[103] 
 
S-β-CD Phenyloxirane and 
phenylethanediol 
Focus on microbiological process [104] 
 
S-β-CD Propafenone and 
metabolites 
Method development and 
application 
[105, 106] 
 
S-β-CD β-aminoketones HPLC method developed as well 
α-CD, β-CD, γ-CD, M-β-CD, 
DM-β-CD, TM-β-CD also tested 
[107] 
 
S-β-CD Verapamil and 
norverapamil 
β-CD, γ-CD, HP-β-CD, M-β-CD, 
sulfobutylether-β-CD, CE-β-CD, 
HS-α-CD, HS-β-CD, and sodium 
deoxycholate micelles also 
screened 
[108] 
 
S-β-CD Catecholamines and 
related enantiomers 
Randomly and singly sulfated 
CDs were used 
[109] 
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Table 1.1 (continued) 
 
 
 
Cyclodextrin(s) Sample Other CDs Screened and/or 
Comments 
Reference 
S-β-CD and α-
CD 
Etomidate and related 
enantiomers 
Dual-CD system 
 
β-CD and HP-β-CD also tested 
[110] 
S-β-CD Epinephrine, 
isoproterenol, 
octopamine, and 
norephedrine 
Temperature study [111] 
S-β-CD Disopyramide Electrochemiluminescence 
detection 
[112] 
Sulfur Containing CDs 
DAS-β-CD Methamphetamine and 
Ephedrine derivatives 
CE-MS 
Native and DM-β-CD, S-β-CD, 
and DMS-β-CD also tested 
[113, 114] 
 
HMAS-β-CD Basic pharmaceuticals Single isomer CD 
Aqueous and nonaqueous BGEs 
[115] 
 
HMS-β-CD Basic pharmaceuticals Single isomer CD 
Aqueous and nonaqueous BGEs 
[116] 
 
Sulfonated-β-CD Arylalcohols Dual-chiral system with silver 
colloid 
[117] 
Sulfato-β-CD, 
CM-γ-CD, 
methyl-β-CD, 
and HP-γ-CD  
Flavanones and 
Flavanone-7-O-
glyclosides 
Several neutral and anionic CDs 
screened in addition to chiral 
micelles 
[118] 
HDAS-β-CD  Cetirizine CM-β-CD, HDMS- β-CD, HP-β-
CD, and TM-β-CD also evaluated 
[119] 
 
HpS-β-CD Atomoxetine 
enantiomers, 
positional isomers, and 
impurities 
Chiral HPLC analysis was main 
focus 
[120] 
 
SB-β-CD Frovatriptan β-CD, DM-β-CD, TM-β-CD, and 
HP-β-CD also tested 
[121] 
 
HpS-β-CD N-(3R)-1-
azabicyclo[2.2.2]oct-
3-ylfuro[2,3-
c]pyridine-5-
carboxamide 
Native β-CD, HP-β-CD, DM-β-
CD, TM-β-CD, S-β-CD, HDMS-
β-CD, HDAS-β-CD, and HS-CDs 
were also screened 
[122] 
 
 
a) Publications for the period of January 2005 through November 2006. 
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Table 1.2.  Chiral EKC applications utilizing cationic cyclodextrins published 
between January 2005 and November 2006. 
 
 
 
Cyclodextrin(s) Sample Comments Reference 
Imidazolium, pyridinium, 
and quaternary ammonium 
substituted β-CDs 
Aromatic carboxylic 
acids 
Novel cationic CDs  [123] 
BuAM-β-CD Hydroxy acids, 
carboxylic acids, and 
amphoteric compounds 
Novel single isomer 
cationic CD 
[124] 
ALAM-CD Dansyl amino acids Novel single isomer 
cationic CD 
[125] 
6-
mono(alkylimidazolium)-
β-CDs 
Dansyl amino acids 8 single isomer cationic 
CDs 
[126] 
PeAM-β-CD Anionic and ampholytic 
acids 
Novel single isomer 
cationic CD 
[127] 
β-CD-NH3Cl Anionic and ampholytic 
acids 
Novel single isomer 
cationic CD and a 
modified synthesis of CD 
precursor 
[128] 
β-CD-NH2 Hydroxy acids, 
carboxylic acids, and 
amino acids 
Application of existing 
CD 
[129] 
PrAM-β-CD Hydroxy acids, 
carboxylic acids, and 
amphoteric compounds 
Novel single isomer 
cationic CD 
[130] 
QA-β-CD 2 dianionic enantiomers Chiral recognition study 
utilizing NMR 
[131] 
HPTMA-β-CD Arylpropionic acids, 
racemic mandelic acid, 
and 3-phenyllactic acid 
Synthesis of highly 
charged CD.  Results 
compared to QA-β-CD 
[132] 
GTA-β-CD Acidic pharmaceuticals Low degree of 
substitution 
[133] 
6-MA-β-CD Clofibric acid 
derivatives 
Chiral analysis with TM-
β-CD, vancomycin, and 
nano-LC also 
demonstrated 
[134] 
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sort of amine functionality is attached to the cyclodextrin during derivatization to impart 
the positive charge.  During the last two years, single isomer cationic selectands were the 
most widely employed.  An important caveat for cationic CDs is that like all positively 
charged species they can electrostatically interact with (adsorb onto) the negatively 
charged walls of silica capillaries, thereby reducing or even reversing the EOF; such CD-
wall interactions should be carefully monitored and controlled.   
 
1.4.1.3   CD-Modified EKC 
In order to improve enantioresolution, cyclodextrins have often been employed in 
conjunction with another chiral selector.  As previously described, the identity and 
concentration ratio of the chiral agents must be examined in order to improve rather than 
degrade enantioselectivity.  Several reports discussed utilizing the combination of a 
neutral CD with another chiral selector.  These are listed in Table 1.3 but not described in 
detail.  Another option when combining a CD with another PSP is to use either a charged 
or neutral CD with a non-chiral PSP, such as SDS micelles.  Numerous papers have 
demonstrated these types of chiral separations, however, they are beyond the scope of 
this introduction. 
 
1.4.2 Crown Ethers 
Crown ethers represent another class of chiral selectors that form inclusion complexes 
with chiral analytes (see [135] for a recent review).  In particular, they are capable of 
resolving enantiomers containing a primary amino group.  The mechanism of recognition 
is hydrogen bonding between oxygens on the planar chiral agent and the hydrogens of the 
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Table 1.3.  Chiral EKC applications using neutral cyclodextrins in combination with 
other chiral selectors published between January 2005 and November 2006. 
 
 
 
Charged Chiral 
Selector 
Neutral 
CD(s) 
Analytes Comments Reference 
DDCV 
Microemulsion 
HP-β-CD  Pseudoephedrine, 
ephedrine, 
methylephedrine, 
metoprolol, indapamide, 
synephrine, octopamine, 
propranolol, and 
chlorpheniramine. 
S-β-CD also 
used 
[136] 
Chiral Crown 
Ether, 18C6H4 
HP-β-CD Amino acids and 
derivatives 
 [137] 
Sodium 
Deoxycholate 
Micelles 
β-CD Serine enantiomers Neural samples [138] 
Chiral Crown 
Ether, 18C6H4 
DM-β-CD 1-phenylethylamine and 
1-cyclohexylethylamine 
Conductivity 
detection 
[139] 
Sodium Cholate 
Micelles 
Native, 
methyl, 
and HP-
CDs 
Flavanones SDS micelles 
with neutral 
CDs also 
reported 
[118] 
Sodium 
Taurodeoxycholate 
Micelles 
β-CD Derivatized amino acids Resolution 
improvement 
due mainly to 
EOF effects 
[140] 
Chiral Crown 
Ether, 18C6H4 
DM-β-CD Small amines Contactless 
conductivity 
detection 
[141] 
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amine group of the analyte [135].  The planar geometry of the selectand allows the 
formation of two diastereomeric complexes based on interactions with the faces of the 
crown ether that have different binding constants [137].  (+)-18-crown-6-tetracarbonic 
acid (18C6H4) is the main chiral crown ether employed in chiral EKC analyses.  During 
the past two years, several reports have been published on the use of 18C6H4 by itself 
[137, 142, 143] and in conjunction with CDs [137, 141].  A novel crown ether, (S,S)-1,7-
bis(4-phenyl-5-hydroxy-2-oxo-3-zapentyl)-1,7-diaza-12-crown-4, was synthesized by 
Wang et al. [144].  
 
1.4.3 Glycopeptide Antibiotics 
Glycopeptides, employed medicinally as antibiotics, were first utilized by Armstrong as a 
chiral stationary phase substituent for HPLC.  The complex nature of these selectors has 
precluded the exact determination of the chiral recognition mechanism.  Specifically, the 
large number of chiral centers (over 18 for vancomycin) makes it difficult to pinpoint the 
location of chiral interactions.  Another complicating factor is the presence of several 
ionizable groups.  Therefore, pH has a major influence on enantiorecognition.  The three 
most common examples of antibiotic chiral agents are vancomycin, ristocetin, and 
teicoplanin.  In chiral EKC, partial filling of the capillary is typically performed with 
these selectors to avoid interference with detection.  The use of macrocyclic 
glycopeptides as chiral selectors has been reviewed by Ward and Farris [145].  Several 
articles were recently published on chiral separations with these chiral agents: [134, 146-
148]. 
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1.4.4 Ligand Exchange 
The basic principle of ligand exchange chiral separations is the formation of a complex 
with a transition metal, typically copper (II), a chiral selector, and the chiral analytes.  
Only enantiomers containing two polar groups can be resolved using ligand exchange 
motifs.  This technique was recently reviewed by Schmid and Gübitz [149].  A simple 
confirmation of the ligand exchange mechanism is the observation of a complete loss of 
resolution when the transition metal ion is removed; this confirmation was performed 
twice in recent reports [150, 151].  A few examples of chiral ligand exchange were 
published in 2005 and 2006 [150-157]. 
  
1.5 Surfactant Based Chiral Selectors 
Chiral selectors formed from chiral surfactants can be divided into three main groups:  
micelles, vesicles, and microemulsions, with the simplest being micelles.  In general, the 
resolution of neutral as well as charged analytes can be achieved with surfactant-based 
PSPs, where differential partitioning into the aggregate results in separation.  The 
enantiomeric separations described in this section are restricted to those achieved solely 
with chiral surfactant systems and are more detailed due to their relevance to the field of 
study discussed in subsequent chapters.  
 
1.5.1 Micelles 
In MEKC, a surfactant (anionic, cationic, or zwitterionic) above its critical micelle 
concentration (CMC, minimum concentration required for the formation of micelles) is 
utilized as a pseudostationary phase (PSP).  Selectivity can be modified by changing 
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surfactant concentration and/or identity; buffer concentration, identity and/or pH; and 
additive content (including organic solvent).  Typically, in chiral MEKC, the chiral 
portion of the surfactant is located close to the surfactant polar head group, i.e., near the 
outer rim of the PSP.  Thus, chiral recognition takes place in the outer portion of the 
micelle.  Bile salts, such as sodium cholate, were among the first chiral surfactants used 
in MEKC [158].  Glycosidic surfactants have also been employed as chiral selectors 
[159].  In addition, synthetic chiral surfactants have been created, many of which are 
derivatized with amino acid functionalities.   
 
More recently, micelle polymers have appeared in the literature for enantiomeric 
separations [160, 161].  In contrast to conventional micelles, micelle polymers are formed 
via covalent bonds and do not have a CMC.  Thus, they are more rigid and remain 
structurally stable in the presence of high concentrations of organic solvents, which also 
facilitates the adjustment and control of their concentration. 
 
A large variety of enantiomeric separations have been published in the field of MEKC, 
with some utilizing multiple chiral selectors.  This section covers chiral MEKC analyses 
where only a chiral micelle was employed.  One such application used chiral bile salt 
micelles (sodium taurocholate) for the resolution of metyrosine enantiomers [162].  BGE 
composition was optimized for surfactant concentration, pH, buffer identity, buffer 
concentration, applied voltage, and temperature.  The method that was developed 
reproducibly separated metyrosine with a resolution of 2.1 and a limit of detection of 1.0 
µg/mL.  Enantiomers of a diethyleneglycol diester benzoporphyrin derivative were 
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successfully separated using sodium cholate micelles in a borate buffer with 30% 
acetonitrile (to prevent analyte aggregation) [163].  Better resolution was obtained when 
the surfactant concentration was increased to 150 mM; still higher concentrations had a 
negative effect on the separation and caused precipitation.  Subsequently in the literature, 
sodium cholate micelles were shown to effectively separate the flavanone-7-O-glycoside 
epimers of neohesperidin and naringin [118].  The chromatographic data were used to 
simulate the epimer interconversion process.  Another application where the selector was 
sodium cholate micelles involved the analysis of palonosetron hydrochloride 
stereoisomers by Tian et al. [164].  The electrolyte solution was optimized with respect to 
organic modifier, pH, selector concentration, and buffer concentration.  
 
The use of chiral polymeric micelles as chiral selectors in MEKC-ESI-MS, the second 
such study, was published in 2005 by Akbay et al. [165].  Poly(sodium N-
undecenoxycarbonyl-L-leucinate) (poly-L-SUCL) was synthesized and employed for the 
concurrent testing of eight β-blockers.  Optimization was performed for both separation 
and detection conditions.  In terms of the MEKC system, an ammonium acetate buffer 
with triethylamine (TEA) was required for mass spectrometry compatibility.  During the 
optimization of surfactant concentration, it was observed that as the surfactant 
concentration was increased, the resolution of hydrophilic β-blockers increased, whereas 
the resolution of the hydrophobic β-blockers decreased.  Although seemingly 
contradictory, both results are most likely due to the well-known trend of increasing 
retention factor with increasing surfactant concentration; in the case of the hydrophilic 
compounds, their initially small retention factors increased to more optimal values, 
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whereas in the case of the hydrophobic compounds their already large retention factors 
increased to still less optimal values.  A comparison was performed between L-SUCL 
and poly-L-SUCL, with the polymeric micelle providing larger signal-to-noise ratio, 
better enantioresolution, higher efficiencies, and a different elution order for each pair of 
enantiomers.   
 
Shamsi’s group conducted another set of experiments using micelle polymers with a 
focus on alkyl chain length and degree of polymerization; the analytes were again β-
blocker enantiomers [166].  Chiral surfactants with chain lengths of 8, 9, 10, and 11 (C11 
monomers with a terminal double bond and a terminal triple bond) were polymerized to 
form micelles.  Characterization of the aggregates demonstrated an increase in CMC with 
decreasing chain length and increase in degree of unsaturation.  The most hydrophobic 
analytes were best separated with shorter chain surfactants at lower concentrations.  In 
general, the micelle polymer formed from the monomer with a terminal triple bond 
provided higher efficiency than its double-bond-terminated analog.  Efficiencies with a 
constant micellar concentration decreased with increasing chain length; the C11 triple 
bond terminated surfactant was an exception to this trend, giving better efficiency than 
the C10 surfactant.  Seven pairs of enantiomers were successfully discriminated in this 
study, with the shortest chain surfactant performing the best.  Molecular micelles 
containing polymerized amino acid-based surfactants were examined for the separation of 
seven pairs of enantiomers (norlaudanosoline, laudanosoline, laudanosine, 
chlorthalidone, and three benzoin derivatives) [167].  A total of 18 different PSPs were 
tested including dipeptide surfactants with a single chiral center (6 variants) or a double 
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chiral center (9 variants) and single amino acid surfactants with a single chiral center (3 
variants).  The compound set was divided into two groups based on steric hindrance.  The 
aspects investigated included surfactant head group impact (single vs. dipeptide), 
dipeptide amino acid order effect, chiral selector head group steric effects, and the role of 
selectand chiral center location.  The results indicated that enantioselectivity could be 
improved with the usage of dipeptide-containing PSPs.  In terms of analyte structure, 
more sterically hindered compounds were better separated with less sterically hindered 
micelle polymers and vice versa.  Another study on MEKC-ESI-MS was conducted using 
micelle polymers for the enantioresolution of oxazepam, lorazepam, and nefopam 
enantiomers [168].  Six different molecular micelles were screened (three each of 
carbamate-type and amide-type) with poly(sodium N-undecenoyl-L-leucinate) (poly-L-
SUL) providing some enantioselectivity for analytes.  The effect of organic modifier was 
studied using poly-L-SUL and indicated some improvement with the addition of 
acetonitrile, however, baseline resolution was still not obtained for all enantiomers.  
Therefore, further method development was performed using the dipeptide polymeric 
micelle (poly(sodium N-undecenoxycarbonyl-L,L-leucyl-valinate) (poly-L,L-SUCLV)).  
Optimization of electrolyte and instrumental parameters led to sufficiently resolved 
peaks.  An interesting observation was that MS signal intensities were PSP-dependent as 
well as analyte-dependent. 
 
The first use of chiral ionic liquids in MEKC was reported by Rizvi and Shamsi in 2006 
[169].  The synthesis and characteristics of two chiral ionic liquids, undecenoxycarbonyl-
L-leucinol bromide (L-UCLB) and undecenoxycarbonyl-L-pyrrolidinol bromide (L-
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UCPB), were described.  The resulting cationic chiral selectors were employed for the 
separation of acidic enantiomers (including phenoxypropionic acid and α-
bromophenylacetic acid) with conventional and polymeric micelles.  The flexibility 
difference between the two surfactants led to enhanced resolution for certain 
selectand/analyte combinations.  Analysis of α-bromophenylacetic acid was better with 
L-UCPB and monomeric micelles; micelle polymers resulted in reduced resolution. 
Phenoxypropionic acid enantiomers were better resolved with L-UCLB and did not 
change significantly when micelle polymers were used instead of monomeric micelles.  
Lastly, a comparison was performed between polymeric anionic chiral surfactants of 
polysodium N-undecenoxycarbonyl-L-leucine sulfate (poly-L-SUCLS) and polysodium 
N-undecenoxycarbonyl-L-leucinate (poly-L-SUCL) and the two new cationic surfactants 
(L-UCLB and L-UCPB).  Only slight resolution (Rs of 0.62) could be achieved with 
poly-L-SUCLS or poly-L-SUCL due to charge repulsion between the anionic selector 
and the negative analytes. 
 
1.5.2 Vesicles 
Vesicles are slightly more complex, larger in size, and more rigid than micelles.  A 
drawback to using this PSP is that the larger size can lower detection limits because of 
increased light scattering.  One of the advantages is that larger elution ranges can be 
obtained due to the typically higher charge density of vesicles.  These aggregates are 
formed by either combining oppositely charged surfactants in an appropriate ratio or by 
using double-tailed surfactants.  A bilayer surfactant structure is formed that envelops a 
water core, and the resulting solution typically has a bluish hue.  Among the surfactant- 
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based PSPs, vesicles have received less attention with a total of just four publications 
detailing chiral separations.  There have been two papers on chiral vesicle EKC for the 
2005-2006 time period. 
 
Mohanty and Dey reported a chiral vesicle composed of sodium N-(4-n-
dodecyloxybenzoyl)-L-valinate (SDLV) for the atropisomeric/enantiomeric separation of 
1,1’-bi-2-naphthol (BOH), 1,1’-binaphthyl-2,2’-diamine (BDA), 1,1’-binaphthyl-2,2’-
diylhydrogenphosphate (BNP), benzoin (BZN), and Tröger’s base (TB) [170].  The 
buffer concentration and pH were optimized to improve resolution and efficiency with 
the best conditions varying slightly from analyte to analyte.  The best separation of BZN 
enantiomers (Rs = 1.61) was found with 4 mM SDLV in 60 mM borate buffer at a pH of 
10.3.  The final chiral compound in this study, TB, could not be baseline resolved even 
under optimized conditions (Rs = 1.06).  The authors state that the resolutions achieved 
with SDLV vesicles were higher than those obtained with other chiral monomeric 
surfactant systems.   
 
In 2006, Mohanty and Dey studied sodium N-(4-n-dodecyloxybenzoyl)-L-leucinate 
(SDLL) and sodium N-(4-n-dodecyloxybenzoyl)-L-isoleucinate (SDLIL) chiral vesicles, 
using the same analytes as noted above, with more focus on chiral recognition 
mechanisms [171].  The researchers optimized the buffer concentration and pH with the 
best separations obtained under conditions identical to their previous study with SDLV.  
Surfactant concentration variations changed the resolution but not the selectivity for the 
different analytes.  Enantioselectivities with SDLL, SDLIL, and SDLV were compared in 
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order to gain insight into the chiral discrimination process.  For the systems evaluated, 
hydrophobic-type interactions did not contribute significantly to chiral selectivity; steric 
hindrance near the chiral center of the surfactant, however, played a large role in 
enantiomer differentiation.  If the surfactant head group is chiral and bulky, analytes 
cannot access the PSP interior, leading to increased association with the chiral center and 
improved enantioselectivity.  Although the data support this conclusion for SDLL, 
SDLIL, and SDLV vesicles, the authors noted that contradictory results exist for BNP 
separations in the literature for other types of chiral systems.  They hypothesized that the 
nature of the chiral selector (vesicle versus polymer micelles, for example) was 
responsible for this discrepancy, although the overall recognition mechanism was 
believed to be similar.  Lastly, the presence of two chiral centers in SDLIL had a negative 
impact on the resolution of BOH and BZN stereoisomers.   
  
1.5.3 Microemulsions 
Microemulsions have been utilized in EKC since 1991.  They are more complex than 
other surfactant aggregates, typically being comprised of three components—a surfactant, 
a cosurfactant, and an oil—that must be combined in a suitable ratio to achieve an 
optically transparent, thermodynamically stable nanodroplet (~ 1 to 5 nm), see Figures 
1.12 and 1.13.  Microemulsions can sometimes be formulated without cosurfactant, but 
their use is infrequent since they are generally less stable.  In comparison to the other 
surfactant PSPs, microemulsions are less rigid, can solubilize more hydrophobic 
compounds, have a more tunable elution range (migration window), and offer a wider 
variety of parameters to optimize.
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Figure 1.12.  General representation of a microemulsion droplet.  The structure consists 
of an oil core surrounded by surfactant monomers.  Cosurfactant molecules are 
interdispersed between the surfactant molecules to further reduce interfacial tension.
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Figure 1.13.  Diagram of an achiral microemulsion containing SDS as the surfactant, 1-
butanol as the cosurfactant, and octane as the oil [172].  The white circles represent water 
molecules.  Free surfactant molecules are also present in the bulk solution but are not 
shown.
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The field of chiral MEEKC (where the only chiral selector(s) is one or more components 
of the microemulsion) has been minimally researched with just twelve publications 
appearing in peer-reviewed journals (Table 1.4).  Three recent reviews on MEEKC have 
included chiral applications [173-175].  The first separation via chiral MEEKC was 
reported by Aiken and Huie et al. in 1993 and utilized a chiral oil, (2R, 3R)-di-n-butyl 
tartrate, in conjunction with an achiral surfactant (SDS) and achiral cosurfactant (1-
butanol) [176] to achieve a selectivity of 2.6 for the enantiomers of ephedrine.  It was 
also shown that the presence of 1-butanol (the cosurfactant) was essential:  no 
enantioseparation could be achieved when it was omitted.  The second chiral MEEKC 
separation was reported by Pascoe and Foley in 2002 and utilized a microemulsion based 
on a chiral surfactant (dodecoxycarbonylvaline, DDCV), an achiral cosurfactant (1-
butanol), and an achiral low-interfacial-tension oil (ethyl acetate) [177].  Nine pairs of 
pharmaceutical enantiomers were tested with this chiral surfactant-based PSP and results 
were compared to those from MEKC using the same chiral surfactant.  One main 
difference between the techniques was the approximately 2.5-fold greater elution range 
observed for MEEKC.  Enantioselectivities were slightly greater with MEEKC than 
MEKC while efficiencies were lower and resolution remained essentially unchanged. The 
underlying cause for the lower efficiency of the MEEKC system was later determined to 
be buffer related [178].  The main advantage to using a microemulsion over a micelle was 
shown to be the 3-fold reduction in analysis time, as exemplified by the simultaneous 
separation of ephedrine and methylpseudoephedrine enantiomers in less than 4 minutes.   
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Table 1.4.  Chiral microemulsion formulations published to date. 
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*Denotes chiral selector
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Two subsequent publications of chiral microemulsion EKC also used the chiral surfactant 
DDCV.  One study examined the impact of oil identity and concentration [179].  Three 
low-interfacial-tension oils of methyl formate, methyl acetate, and methyl propionate 
were used in microemulsion formulations and were compared to the original ethyl acetate 
system using both equimolar (51 mM) and equal v/v% (0.5%) concentrations for the 
separation of 14 pharmaceutical compounds.  The aggregates prepared with methyl 
formate were not stable, reverting back to the individual components after one week.  
Ethyl acetate performed better than the other oils (compared at constant v/v%) in terms of 
elution range, enantioselectivity, and number of pairs of baseline-resolved enantiomers.  
Efficiency did not vary significantly with the changes in oil identity.  The results 
indicated that the identity of the achiral oil had an impact on the quality of 
enantioseparation, and that the ethyl acetate system was the best overall.  The next 
published experiments focused on the combination of derivatized cyclodextrins (HP-β-
CD, S-β-CD, and HS-β-CD) with both DDCV and SDS microemulsions [136].  The 
efficiencies observed with the CD-DDCV microemulsion systems were evaluated with 
respect to three buffers: ACES, Tris, and phosphate.  ACES exhibited excessive UV 
absorbance at the desired wavelengths and was excluded from further study; although 
acceptable baselines and efficiencies could be obtained for a few compounds using Tris, 
phosphate provided better results for all compounds. 
  
Next to appear was the first report on chiral polymeric MEEKC [180].  The 
microemulsion was prepared using a polymeric chiral surfactant (poly-D-SUV), 1-
butanol as the cosurfactant, and n-heptane as the oil.  Barbiturate, binaphthyl, and 
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paveroline enantiomers were analyzed.  Interestingly, chiral separations were obtained for 
BNP in the absence of oil but not in the absence of cosurfactant.  It was suggested that 
hydrogen bonding interactions between the analyte and PSP were enhanced by 1-butanol, 
allowing enantioresolution.  This effect was analyte dependent, with differing trends for 
other binaphthyl derivatives (BOH and BNA).  Optimization of surfactant, cosurfactant, 
and oil concentrations was performed for the various types of enantiomers.  Increasing 
the concentration of cosurfactant led to varying effects on the chiral resolution for anionic 
and neutral vs. cationic enantiomers.  Results were compared with MEKC and solvent-
modified MEKC conditions.  Larger efficiency and resolution were obtained with the 
MEEKC system for barbiturates.  
 
The chiral surfactant DDCV was employed in chiral MEEKC in six additional 
publications.  One study focused on the impact of surfactant concentration and buffer 
identity [178].  As previously described, the identity of the buffer was found to have a 
major impact on the quality of separations.  Subsequent to these initial observations, 
improvements in system stability were found when phosphate was used instead of ACES.  
In addition, with phosphate buffer a larger increase in efficiency was achieved as the 
percentage of DDCV was increased.  Overall resolution increased as the surfactant 
concentration was increased as a result of more optimal retention factors.  A system 
containing four times as much microemulsion (4% w/v DDCV, 4.8% v/v 1-butanol, and 
2.0% v/v ethyl acetate) was also tested and resulted in a decreased elution range.  
Although analyte efficiency was better than that with 4% DDCV, reduced resolutions and 
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noisy baselines were observed.  The importance of surfactant concentration optimization 
in chiral MEEKC was demonstrated.    
 
DDCV-based microemulsions were next used in a temperature study [182].  Nine pairs of 
chiral enantiomers were used to determine the effect of temperature on enantioselectivity 
and resolution as well as to conduct a van’t Hoff (thermodynamic) analysis.  
Enantioselectivity and resolution were confirmed to decrease at higher temperature, as 
predicted, due to lower solution viscosity, higher EOF, lower retention, and a smaller 
elution range.  It was shown that van’t Hoff plots (ln Keq versus 1/T) were linear for the 
1% DDCV formulation but not the 4% version.  It was hypothesized that temperature had 
more of an impact on the phase ratio and/or microemulsion structure when a larger 
amount of surfactant was used.  Negative enthalpies of transfer were observed for all 
compounds, representing a preference for the PSP over the buffer.  Entropies of transfer 
were positive or negative, where positive values signified an increase in disorder for 
analyte partitioning into the PSP and negative values indicated a decrease in disorder for 
penetration into the microemulsion.  Examination of Gibb’s free energy changes with 
enthalpy and entropy revealed that chiral discrimination mechanisms rely more heavily 
on the entropic contribution.   Finally, the existence of enthalpy/entropy compensation 
was demonstrated with a compensation temperature of 227 K (at which ΔG° is similar for 
all enantiomers).  Thermodynamic results were compared to DDCV micellar data and 
revealed that a larger achiral attraction exists for the micelles.  
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A comparison of chiral MEKC, solvent-modified chiral MEKC, and chiral MEEKC was 
conducted using the chiral surfactant DDCV with identical concentrations [186].  The 
baselines obtained using micelles and butanol-modified micelles at 4% w/v DDCV were 
unstable, in contrast to the stable baselines observed with the equivalent microemulsions.  
Irrespective of surfactant concentration, the elution range decreased from micelles to 
solvent-modified micelles to microemulsion, due mainly to the PSP electrophoretic 
mobility (micelles had the smallest size and largest mobility).  Retention factors of the 
chiral analytes were somewhat larger using micelles and similar between microemulsions 
and butanol-modified micelles.  At 2% DDCV, the efficiency obtained with 
microemulsions and butanol-modified micelles was comparable and somewhat better 
than that obtained with the plain micelles, probably due to the former’s larger aggregate 
fluidity and improved mass transfer from the presence of the alcohol modifier; at 4% 
DDCV the average efficiency doubled to nearly 70,000 using the microemulsion but 
remained the same for the micelles and butanol-modified micelles.  Finally, a slightly 
better average resolution was obtained using micelles at 2% DDCV and butanol-modified 
micelles at 4% DDCV, although the microemulsion provided similar results at both 
concentrations.  Moreover, in a comparison of all results achieved with a stable baseline, 
the optimal microemulsion provided the highest average efficiency and resolution with a 
slightly lower enantioselectivity. 
 
The next DDCV publication was the first to describe the simultaneous incorporation of 
two chiral selectors into one microemulsion that was subsequently employed for the 
separation of N-methyl ephedrine and pseudoephedrine enantiomers (Chapter 3) [183].  
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Each chiral surfactant enantiomer (R- and S-DDCV) was combined with one enantiomer 
of a chiral cosurfactant (S-2-hexanol).  Interestingly, the microemulsion prepared with S-
DDCV and S-2-hexanol provided improved efficiency and resolution values for both 
analytes.  Enantioselectivity for N-methyl ephedrine was unaffected by the chiral 
surfactant stereochemistry, but pseudoephedrine showed a higher value with R-DDCV.  
Thermodynamic synergies (beneficial and detrimental) with dual-chirality 
microemulsions were identified and postulated to be a result of either a) interaction of the 
chiral surfactant and chiral cosurfactant, or b) a three-way interaction between the chiral 
microemulsion components and the enantiomers.  In addition, racemic 2-hexanol was 
tested as a cosurfactant and found to greatly improve efficiency over the previously used 
1-butanol.  Another DDCV study compared the effects of seven different achiral 
cosurfactants (primary, secondary, and cyclic alcohols at equimolar concentrations) on 
the enantioseparation of six pairs of pharmaceutical enantiomers (Chapter 4) [184].  The 
main trends identified were:  higher enantioselectivity with cyclic and short chain 
primary alcohols (1-butanol and cyclopentanol), lower enantioselectivity with longer 
chain primary alcohols, best overall efficiency with 1-hexanol, and best overall resolution 
with 1-butanol.  Changing the cosurfactant was also shown to modify the separation 
selectivity.  Methylene selectivity (aggregate hydrophobicity) decreased sequentially with 
1-hexanol > 2-hexanol > 1-pentanol > 2-pentanol ≥ cyclohexanol ≥ 1-butanol > 
cyclopentanol, demonstrating that the cosurfactant has a significant impact on analyte 
partitioning and microemulsion polarity.  The most recent DDCV study described results 
obtained with the first combination of a chiral surfactant (DDCV) with a chiral oil 
(dibutyl tartrate) (Chapter 5) [185].   For ephedrine-based analytes, two-chiral-component 
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microemulsions with the surfactant and oil in opposite stereochemical configurations 
provided higher enantioselectivities than the single-chiral component microemulsion.  
Enantioselective synergies were determined using a thermodynamic model and showed 
that the second proposed explanation reported in the first dual-chirality publication 
([183], see above) was the most probable.  Efficiencies observed with microemulsions 
comprised of racemic dibutyl tartrate or dibutyl D-tartrate were significantly higher than 
those obtained with dibutyl L-tartrate.  The dual-chirality system containing R-DDCV 
and dibutyl D-tartrate provided significantly better resolution than the remaining one- and 
two-chiral-component microemulsions for the ephedrine-based compounds, but only 
slightly better or equivalent resolution for non-ephedrine compounds.   
 
The final chiral MEEKC paper in the literature utilized chiral cosurfactants (secondary 
alcohols) in conjunction with an achiral surfactant (SDS) and an achiral oil (n-octane) for 
the analysis of five pharmaceutical compounds [181].  Enantioresolution could not be 
achieved with R-2-butanol and improved going from R-2-pentanol to R-2-hexanol.  The 
use of R-2-heptanol provided the only separation of propranolol enantiomers, but 
degraded the resolution of other analytes.  N-methyl ephedrine could not be resolved with 
the systems tested, most likely due to its structure.  Furthermore, use of the alternative 
cosurfactant enantiomer, S-2-hexanol, effectively reversed the elution order.  Variations 
of the oil phase demonstrated that octane performed better than ethyl acetate for this 
microemulsion formulation; removal of the oil from this formulation resulted in a 
complete loss of enantioresolution.  
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The research in chiral MEEKC has established that optimization of microemulsion 
conditions is complex, with the concentration and identity of the aggregate components, 
as well as analyte identity, requiring consideration.  Continued focus on this field will 
expand the knowledge base and lead to increased acceptance of MEEKC.  The work 
reported herein provides additional information on chiral microemulsion formulation 
intricacies and their effect on chiral separations.  The applicability of novel 
microemulsion-based PSPs is also demonstrated. 
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Chapter 2:  Methods and Materials 
 
 
 
The instrumentation, reagents, microemulsion preparation, sample preparation, and 
calculations utilized for Chapters 3 through 7 are presented in this section.  Any 
deviations from this standard protocol are given in the relevant chapter(s). 
 
 
2.1 Instrumentation 
 
Particle size measurements were taken on a Horiba dynamic light scattering particle size 
analyzer, model LB-500 (Horiba Instruments, Inc., Irvine, CA, USA).  Data analysis was 
performed with Horiba LB-500 software versions 3.19 and 3.36.  The microemulsion 
refractive index was set to 1.340 and temperature was maintained at 25°C.  The wait time 
prior to data collection was 2 minutes and 100 measurements were taken per analysis.  
The calculation level employed was 3000. 
 
An Agilent 3DCE instrument, model G1600AX, equipped with a UV diode array detector 
(Agilent Technologies, Waldbronn, Germany) was employed for electrophoretic 
separations.  Data were recorded at detection wavelengths of 200, 215, 236, 246, and 254 
nm; enantiomers and alkylphenones were analyzed at 215 nm and 236 nm (bandwidth of 
± 5 nm), respectively.  ChemStation software, revisions A.08.03 and A.09.03, was 
utilized for data collection and processing.  The capillary cartridge was maintained at 
25°C and the autosampler was at ambient conditions.  Fused silica capillaries (50 µm i.d. 
x 365 µm o.d.) (Polymicro Technologies, Phoenix, AZ, USA) with a total capillary 
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length of 32 cm and an effective length (inlet to detector) of 23.6 cm were used.  The 
conditioning procedure for new capillaries consisted of flushing (920 mbar) with HPLC-
grade water for 10 minutes, 1 M base for 10 minutes (sodium hydroxide (NaOH) or 
tetrapropylammonium hydroxide (TPAH) in Chapter 3 and TPAH for Chapters 4 through 
7), 0.1 M base for 5 minutes (NaOH or TPAH in Chapter 3 and TPAH for Chapters 4 
through 7), HPLC-grade water for 3 minutes, and microemulsion for 15 minutes, 
corresponding to 47, 47, 23, 14, and 70 capillary volumes, respectively.  Between 
injections, the capillaries were flushed with microemulsion for 2 minutes (9 volumes).  In 
Chapter 3, used capillaries were re-conditioned between analyses by flushing for 10 
minutes with HPLC-grade water, 10 minutes with 0.1 M NaOH or TPAH, 3 minutes with 
HPLC-grade water, and 15 minutes with microemulsion.  In the remaining chapters, 
capillaries were re-conditioned on each day of use with the conditioning procedure for 
new capillaries.  A new capillary was made for each microemulsion preparation.  
Hydrodynamic injections were performed at 25 mbar for two seconds.  The applied 
voltage was 11.5 kV for all experiments (Joule heat level of approximately 1.9 W/m) 
with a voltage ramp of 0.3 minutes at the onset of each separation.  Microemulsions were 
tested on a minimum of three separate days with a minimum of five replicate injections 
per sample. 
 
2.2 Reagents 
 
Dodecoxycarbonylvaline (DDCV, see Figure 2.1), marketed under the trade name 
EnantioselectTM, was provided by Waters Corporation (Milford, MA, USA).  Ephedrine, 
N-methyl ephedrine, pseudoephedrine, 1 M TPAH, ethyl acetate, 1-pentanol, 2-pentanol,  
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Figure 2.1.  Structure of the chiral surfactant dodecoxycarbonylvaline (DDCV). 
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S-2-hexanol, diethyl L-tartrate (see Figure 2.2), acetophenone, butyrophenone, 
valerophenone, hexanophenone, heptanophenone, and octanophenone were purchased 
from Aldrich (Milwaukee, WI, USA).  Atenolol, metoprolol, synephrine, propiophenone, 
and 1-butanol were obtained from Sigma (St. Louis, MO, USA).  1-hexanol, racemic 2-
hexanol, cyclohexanol, and diethyl D-tartrate (see Figure 2.2) were purchased from Alfa 
Aesar (Ward Hill, MA, USA).  Cyclopentanol, dibutyl L-tartrate (see Figure 2.2), and 
dibutyl D-tartrate (see Figure 2.2) were obtained from Acros (Morris Plains, NJ, USA).  
Monosodium dihydrogen phosphate monohydrate and methanol were procured from J.T. 
Baker (Phillipsburg, NJ, USA) and Fisher (Pittsburgh, PA, USA), respectively.  The 
structures of the chiral test compounds are shown in Figure 2.3. 
 
 
2.3 Microemulsion Preparation 
 
Microemulsions were prepared by first weighing the appropriate quantities of surfactant 
(R- and/or S-DDCV, 2.0% (w/v); 60.7 mM) and buffer (phosphate, 50 mM) followed by 
dissolving them in HPLC-grade water (~three-fourths of the final volume) with addition 
of 1.0 M TPAH.  Once the solids were completely in solution, the pH was adjusted to 7.0 
with 1.0 M TPAH, and the cosurfactant (131 mM) and oil (51.2 mM) were added.  The 
resulting mixture was then sonicated, while covered, for approximately 45 minutes until a 
transparent solution with no visible oil droplets was achieved (90 minute sonication 
required for microemulsions containing dibutyl tartrate (Chapter 5)).  The cooled 
microemulsion solutions were diluted to their final volume, mixed, and allowed to stand 
for a minimum of one hour prior to use.  Microemulsions were filtered with a 0.45 µm 
syringe filter and sonicated prior to vialing.
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Figure 2.2.  Structures of the chiral oils used in microemulsion formulations (Chapters 5, 
6, and 7). 
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Figure 2.3.  Structures of the chiral analytes. 
 
 
  
79 
2.4 Sample Preparation 
 
Chiral analyte test solutions were prepared at a concentration of 0.5 mg/mL using 
microemulsion with a small amount of methanol (t0 marker, approximately 1 drop per 3 
mL microemulsion) as the diluent.  Microemulsion migration time was determined using 
a tme marker of octanophenone.  The selection of this PSP marker was based on the fact 
that DDCV microemulsions could not baseline separate alkylphenone homologs of 
heptanophenone and octanophenone.  Therefore, octanophenone, which can be 
solubilized with relative ease in microemulsion diluent, was an appropriate marker for the 
systems being studied.  For Chapters 3, 4, and portions of 5 and 6, a separate solution 
(0.35 µL octanophenone in 1 mL microemulsion with a small amount of methanol, t0 
marker) was used for this measurement.  In the last experiments (portions of Chapters 5 
and 7 and all of Chapter 8), octanophenone was added to individual sample solutions to 
ascertain the microemulsion mobility for each injection.  The methylene selectivity of 
each microemulsion was determined using a test mixture of alkylphenone homologs 
(acetophenone through heptanophenone, 0.30 µL each) in 1 mL microemulsion with a 
small amount of methanol as a t0 marker. 
 
2.5 Calculations 
 
Chiral separations were analyzed in terms of enantioselectivity (αenant), average efficiency 
(theoretical plates, Navg), and resolution (Rs).  In some studies, methylene selectivity 
(αmeth) was also examined.  For some analytes, the resolution achieved was less than 
baseline, requiring the use of half-height calculations for both efficiency and resolution, 
instead of the preferred methods for fully resolved peaks of statistical moments (available 
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with ChemStation) or the Foley-Dorsey equation (using peak width and asymmetry factor 
at 10%) [1].  Equations based on peak width and asymmetry factor at 50% [2] could not 
be employed because the ChemStation software does not provide the asymmetry factor at 
50%. 
 
ChemStation utilizes the following equations to calculate resolution and efficiency from 
experimentally measured chromatographic data: 
! 
R
s
=
1.18(t
R (b ) " tR(a ))
W50(b ) +W50(a )
        (2.1) 
! 
N = 5.54
t
R
W
50
" 
# 
$ 
% 
& 
' 
2
        (2.2) 
where tR is the peak retention time, “a” and “b” signify peak one and two, respectively, 
and W50 is the peak width at half-height. 
 
Mobilities (µ) were determined using retention times corrected for the voltage ramp (tVRC, 
in seconds) via the following equations: 
! 
t
VRC
= t
R
"
t
VR
2
         (2.3) 
! 
µ =
LtotLeff
tVRCV
         (2.4) 
where tR is the retention time in seconds, tVR is the time for the voltage ramp (equal to 18 
seconds for all injections), Ltot is the total length of the capillary in centimeters, Leff is the 
length to the detector in centimeters, and V is the applied voltage in volts.  Equations 2.3 
and 2.4 were used with the t0 and tme marker retention times to calculate the 
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electroosmotic flow (µeo) and the net mobility of the microemulsion (µme), respectively.  
Microemulsion electrophoretic mobility (µep,me) was calculated by subtracting µeo from 
µme. 
 
The direct measurement of electrophoretic mobilities for charged analytes (µep) in a 
microemulsion system cannot be done because both electrophoretic and chromatographic 
separation mechanisms are occurring in MEEKC.  Therefore, an approximation that uses 
CZE electrophoretic mobilities and a viscosity correction factor for the difference 
between the CZE buffer and the microemulsion [3] was applied to estimate analyte 
electrophoretic mobilities in each microemulsion: 
  
! 
µep,MEEKC " µep,CZE
tP ,CZE
tP ,MEEKC
# 
$ 
% 
& 
' 
(        (2.5)  
where, µep,MEEKC is the estimated analyte electrophoretic mobility under MEEKC 
conditions,  µep,CZE is the measured analyte electrophoretic mobility under CZE conditions 
(equivalent conditions to MEEKC without the PSP), tP,CZE and tP,MEEKC are the retention 
times for a plug of isopropanol to be detected using a pressure of 50 mbar and no voltage 
for CZE and MEEKC conditions, respectively.  The values for µep,CZE and tP,CZE were 
collected once (5 replicate injections) with the averages used to calculate µep,MEEKC for 
each subsequent MEEKC analysis (tP,MEEKC was obtained during each individual MEEKC 
run).   
 
Retention factors (k) for each individual enantiomer were calculated via the following 
equation: 
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! 
k =
tR ,VRC (1+ µep,MEEKC /µeo) " t0,VRC
t
0,VRC " (1+ µep,me /µeo)tR ,VRC
      (2.6) 
Values for tR,VRC, µeo, t0,VRC, and µep,me were determined for each MEEKC analysis and 
µep,MEEKC was calculated as previously stated.  The ratio of retention factors for pairs of 
enantiomers (k2/k1) gives enantioselectivity (αenant).  
 
In studies where microemulsions contained more than one chiral component (Chapters 3, 
5, 6, and 7), Gibb’s free energy changes were determined for enantioselective synergy 
analysis: 
! 
""G
°
= #RT ln$
enant
        (2.7) 
 
Methylene selectivities (αmeth) were calculated from the antilogarithm of the slope of a 
graph of the natural logarithm of retention factors (ln k) versus carbon number (n) of six 
alkylphenone homologs (acetophenone through heptanophenone).  The tpsp value needed 
to compute ln k for each of the homologs was optimized by using Microsoft Excel’s 
Solver data analysis tool to maximize the correlation coefficient (r2) of the linear ln k vs. 
n fit in an iterative fashion until convergence was reached [4]. 
 
 
2.6 Statistical Analysis for Chapters 5 through 7 
 
Statistical differences between enantioselectivities, average efficiencies, resolutions, and 
methylene selectivities obtained with the various microemulsions were established using 
multiple comparison tests at the 0.05 significance level (SPSS, versions 11.0.4 and 13.0, 
SPSS Inc., Chicago, IL, USA).  Four methods were chosen from the wide spectrum 
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available based on their statistical characteristics:  a liberal test for populations with equal 
variances, LSD; a conservative test for equal variances, Scheffe; a moderately 
conservative, widely used test for equal variances, Tukey; and a moderately conservative 
test for unequal variances, Dunnett’s T3.  In cases where the four multiple comparison 
tests did not give the same outcome, individual t-tests were performed for confirmation in 
Excel.
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Chapter 3:  Chiral Microemulsion Electrokinetic Chromatography with Two Chiral 
Components: Improved Separations via Synergies Between a Chiral Surfactant and 
a Chiral Cosurfactant 
 
 
 
3.1 Introduction 
 
The number of materials and products developed with chiral components has continued 
to increase, particularly in the pharmaceutical industry.  As a result, techniques that have 
the ability to separate enantiomers continue to be heavily researched [1].  Electrokinetic 
chromatography (EKC) has proven highly successful and advantageous in this area.  
Short analysis times, high efficiencies, minute sample sizes, minimal waste, variety of 
pseudostationary phases (PSPs), and lower cost are among the benefits of using EKC 
over other separation methods such as HPLC, gas chromatography (GC), or supercritical 
fluid chromatography (SFC).  One approach to enantiomeric separations is termed the 
direct method and involves a temporary interaction, diastereomeric in nature, between an 
enantiomer and a chiral selectand [2].  Direct methods of chiral separation are easily 
implemented in EKC via the addition of a chiral additive or PSP to the separation 
medium.  Examples of chiral additives or PSPs include micelles, microemulsions, 
cyclodextrins, glycopeptides, and crown ethers [3-5]. Exact mechanisms of chiral 
differentiation are still being elucidated to simplify method development and 
optimization [6]. 
 
Microemulsion electrokinetic chromatography (MEEKC) is one of the newer subsets of 
EKC in which a microemulsion is employed as the pseudostationary phase.  There are 
two categories for microemulsions [7]:  oil-in-water and water-in-oil [8, 9].  The majority 
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of work in EKC has focused on oil-in-water microemulsions [10].  These aggregates are 
composed of a surfactant, a cosurfactant (typically a short chain alcohol), and an oil 
(hydrocarbon or other water immiscible liquid) [11].  The proportions of the components 
are varied to achieve a liquid that is optically transparent and thermodynamically stable.  
This pseudostationary phase is spherical in shape and on the order of 1-5 nm in size.  The 
oil forms the core of the microemulsion with the surfactant on the outside and the 
cosurfactant interdispersed with the surfactant to ease interfacial tension between the oil 
and surfactant. 
 
Compared to other chiral pseudostationary phases employed in EKC, chiral 
microemulsions offer added flexibility in terms of selectivity [12], elution range [10, 13, 
14], and composition [15, 16].   The identity and concentration of the microemulsion 
constituents (surfactant, cosurfactant, and oil) can be altered along with buffer identity, 
pH, and concentration to fine-tune the separation [17].  Typically, the elution range 
cannot be adjusted in EKC due to the PSPs used.  However, the charge density of a 
microemulsion can be varied with surfactant concentration, thereby altering the elution 
range [13, 14].  Another characteristic that makes microemulsions preferential is their 
ability to solubilize highly hydrophobic compounds, which has been more difficult to do 
in other aqueous EKC techniques.  The oil core in the microemulsion aids in the 
solubilization of analytes in conjunction with the fluidity of the PSP [11, 13].  The 
reduced rigidity of this aggregate has been postulated to increase mass transfer from the 
mobile phase to PSP and vice-versa, although this effect has yet to be irrefutably 
established [10, 16, 18, 19]. 
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To date, the combination of two chiral components into a microemulsion formulation has 
not been reported.  This work focuses on the incorporation of the chiral surfactant DDCV 
and chiral cosurfactant S-2-hexanol with the achiral oil ethyl acetate into a microemulsion 
for the separation of the ephedrine derivates N-methyl ephedrine and pseudoephedrine.  
The effect of surfactant configuration (R or S) on efficiency, resolution, 
enantioselectivity, and Gibb’s free energy changes was examined while keeping the 
cosurfactant configuration constant.  Additionally, the results were compared to those 
from DDCV microemulsions with cosurfactants of 1-butanol (previously reported [20]) 
and racemic 2-hexanol (new formulation).  The data show that changing the cosurfactant 
from 1-butanol to racemic 2-hexanol significantly improves the efficiency.  Resolution 
between enantiomers also increased with racemic 2-hexanol as the cosurfactant.  
Efficiencies using the chiral cosurfactant further increased for N-methyl ephedrine when 
combined with S-DDCV and decreased for both compounds with R-DDCV.  The 
resolution continued to improve with the incorporation of S-2-hexanol with S-DDCV for 
the analytes studied.  Evaluation of the changes in Gibb’s free energy indicated the 
existence of a synergy when the number of chiral selectands in the microemulsion 
increased from one to two. 
 
3.2 Results and Discussion 
3.2.1 Microemulsion Formulations 
Previous chiral microemulsions were formed using 2% (w/v) DDCV as the surfactant, 
1.2% (v/v) 1-butanol as a cosurfactant, 0.5% (v/v) ethyl acetate as the oil, and a 50 mM 
phosphate buffer, pH 7 [20].  Throughout all experiments, the identity and concentration 
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were kept constant for both the oil and buffer.  In addition, buffer pH and surfactant 
concentration remained the same for all microemulsions.  Initially, a microemulsion with 
S-2-hexanol was prepared in the same manner, changing only the cosurfactant identity.  
Studies performed with the S-DDCV/1.2% (v/v) S-2-hexanol microemulsion resulted in 
splitting peaks (data not reported), most likely caused by insufficient cosurfactant for this 
stereochemical combination of components; subsequent studies with an increased 
concentration of alcohol did not result in poor peak shape.  Separations with the R-
DDCV/1.2% (v/v) S-2-hexanol microemulsion did not exhibit the same degradation in 
peak shape as the S-DDCV version (data not reported).  The fact that split peaks were not 
observed with R-DDCV/1.2% (v/v) S-2-hexanol indicates that the concentration of 
alcohol used with this stereochemical combination was sufficient to create a more ideal 
microemulsion that separated the analytes without peak distortion.  Based on these initial 
findings, multiple studies were performed with the R-DDCV/S-2-hexanol microemulsion 
on a variety of pharmaceutical enantiomers; however, large improvements in the 
separations were not observed. 
 
Following the preliminary research on chiral microemulsions with two chiral 
components, it was determined that the concentration of cosurfactant when switching 
from 1-butanol to S–2-hexanol should be kept constant in terms of molarity, not 
volume/volume percentage, to maintain the same ratio of components.  Stable 
microemulsions were achieved with 2% (w/v) DDCV (R or S configuration) and 1.65% 
(v/v) S-2-hexanol.  A comprehensive performance comparison of the microemulsions 
prepared with each enantiomer of DDCV (2% (w/v)) and 1.65% (v/v) S-2-hexanol 
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(abbreviated as RS or SS microemulsion, where surfactant configuration is indicated by 
the first letter and cosurfactant configuration by the second letter) was conducted using 
pseudoephedrine and N-methyl ephedrine as chiral analytes.  Additionally, a 
microemulsion with 2% (w/v) R-DDCV and 1.65% (v/v) racemic 2-hexanol (abbreviated 
as RX microemulsion) was prepared and used to evaluate the differences in separation 
from the previous 1-butanol microemulsion (abbreviated as RB microemulsion), and as a 
baseline for the S-2-hexanol microemulsions. 
 
3.2.2 Comparison of 1-Butanol and Racemic 2-Hexanol as Cosurfactants 
Prior studies performed by our group utilized DDCV microemulsions with 1-butanol as 
the cosurfactant [20-24].  Table 3.1 shows electrophoretic data from the most similar 
study [20] along with recent results using racemic 2-hexanol as a cosurfactant.  
Importantly, after changing the cosurfactant, there was no appreciable difference in 
electroosmotic flow (µeo), electrophoretic mobility of the microemulsion (µep,me), or 
elution range.  Under the present microemulsion conditions, based on this information, it 
appears that simultaneously increasing the chain length of the cosurfactant and replacing 
a primary alcohol with a secondary alcohol does not have a major impact on the mobility 
characteristics. 
 
The DDCV microemulsion with racemic 2-hexanol was used to separate the enantiomers 
of N-methyl ephedrine and pseudoephedrine.  A dramatic increase in efficiency (Navg) 
was observed for both compounds (Table 3.2).  Average efficiencies for N-methyl 
ephedrine and pseudoephedrine were 32,000 and 31,000, respectively, with the 
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Table 3.1.  Comparison of electrophoretic parameters and elution range for 1-butanol and 
2-hexanol DDCV microemulsions. 
 
Cosurfactanta) µeo (104) 
cm2V-1s-1 
µep,me (104) 
cm2V-1s-1 
Elution Range 
µeo/µme 
1.2% (v/v) 1-butanolb) 3.93 ± 0.05 -2.91 ± 0.01 4.7c) 
1.65% (v/v) 2-hexanol 3.78 ± 0.17d) -2.90 ± 0.08e) 4.3 
 
a) Microemulsion composition:  2% (w/v) DDCV, 0.5% (v/v) ethyl acetate, 50 mM 
phosphate buffer, pH 7. 
b) Previously published [20]. 
c) Calculated using the ratio of tme to to. 
d) Average of 60 injections. 
e) Average of 16 injections.
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Table 3.2.   Effect of cosurfactant identity on efficiency (Navg), resolution (Rs), and 
enantioselectivity (αenant) for DDCV microemulsions. 
 
 1-butanola,b)  2-hexanola) 
Compound Navgc) Rs αenant  Navgc) Rs αenant 
N-methyl ephedrine 32000 1.69 1.10  83000 2.10 1.077 
Pseudoephedrine 31000 3.08 1.20  85000 3.45 1.135 
 
a) 2% (w/v) DDCV, cosurfactant concentrations of 1.2% (v/v) 1-butanol and 1.65% 
(v/v) racemic 2-hexanol. 
b) Previously reported [20]. 
c) Average efficiency for enantiomer peaks 1 and 2 based on 18-26 injections.
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cosurfactant 1-butanol.  An almost three-fold improvement in average efficiency to 
83,000 and 85,000 for N-methyl ephedrine and pseudoephedrine was achieved by 
employing racemic 2-hexanol as the cosurfactant.  In contrast to the improvements in 
Navg, the enantioselectivities decreased by a small amount:  1.10 to 1.077 for N-methyl 
ephedrine and 1.20 to 1.135 for pseudoephedrine.  Concomitant with the increase in 
efficiency, a moderate increase in resolution (Rs) was achieved with this racemic 2-
hexanol microemulsion formulation compared to the 1-butanol microemulsion: 1.69 to 
2.10 for N-methyl ephedrine and 3.08 to 3.45 for pseudoephedrine resolution.   
 
We hypothesize that the higher efficiencies with racemic 2-hexanol are due to an 
enhancement in mass transfer.  The microemulsion structure changes with the structure of 
the cosurfactant.  As noted above, there are two main structural differences between 1-
butanol and 2-hexanol:  chain length and substituent position.  Both of these factors play 
a role in altering electrophoretic parameters and the chromatographic figures of merit.  In 
regard to this particular PSP, the position of the hydroxyl group plays a significant role in 
mass transfer.  The cosurfactant aligns itself with the hydrophobic tail oriented toward the 
oil core as a result of hydrophobic interactions with both the surfactant hydrocarbon 
chain and the hydrophobic oil.  The hydrophilic hydroxyl group of the alcohol is oriented 
toward the aqueous buffer due to hydrogen bonding with the polar surfactant head group 
and water in the mobile phase.  The positioning of the substituent as a secondary alcohol 
creates a bulkier group that increases the distance between the surfactant monomers, in 
effect enhancing the fluidity of the microemulsion surface.  The reduction of surface 
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rigidity aids in solute partitioning into and out of the microemulsion, resulting in greater 
efficiencies.   
 
Evaluation of the fundamental resolution equation (eqn. 1.6) demonstrated that the main 
contributor to the improvement in resolution with 2-hexanol was the efficiency increase 
(increased mass transfer between the PSP and mobile phase). The separation quality was 
not compromised by the lower enantioselectivity (decreased chiral recognition) and 
elution range (increased EOF and/or decreased PSP mobility) with 2-hexanol.  
Additionally, the average retention factors were less optimal when the cosurfactant was 
2-hexanol instead of 1-butanol, i.e., analytes interacted less with the microemulsion.  The 
ratios of kavg/kopt for N-methyl ephedrine and pseudoephedrine with 1-butanol were 0.97 
and 1.0, respectively.  These values decreased with the employment of 2-hexanol with 
both analytes having a value of 0.69.    
 
3.2.3 Simultaneous Use of Chiral Surfactant and Chiral Cosurfactant 
The use of more than one chiral selectand in a PSP creates a more complex system.  It is 
probable that one combination of the two chiral entities could result in better separation 
figures of merit (Navg, αenant, and/or Rs) and the other worse.  In this portion of the study, 
the concentration and stereochemical configuration of the cosurfactant were kept 
constant.  Microemulsions were prepared using S-2-hexanol (1.65% (v/v)) and each 
enantiomer of DDCV (R and S, 2% (w/v)).  The values obtained for efficiency, 
enantioselectivity, and resolution for N-methyl ephedrine and pseudoephedrine with each 
PSP are given in Table 3.3.  For both compounds, greater efficiencies and resolutions 
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Table 3.3. Effect of DDCV stereochemical configuration on efficiency, resolution, and 
enantioselectivity for microemulsions with the cosurfactant S-2-hexanol.  
 
 RS Microemulsiona)  SS Microemulsionb) 
Compound Navgc) Rs αenant  Navgc) Rs αenant 
N-methyl ephedrine 68000 1.72 1.071  97000 2.37 1.072 
Pseudoephedrine 49000 2.98 1.168  80000 3.69 1.134 
 
a) RS Microemulsion:  2% (w/v) R-DDCV with 1.65% (v/v) S-2-Hexanol. 
b) SS Microemulsion:  2% (w/v) S-DDCV with 1.65% (v/v) S-2-Hexanol. 
c) Average efficiency for enantiomer peaks 1 and 2 based on 16-22 injections.
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were realized with the SS microemulsion (S-DDCV/S-2-hexanol) versus the RS 
microemulsion (R-DDCV/S-2-hexanol).  The RS microemulsion resulted in average 
efficiencies of 68,000 and 49,000 for N-methyl ephedrine and pseudoephedrine 
respectively, compared to 97,000 and 80,000 with the SS microemulsion.  Moreover, 
these efficiency values are higher than those previously reported with the RB 
microemulsion (DDCV/1-butanol).  Perhaps the most notable trend in Tables 3.2 and 3.3 
is the increase in efficiency for N-methyl ephedrine among the 2-hexanol based DDCV 
microemulsions in the order RS < RX < SS microemulsion.  A similar trend in 
pseudoephedrine efficiency is also evident (RS < RX ≈ SS), where the efficiency using the 
RX microemulsion is not statistically different from that with the SS microemulsion.  As 
shown by these data, the complementary interaction in chiral selectands occurs between 
S-DDCV and S-2-hexanol.  Figures 3.1 and 3.2 show representative electropherograms 
for N-methyl ephedrine and pseudoephedrine with the three 2-hexanol microemulsions 
studied.  Elution order reversal occurred only with changes in DDCV stereochemical 
configuration.  
 
Unlike the increases in efficiency obtained when two chiral constituents were employed 
in a microemulsion, the enantioselectivity either remained essentially constant or 
decreased.   For N-methyl ephedrine, enantioselectivity was 1.071 with the RS aggregate 
and 1.072 with the SS microemulsions.  These values were slightly lower than those 
found with the RX microemulsion (1.077).  Huie and co-workers [19] previously 
explained the lack of separation for N-methyl ephedrine with S-2-hexanol by the absence 
of β-amino hydrogens that would participate in hydrogen bonding with the chiral alcohol. 
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Figure 3.1.  Effect of cosurfactant stereochemical configuration on the enantiomeric 
separations of N-methyl ephedrine:  (A)  RX microemulsion (R-DDCV/Racemic 2-
hexanol), (B) RS microemulsion (R-DDCV/S-2-hexanol), and (C) SS microemulsion (S-
DDCV/S-2-hexanol).  Peak identification:  1S,2R = (1S,2R)-N-methyl ephedrine; 1R,2S = 
(1R,2S)-N-methyl ephedrine.  Surfactant concentration = 2% (w/v); cosurfactant 
concentration = 1.65% (v/v); 0.5% (v/v) ethyl acetate; 50 mM phosphate buffer, pH 7.0; 
detection wavelength = 215 ± 5 nm; capillary dimensions:  Ltot = 32 cm, Leff = 23.6 cm, 
i.d. = 50 µm; hydrodynamic injection = 25 mbar for 2 s; applied voltage = 11.5 kV.
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Figure 3.2.  Effect of cosurfactant stereochemical configuration on the enantiomeric 
separations of pseudoephedrine. (A) RX microemulsion, (B) RS microemulsion, and (C) 
SS microemulsion.  Peak identification:  1S,2S = (1S,2S)-pseudoephedrine; 1R,2R = 
(1R,2R)-pseudoephedrine.  Other conditions as in Fig. 3.1.
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The data collected in this study substantiate this mechanism of chiral interaction.  A 
chiral separation was obtained for N-methyl ephedrine, but this result was due only to the 
chiral surfactant, since a nearly constant enantioselectivity was observed for RX, RS, and 
SS microemulsion preparations. 
 
In contrast to N-methyl ephedrine, the enantioselectivity of pseudoephedrine varied more 
significantly when different chiral microemulsions were employed.  The largest value, 
1.168, was achieved with the RS microemulsion.  The SS and RX microemulsions gave 
similar results of 1.134 and 1.135, respectively, for enantioselectivity.  The small 
differences in enantioselectivity with the two-chiral-component microemulsions studied 
(RS and SS) demonstrate the minimal contribution from the chiral cosurfactant to the 
separation of these enantiomers.  
 
Resolution increased from 1.72 to 2.37 for N-methyl ephedrine and 2.98 to 3.69 for 
pseudoephedrine when the surfactant enantiomer was changed from R-DDCV to S-
DDCV in combination with S-2-hexanol.  In the case of N-methyl ephedrine, 
enantioresolution was enhanced with all 2-hexanol based DDCV microemulsions 
compared to the 1-butanol formulation, using equimolar concentrations of cosurfactant. 
Improvements in resolution for both pairs of enantiomers were achieved with the 
cosurfactant 2-hexanol in the order RS < RX < SS.  Examination of each term in the 
fundamental resolution equation (eqn. 1.6) shows that resolution enhancement for N-
methyl ephedrine with the SS formulation was due to the increases in efficiency and 
elution range (5.8 with SS vs. 5.1 with RS).  The other terms in eqn. 1.6, 
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enantioselectivity and retention factors, did not vary drastically between the two systems 
(kavg/kopt=0.67 and 0.70 with SS and RS, respectively).  The factors influencing the 
resolution changes for pseudoephedrine were slightly different in that enantioselectivity 
and kavg/kopt were better with the RS combination (kavg/kopt=0.64 and 0.75 with SS and RS, 
respectively).  However, the large increase in efficiency and moderate increase in elution 
range with the SS microemulsion outweighed the slight decreases in the other terms such 
that the SS aggregate provided the best resolution for this pair of enantiomers. 
 
3.2.4 Thermodynamic Synergies in Chiral Recognition 
To further probe the interactions of the chiral surfactant and chiral cosurfactant, a 
thermodynamic evaluation was necessary.  Direct comparisons via addition and/or 
subtraction were not possible with the previously discussed enantioselectivities and it was 
therefore necessary to determine free energy changes (ΔΔG°) to which mathematical 
operations could be applied.  The change in free energy (ΔΔG° = ΔG°2 - ΔG°1) represents 
the energetic difference between analytes, enantiomers in this case, in their transfer from 
the mobile phase to the pseudostationary phase (PSP).  Negative values of ΔΔG° are 
obtained when retention in the PSP is preferred over the aqueous phase and positive 
values occur when the mobile phase is favored (no retention).  To complete a 
thermodynamic analysis of the data, the effect of each chiral component on an individual 
basis was needed.  The RX microemulsion results provided the desired information about 
the role of the chiral surfactant DDCV; an SX microemulsion was not tested because 
DDCV enantiomers give equal separations with elution order reversal [25].  The 
cosurfactant contribution was evaluated with a microemulsion prepared using a 50/50 
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(w/w) mixture of the DDCV enantiomers (total concentration of 2% (w/v)), effectively 
acting as an achiral surfactant, and the cosurfactant S-2-hexanol, 1.65% (v/v), (XS 
microemulsion).  This microemulsion did not demonstrate any detectable 
enantioselectivity.  Addition of the individual changes in Gibb’s free energy for the one-
chiral-component microemulsions should give the change in Gibb’s free energy for the 
dual chirality microemulsions (i.e., ΔΔG°RX (or ΔΔG°SX) plus ΔΔG°XS should equal 
ΔΔG°RS (or ΔΔG°SS)).  The enantioselectivity values and changes in Gibb’s free energy 
are given in Table 3.4.  Information on the XS microemulsion was included in the table 
for completeness, however, no contributions to enantioselectivity or changes in free 
energy were made by this system and it was omitted from further calculations.  For N-
methyl ephedrine, the differences in the Gibb’s free energy of transfer for the RX/SX, RS, 
and SS microemulsions were -0.185, -0.169, and –0.171 kJ/mol, respectively.  Gibb’s free 
energy changes for pseudoephedrine were –0.313, -0.385, and –0.311 kJ/mol for the 
RX/SX, RS, and SS microemulsions.   The negative values demonstrate that the analytes 
have a greater thermodynamic affinity for the pseudostationary phase than the mobile 
phase. 
 
The existence/nonexistence of a beneficial/detrimental synergy with two chiral 
microemulsion components was determined by subtracting the free energy change for the 
chiral surfactant/racemic 2-hexanol microemulsion (RX or SX) from the chiral 
surfactant/S-2-hexanol microemulsion (RS or SS), results given in Table 3.4.  N-methyl 
ephedrine gives a difference of 0.016 kJ/mol for the RS microemulsion and 0.014 kJ/mol 
for the SS microemulsion.  The differences for pseudoephedrine were –0.072 kJ/mol and  
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Table 3.4.  Evaluation of synergies for two-chiral-component microemulsions via 
analysis of changes in Gibb’s free energy. 
 
 
 N-methyl ephedrine Pseudoephedrine 
Microemulsiona) αenant %RSDb) ΔΔG°c) αenant %RSDb) ΔΔG°c) 
XS 1.000 N/Ad) 0.000 1.000 N/Ad) 0.000 
RXe) 1.077 0.1 -0.185 1.135 0.5 -0.313 
RSe) 1.071 0.1 -0.169 1.168 0.4 -0.385 
SXf,g) 1.077 0.1 -0.185 1.135 0.5 -0.313 
SSg) 1.072 0.1 -0.171 1.134 0.2 -0.311 
ΔΔG°RS - ΔΔG°RX   0.016   -0.072 
ΔΔG°SS - ΔΔG°SX   0.014   0.002 
 
a) Microemulsions:  2% (w/v) surfactant, 1.65% (v/v) cosurfactant; XS = Racemic 
DDCV/S-2-hexanol, RX = R-DDCV/Racemic 2-hexanol, RS = R-DDCV/S-2-hexanol, 
SX = S-DDCV/Racemic 2-hexanol, SS = S-DDCV/S-2-hexanol. 
b) RSD based on 16-22 injections. 
c) ΔΔG° = ΔG°2 - ΔG°1, kJ/mol.  Average uncertainty for ΔΔG° is ± 0.002 kJ/mol based 
on error propagation of αenant uncertainties. 
d) No separation achieved. 
e) Elution order with R-DDCV:  (1S,2R)- then (1R,2S)-N-methyl ephedrine; (1S,2S)- 
then (1R,2R)-pseudoephedrine. 
f) SX microemulsion not prepared, R-DDCV and S-DDCV give same enantioselectivity 
with elution order reversal [25]. 
g) Elution order with S-DDCV:  (1R,2S)- then (1S,2R)-N-methyl ephedrine; (1R,2R)- 
then (1S,2S)-pseudoephedrine. 
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0.002 kJ/mol (essentially zero) for the RS and SS microemulsions respectively.  The 
positive differences indicate a detrimental synergy for N-methyl ephedrine with both two-
chiral-component microemulsions (RS and SS).  The negative difference in free energies 
for pseudoephedrine with the RS microemulsion demonstrates a beneficial synergy.  The 
minimal difference with the SS microemulsion for pseudoephedrine signifies the absence 
of a synergistic effect. 
 
If there were no synergistic interactions (beneficial or detrimental) between the surfactant 
and cosurfactant, it would be expected that the individual contributions of the chiral 
components would be additive, but this was not the case for three out of four results. 
Pseudoephedrine exhibits a larger, beneficial synergistic effect with the RS 
microemulsion compared to the detrimental synergistic effect found for N-methyl 
ephedrine, indicating some dependence on analyte structure.  Synergies with the SS 
microemulsion are negative for both analytes, with N-methyl ephedrine having the larger 
value.  The calculated synergy for N-methyl ephedrine was nearly identical with both RS 
and SS microemulsions, which is not the case for pseudoephedrine, again suggesting a 
dependence on analyte structure.  The dual-chiral-component synergies observed have 
two potential sources:  an interaction between the chiral surfactant and chiral cosurfactant 
or a three-way interaction between the chiral surfactant, chiral cosurfactant, and chiral 
analyte.  The possible interaction of the chiral cosurfactant with the chiral surfactant 
could diminish the overall chirality of the microemulsion or create a sterically hindered 
site for analyte interaction, resulting in detrimental synergies.  Conversely, the 
association of the chiral surfactant and chiral cosurfactant could result in a beneficial 
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synergy, which would enhance the chirality of the PSP.  The potential interrelation of 
surfactant, cosurfactant, and analyte (all chiral) in the establishment of a temporary 
diastereomeric linkage could be manifested as either a beneficial or detrimental synergy, 
dependent on analyte structure.  For the analytes being studied, the interplay of R-DDCV 
and S-2-hexanol had an impact on the quality of separation, negatively affecting 
efficiency and resolution.  Despite these drawbacks, the synergy within the RS 
microemulsion also resulted in an increase in enantioselectivity for pseudoephedrine.  
Based on these findings, it is anticipated that synergistic effects from two or more chiral 
components in a microemulsion could improve or degrade chiral enantioselectivity and 
chromatographic figures of merit (Navg and Rs) depending on the identity of 
microemulsion components and the analytes being separated. 
 
3.3 Concluding Remarks 
The results of this study clearly demonstrate a vast improvement in efficiency for N-
methyl ephedrine (32,000 to 83,000 plates) and pseudoephedrine (31,000 to 85,000 
plates) with a change in microemulsion cosurfactant from 1-butanol to 2-hexanol.  
Resolution also improved with the replacement of 1-butanol with 2-hexanol for both 
analytes studied (1.69 to 2.10 for N-methyl ephedrine and 3.08 to 3.45 for 
pseudoephedrine).  Further enhancements in efficiency and resolution were achieved with 
the combination of chiral cosurfactant, S-2-hexanol, and chiral surfactant, S-DDCV, for 
N-methyl ephedrine (97000 plates, resolution of 2.37).  Pseudoephedrine enantiomers 
were better resolved (Rs of 3.69) when the two chiral components S-DDCV and S-2-
hexanol were employed in the formation of a microemulsion.  The enantioselectivities 
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did not increase with the use of two chiral selectands in the microemulsion formulation 
(RS/SS) as compared to the original 1-butanol based microemulsion (RB).  However, the 
differences in Gibb’s free energy changes indicate that there is a synergistic effect when 
using two chiral components in a microemulsion.  The synergy observed can be 
beneficial or detrimental and appears to be analyte dependent.  Additional research on the 
interactions of chiral microemulsion components would provide further elucidation of the 
separation mechanism and enable optimization of the analytical technique.
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Chapter 4:  Effect of Cosurfactant Identity on Enantioselectivity, Methylene 
Selectivity, and Other Chromatographic Figures of Merit 
 
 
 
4.1 Introduction 
Multiple studies have been performed in MEEKC to find the best microemulsion 
formulation for a given set of analytes [1].  In some publications, each component of the 
system is varied to find the optimal identity and/or concentration of each [2-7].  One 
study that focused solely on cosurfactant identity (nine cosurfactants tested with the 
surfactant SDS) found varying selectivity for the analysis of green tea catechins [8].  
Within the field of chiral MEEKC, significantly fewer optimization studies have been 
reported.  Examples of microemulsion formulation experiments for chiral analyses 
include:  the impact of surfactant concentration and buffer identity [9], use of chiral 
cosurfactants [10], and the effect of oil identity (achiral [11] and chiral [12]).  Based on 
the literature for achiral and chiral MEEKC, it is evident that optimization of a 
microemulsion formulation is strongly dependent on the identity of the individual 
constituents.   
 
To date, chiral MEEKC separations utilizing the chiral surfactant DDCV have not been 
optimized in terms of achiral cosurfactant identity.  This study focuses on the impact of 
cosurfactant chain length and alcohol substitution on chiral separations.  Seven alcohols 
were used in microemulsion formulations with R-DDCV (1-butanol, 1-pentanol, 2-
pentanol, 1-hexanol, 2-hexanol, cyclopentanol, and cyclohexanol) to separate six chiral 
analytes (ephedrine, N-methyl ephedrine, pseudoephedrine, atenolol, metoprolol, and 
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synephrine).  The data show that secondary alcohols (both straight chain and cyclic) 
provide improvements in enantioselectivity over primary alcohols, with the exception of 
1-butanol.  Also, differences in retention factors from one microemulsion to the next 
show elution order changes for ephedrine, N-methyl ephedrine, and pseudoephedrine.  
Efficiencies and resolutions were affected by the cosurfactant identity as well.  
Separations using 2-pentanol resulted in the lowest average efficiencies for four of the six 
compounds in contrast to its rank for enantioselectivities (third highest value for four of 
the six compounds and highest overall for one).  Additionally, methylene selectivities for 
the seven microemulsions were larger with longer chain alcohols (1-hexanol for example) 
and decreased when the substituent position was changed from primary to secondary (1-
hexanol to 2-hexanol).   
 
4.2 Additional Calculations 
The methods and materials used for this chapter were given in Chapter 2.  In addition to 
the calculations listed there, arithmetic and geometric means were determined for 
efficiency, resolution, and enantioselectivity for each microemulsion.  The two means 
were almost identical for efficiency and enantioselectivity, therefore only the arithmetic 
mean is reported.  
 
4.3 Results and Discussion 
4.3.1 Microemulsion Formulations, Stability, and Particle Size 
The microemulsions were composed of 60.7 mM (2% w/v) surfactant (R-DDCV), 131 
mM cosurfactant (% v/v as in Table 4.1) and 51.2 mM (0.5% v/v) oil (ethyl acetate).  The 
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Table 4.1.  Cosurfactant abbreviations and volume/volume percentages in microemulsion 
formulationsa). 
 
 
 
Cosurfactant 
Cosurfactant 
Abbreviation 
Volume/Volume % in 
Microemulsion 
1-Butanol  1B 1.20% 
1-Pentanol  1P 1.42% 
2-Pentanol  2P 1.42% 
1-Hexanol  1H 1.65% 
2-Hexanol  2H 1.65% 
Cyclopentanol  CP 1.19% 
Cyclohexanol  CH 1.39% 
 
a) Microemulsion formulation:  2% w/v R-DDCV, 131 mM cosurfactant, 0.5% v/v 
ethyl acetate, 50 mM phosphate buffer pH 7.0. 
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buffer was kept constant at 50 mM phosphate, pH 7.0.  The millimolar concentration was 
kept constant to provide a fair comparison of the effect of each cosurfactant.  On the 
molecular level, using a constant millimolarity ensured the same number of cosurfactant 
molecules were incorporated into the surfactant aggregate.  The stability of the solutions 
with each cosurfactant was excellent with no phase separation after several months. 
 
Particle size analysis was performed on two samples from each microemulsion, the data 
are presented in Table 4.2.  The range of mean particle diameters was 4.7 to 6.8 nm.  No 
correlation between cosurfactant structure and microemulsion diameter was observed. 
Pomponio et al. [8] reported microemulsion sizes ranging from 3.4 to 35.4 nm at 20°C 
for nine microemulsions with different cosurfactants at varying concentrations.  In 
comparison, the size of the DDCV microemulsions was not largely affected by 
cosurfactant identity (among the seven alcohols examined) when a concentration of 131 
mM was used.  It can be inferred from these data that the alcohols selected for this study 
are interdispersed between surfactant monomers in a similar fashion, resulting in similar 
particle sizes. 
 
 
4.3.2 Elution Range, Retention Factors, and Enantioselectivity 
 
The elution range for each microemulsion was calculated with two methods, results are 
shown in Table 4.2.  One measurement utilized the tpsp marker octanophenone and the 
other was calculated using the alkylphenone homologs.  The data using octanophenone 
had a range of 5.3 to 6.8 and decreased in the order 2H > CH > 2P > 1P > 1H > CP > 1B.  
  
112 
Table 4.2.  Particle size analysis for microemulsions and elution ranges with different 
cosurfactants. 
 
 
 
 
Cosurfactant 
Microemulsion 
Mean Particle 
Size (nm) 
Elution Rangea,b) 
(µeo/µme) 
Elution Rangec,d) 
(Alkylphenones) 
Cyclohexanol 4.7 ± 0.2 nm 6.7 5.4 
2-Hexanol 5.1 ± 0.2 nm 6.8 3.6 
1-Pentanol 5.3 ± 0.3 nm 6.1 4.3 
2-Pentanol 5.5 ± 0.2 nm 6.5 6.0 
Cyclopentanol 5.6 ± 0.3 nm 5.5 6.6 
1-Butanol 5.8 ± 0.2 nm 5.3 5.8 
1-Hexanol 6.8 ± 0.3 nm 5.7 3.6 
 
a) Elution range calculated using the microemulsion marker octanophenone. 
b) Average based on 10-24 injections. 
c) Elution range calculated from alkylphenones. 
d) Average based on 15-26 injections. 
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For all but two microemulsions, cyclopentanol and 1-butanol, the elution range 
determined using the alkylphenones was lower than that calculated with octanophenone.  
The variation in elution range between the two methods is due to the fact that methylene 
selectivity (separation of alkylphenones) was studied separately from the 
enantioselectivity (separation of chiral analytes, octanophenone analysis also performed).  
As previously described [11], the iterative method for tpsp computations with DDCV 
microemulsions has not been completely reliable and was not used to calculate elution 
range or retention factors.  In this study, the correlation coefficients for the ln k vs. n fit 
were all 0.999 and greater.  The elution ranges from this approach had values from 3.6 to 
6.6 and an order of CP > 2P > 1B > CH > 1P > 1H > 2H.  All retention factor calculations 
were performed with the octanophenone data because this marker was analyzed at the 
same time as the enantiomers, and under identical capillary conditions, therefore 
providing a more accurate measure of the PSP mobility at the time of chiral separation. 
 
The retention factor data for the seven microemulsions tested were analyzed for changes 
in elution order.  For the enantiomers tested, all retention factors fell within the range of 
0.7-5.0.  Changes in cosurfactant did not result in significant changes in retention.  The 
enantiomers of synephrine eluted first for all microemulsion systems, followed by the 
enantiomers of atenolol.  In all cases, the enantiomers of metoprolol had the largest 
retention factors.  Since the only chiral entity in the microemulsion was held to a constant 
stereochemical configuration (R-DDCV), no changes in elution order for a pair of 
enantiomers were expected or observed.   
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Among the ephedrine derivatives (ephedrine (e), N-methyl ephedrine (N), and 
pseudoephedrine (p)), however, variations in elution order of the enantiomer peaks were 
observed (see Figure 4.1).  With 1-butanol and 1-pentanol microemulsions, the order of 
retention factors for (e), (N), and (p) was p1 < N1 < e1 < N2 < p2 < e2.  The retention 
factor orders with 2-pentanol, 1-hexanol, and 2-hexanol were N1 ≈ p1 < N2 < e1 < p2 < 
e2, p1 < N1 < N2 < p2 < e1 < e2, and p1 < N1 < N2 < p2 < e1 < e2, respectively.  In six 
of the seven microemulsions, a pseudoephedrine enantiomer eluted first.  N-methyl 
ephedrine eluted first when 2-pentanol was employed as the cosurfactant.  The majority 
of the time, 6 out of 7 systems, the second enantiomer of ephedrine eluted last among the 
ephedrine derivatives.  These results indicate that the cosurfactant identity has a 
significant impact on retention, elution order, and thus selectivity among different 
pharmaceutical compounds.  It is beneficial to be able to tune selectivity via a parameter 
such as cosurfactant identity in the event of coeluting peaks.   
 
Another aspect of the retention factor data examined was the optimal retention factor, kopt, 
which is determined by the elution range and relative electrophoretic mobilities of the 
analytes.  Values of kavg (the average retention factor for each pair of enantiomers) and 
the ratio kavg/kopt are given in Table 4.3.  When kavg deviates considerably from kopt (or 
when kavg/kopt deviates significantly from unity), the resolution that is obtainable will 
decrease.  Overall, the cosurfactant 1-butanol provided average retention factors closest 
to the optimal for five out of six analytes.  The last analyte, metoprolol, was retained 
most optimally with 2-hexanol.  The correlation between kavg/kopt and Rs in this study is 
discussed in section 4.3.3. 
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Figure 4.1.  Changes in elution order for ephedrine derivatives with different 
cosurfactants.  Cosurfactant identities:  1B = 1-butanol, 1P = 1-pentanol, 2P = 2-pentanol, 
1H = 1-hexanol, 2H = 2-hexanol, CP = cyclopentanol, and CH = cyclohexanol.  Analyte 
identities:  e1 = ephedrine enantiomer 1, e2 = ephedrine enantiomer 2, N1 = N-methyl 
ephedrine enantiomer 1, N2 = N-methyl ephedrine enantiomer 2, p1 = pseudoephedrine 
enantiomer 1, p2 = pseudoephedrine enantiomer 2. 
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Table 4.3:  Comparison of average retention factor and optimal retention factor with different 
cosurfactants. 
 
  
 1-Butanol 1-Pentanol 2-Pentanol 1-Hexanol 2-Hexanol Cyclopentanol Cyclohexanol 
 
Compound kavg 
! 
kavg
kopt
a) 
kavg 
! 
kavg
kopt
a) kavg 
! 
kavg
kopt
a) kavg 
! 
kavg
kopt
a) kavg 
! 
kavg
kopt
a) kavg 
! 
kavg
kopt
a) kavg 
! 
kavg
kopt
a) 
Ephedrine 2.53 0.94 2.05 0.69 2.25 0.70 2.12 0.69 1.93 0.59 2.64 0.90 2.14 0.72 
N-methyl ephedrineb) 2.33 0.86 1.95 0.64 2.04 0.63 1.92 0.71 1.73 0.68 2.41 0.82 2.10 0.71 
Pseudoephedrineb) 2.32 0.87 1.97 0.66 2.12 0.73 1.88 0.66 1.69 0.69 2.41 0.82 2.08 0.68 
Atenolol 1.01 0.38 0.85 0.28 0.94 0.32 0.79 0.27 0.84 0.26 1.02 0.38 0.92 0.31 
Metoprolol 4.35 1.67 3.50 1.21 3.75 1.19 3.78 1.35 3.69 1.19 4.79 1.70 3.83 1.35 
Synephrine 0.94 0.34 0.72 0.24 0.82 0.28 0.69 0.26 0.73 0.23 0.94 0.32 0.83 0.27 
               
Arithmetic Mean 2.25 0.84 1.84 0.62 1.99 0.64 1.87 0.66 1.77 0.61 2.37 0.82 1.98 0.67 
Geometric Mean 1.96 0.73 1.60 0.54 1.74 0.57 1.59 0.56 1.53 0.52 2.03 0.71 1.73 0.58 
 
a) kopt calculated via eqn. (1.8). 
b) Pseudoephedrine and N-methyl ephedrine data for the 2-hexanol microemulsion previously 
published [13].
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Of greater interest was the effect of cosurfactant on enantioselectivity.  Initially, the 
results were analyzed prior to collection of the 1-butanol data.  The trend for 
enantioselectivity, at that point, was enhanced enantioselectivity with the employment of 
secondary alcohols with shorter chains or cyclic structures.  After enantioselectivities 
with 1-butanol were calculated, the trend was not as clear-cut, as shown by the data in 
Table 4.4.  The cosurfactant 1-butanol replaced cyclopentanol as the provider of the 
highest enantioselectivity for two compounds and ranked second for the other four 
analytes.  For ephedrine, the cosurfactant order in terms of enantioselectivity was CP > 
1B > 2P > CH > 2H > 1P > 1H with a range of 1.096-1.076.  With the exception of the 1-
butanol microemulsion, the other analytes also had a trend of larger enantioselectivity 
values with secondary alcohols:  2P > 1B > CP > CH > 2H > 1H > 1P for N-methyl 
ephedrine (range of 1.088-1.073), 1B > CP > 2P > CH > 1P > 2H > 1H for 
pseudoephedrine (range of 1.179-1.129), CP ≈ 1B > 2P > CH > 2H > 1P > 1H for 
atenolol (range of 1.033-1.023), CP > 1B > CH > 2P > 2H > 1P > 1H for metoprolol 
(range of 1.069-1.051), and 1B ≈ CP > 2P > CH > 2H > 1P > 1H for synephrine (range of 
1.061-1.049).  In terms of atenolol, the poor enantioselectivity results from both the 
higher hydrophilicity of this compound,  meaning less interaction with the hydrophobic 
chiral microemulsion, and the large group containing the chiral center that could prohibit 
adequate interaction with the chiral selector.  Primary alcohols with carbon chains longer 
than that of 1-butanol gave the worst enantioselectivities for all compounds tested.   
 
Based on these data, the secondary alcohols most likely align between the surfactant 
chains in such a way that the chiral center is more open and accessible, thus improving 
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Table 4.4.  Changes in enantioselectivity values with different cosurfactantsa,b). 
 
 
 
Compound 
1B 
αenant 
1P 
αenant 
2P 
αenant 
1H 
αenant 
2H 
αenant 
CP 
αenant 
CH 
αenant 
Atenolol 1.033 1.025 1.031 1.023 1.027 1.033 1.030 
Synephrine 1.061 1.054 1.060 1.049 1.055 1.061 1.057 
Metoprolol 1.064 1.056 1.059 1.051 1.058 1.069 1.061 
N-methyl ephedrinec) 1.087 1.073 1.088 1.074 1.078 1.085 1.081 
Ephedrine 1.092 1.077 1.090 1.076 1.082 1.096 1.085 
Pseudoephedrinec) 1.179 1.141 1.165 1.129 1.135 1.167 1.154 
        
Arithmetic Mean 1.086 1.071 1.082 1.067 1.073 1.085 1.078 
 
a) Microemulsion formulation:  2% w/v R-DDCV, cosurfactant v/v% as in Table 4.1, 0.5% v/v ethyl acetate, 50 mM 
phosphate buffer, pH 7.0. 
b) Values based on an average of 14-23 injections, % RSD’s less than 0.5%. 
c) N-methyl ephedrine and pseudoephedrine results for 2-hexanol previously published [13].
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the enantioselectivity.  The cyclic alcohols would not be able to align with the surfactant 
tails due to their puckered conformation (chair or boat), providing a better opportunity for 
analytes to come in contact with the chiral selectand.  The high enantioselectivity values 
for 1-butanol, although not expected, are reasonable when the chain of this alcohol is 
considered.  The trend for the other primary alcohols showed greater enantioselectivity 
with shorter chain length.  The alkyl chain in 1-butanol is the shortest chain in this study 
and resulted in the largest enantioselectivity values for a primary alcohol.  Another factor 
that could influence the enantioselectivity values is the amount of water inside the 
microemulsion droplet.  The orientation of the cosurfactant among the surfactant head 
groups could allow more or less water to enter the aggregate.  Hydrogen bonding 
between the water molecules and analytes could improve the interaction with the chiral 
selectand, thus improving enantioselectivity.  Primary alcohols would inhibit water 
penetration into the PSP, resulting in lower enantioselectivity values and a more 
hydrophobic PSP.  Secondary alcohols open up more space between the surfactant head 
groups, increasing the water concentration and enantioselectivity.  The microemulsions 
with more aqueous internal environments would be less hydrophobic and this would also 
be reflected in a lower methylene selectivity [14, 15]. 
 
4.3.3 Efficiency and Resolution 
The effect of each alcohol on efficiency and resolution was analyzed to gain further 
insight into the preferred cosurfactant.  As shown in Table 4.5, the average efficiencies 
varied by almost 50% for most of the analytes among the cosurfactants tested.  Ephedrine 
efficiencies increased with different alcohols in the order of 2P < CH ≈ 2H < 1B < CP <  
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Table 4.5.  Efficiencies obtained with R-DDCV microemulsions with various cosurfactantsa). 
 
 
 
Compound: 
1H 
Navg 
1P 
Navg 
2H 
Navg 
1B 
Navg 
CP 
Navg 
2P 
Navg 
CH 
Navg 
N-methyl ephedrineb) 82600 76300 82900 63500 68600 48400 54500 
Ephedrine 83500 84200 62700 68500 70100 54200 61900 
Metoprolol 91900 75100 77200 76600 73400 69600 56900 
Pseudoephedrineb) 94800 79500 85100 60200 54700 58800 45800 
Atenolol 98900 89300 89800 115800 117800 70800 71800 
Synephrine 100600 67600 72200 72800 72100 47100 54600 
        
Minimum value 82600 67600 62700 60200 54700 47100 45800 
Arithmetic Mean 92000 78700 78300 76200 76100 58100 57600 
 
a) Average efficiency for enantiomer peaks 1 and 2. 
b) N-methyl ephedrine and pseudoephedrine data with 2-hexanol previously published [13].
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1H < 1P, ranging from 54,200 to 84,200 plates.  Improvements in efficiency for N-methyl 
ephedrine progressed from 2-pentanol to 2-hexanol (2P < CH < 1B < CP < 1P < 1H ≈ 
2H, ranging from 48,400 to 82,900).  Pseudoephedrine, the last ephedrine derivative 
tested, had the highest efficiency with 1-hexanol and the lowest with cyclohexanol (CH < 
CP < 2P < 1B < 1P < 2H < 1H, range 45,800-94,800).  The order of increasing efficiency 
for atenolol was 2P < CH < 1P ≈ 2H < 1H < 1B < CP (range 70,800-117,800).  The final 
two analytes, metoprolol and synephrine, showed improvements in efficiency in the 
sequence CH < 2P < CP < 1P < 1B < 2H < 1H (range 56,900-91,900) and 2P < CH < 1P 
< CP ≈ 2H < 1B < 1H (range 47,100-100,600), respectively.   
 
Comparing the cosurfactants in terms of best enantioselectivity and efficiency, there was 
only one instance where one alcohol provided the highest result for both:  cyclopentanol 
for the analyte atenolol.  A trade-off occurred between increasing the enantioselectivity 
and maintaining high efficiencies.  It is hypothesized that the three-point interaction 
required for chiral separations results in slower mass transfer.  Most likely, each 
intermolecular interaction in the chiral mechanism (described in section 1.3) will not 
occur at the same time, leading to longer association times for stereoselective interactions 
over non-stereoselective ones.  The slower interaction decreases mass transfer and 
efficiency.  The secondary alcohols, which overall enhanced enantioselectivity, gave 
some of the lowest efficiency values.  For all of the analytes, either cyclohexanol or 2-
pentanol had the worst efficiency data.  The selection of cosurfactant to provide the most 
efficient peaks is analyte dependent with 1-hexanol performing the best for three 
  
122 
compounds and 1-pentanol, 2-hexanol, and cyclopentanol ranking first for one compound 
each. 
 
Given the relationship between resolution and the other chromatographic figures of merit 
(efficiency, selectivity, retention, and elution range) shown in the equation below, 
! 
Rs =
N
4
" #1
"
$ 
% 
& 
' 
( 
) 
k
2
1+ kavg
$ 
% 
& & 
' 
( 
) ) 
1+ µr # to / t psp
1+ µr + (to / t psp )kavg
$ 
% 
& & 
' 
( 
) )     (1.6) 
it is not surprising that the trends in resolution did not mirror those in efficiency or 
enantioselectivity (data in Table 4.6).  There were some cases where the cosurfactant 
rank for resolution matched that for efficiency or enantioselectivity.  Ephedrine had the 
worst enantioselectivity with 1-hexanol, which also resulted in the lowest resolution (Rs 
of 2.34 with a high value of 2.50, 1H ≈ 2P < CP ≈ 1P < 1B < 2H < CH).   Interestingly, 
the alcohol that gave the best enantioselectivity for N-methyl ephedrine, 2-pentanol, 
provided the worst efficiency and resolution.  The range of resolutions was 2.07-2.32 
with an order of 2P < 2H < 1P < 1B < 1H ≈ CP < CH.  Representative electropherograms 
are shown for each microemulsion in Figures 4.2 and 4.3.  Two cosurfactants had the 
same ranking for pseudoephedrine in terms of efficiency and resolution:  1-pentanol (3rd 
highest) and cyclopentanol (next to the last).  Resolution ranged from 3.45-4.36 for 
pseudoephedrine with an alcohol order of 2H < CP < CH ≈ 1H < 1P < 1B < 2P.  The two 
best cosurfactants for atenolol resolution, efficiency, and enantioselectivity were 
cyclopentanol (Rs of 0.93, N of 117,800, αenant of 1.033) and 1-butanol (Rs of 0.92, N of 
115,800, αenant of 1.033).  The order of increasing resolution for atenolol was 1H < 1P < 
2P < CH ≈ 2H < 1B ≈ CP (range 0.57-0.93).  Although this particular analyte was not  
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Table 4.6.  Resolution achieved with different cosurfactant identity for DDCV 
microemulsions. 
 
 
 
Compound 
1B 
Rs 
1P 
Rs 
2P 
Rs 
1H 
Rs 
2H 
Rs 
CP 
Rs 
CH 
Rs 
Atenolol 0.92 0.67 0.72 0.57 0.73 0.93 0.73 
Synephrine 1.34 1.05 1.02 1.10 1.21 1.38 1.17 
Metoprolol 1.62 1.65 1.71 1.72 1.97 1.74 1.87 
N-methyl ephedrinea) 2.21 2.12 2.07 2.29 2.10 2.29 2.32 
Ephedrine 2.42 2.36 2.34 2.34 2.48 2.36 2.50 
Pseudoephedrinea) 4.32 4.10 4.36 3.68 3.45 3.61 3.67 
        
Minimum Value 0.92 0.67 0.72 0.57 0.73 0.93 0.73 
Arithmetic Mean 2.14 1.99 2.04 1.95 1.99 2.05 2.04 
Geometric Mean 1.90 1.69 1.73 1.67 1.78 1.88 1.80 
 
a) N-methyl ephedrine and pseudoephedrine data with 2-hexanol previously published 
[13].
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Figure 4.2.  Effect of cosurfactant identity on the separation of N-methyl ephedrine 
enantiomers using chiral microemulsion electrokinetic chromatography (chiral MEEKC) 
based on dodecoxycarbonylvaline.  A) 1-pentanol (1.40% v/v); B) 2-pentanol (1.40% 
v/v); C) 1-hexanol (1.65% v/v); D) 2-hexanol (1.65% v/v). Other conditions: 2% (w/v) 
DDCV; 0.5% (v/v) ethyl acetate; 50 mM phosphate buffer, pH 7.0; detection wavelength 
= 215 ± 5 nm; capillary dimensions:  Ltot = 32 cm, Leff = 23.6 cm, i.d. = 50 µm; 
hydrodynamic injection = 25 mbar for 2 s; applied voltage = 11.5 kV.
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Figure 4.3:  Effect of cosurfactant identity on the separation of N-methyl ephedrine 
enantiomers using chiral microemulsion electrokinetic chromatography (chiral MEEKC) 
based on dodecoxycarbonylvaline.  A) 1-butanol (1.20% v/v); B) Cyclopentanol (1.19% 
v/v); C) Cyclohexanol (1.39% v/v).  Other conditions as in Figure 4.2. 
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baseline resolved (four of six enantiomer pairs were baseline resolved), the separation 
differences observed with the seven microemulsions are readily apparent from the 
electropherograms in Figures 4.4 and 4.5.  Metoprolol had the same rank for 
enantioselectivity and resolution with 1-pentanol (second worst).  The resolution range 
for this compound was 1.62 to 1.97 with an order of 1B < 1P < 2P < 1H < CP < CH < 
2H.  Synephrine had three instances where the efficiency rank of a cosurfactant matched 
its resolution rank:  second highest was 1-butanol (Rs of 1.34, N of 72,800), third highest 
was 2-hexanol (Rs of 1.21, N of 72,200) and lowest was 2-pentanol (Rs of 1.02, N of 
47,100).  The resolution obtained increased in the order 2P < 1P < 1H < CH < 2H < 1B < 
CP with a range of 1.02-1.38 for synephrine.  The data for efficiency and resolution did 
not demonstrate a direct relationship.  Improvements made in efficiency for certain 
alcohols did not necessarily result in increases in resolution.  Only one compound, 
atenolol, had the best efficiency and resolution with the same cosurfactant.  The results 
further support the conclusion that the selection of the best cosurfactant for a particular 
chiral separation is dependent on the analyte. 
 
Other chromatographic figures of merit being equal, resolution should be highest when 
retention factors are near their optimum.  Given the slight to moderate changes in these 
figures of merit, it was expected that kavg/kopt ratio (Table 4.3) and resolution (Table 4.6) 
would not be perfectly correlated.  There were, however, several instances where the 
proximity to kopt was reflected in Rs:  the cosurfactant 1-pentanol for synephrine (second 
worst); 2-pentanol for N-methyl ephedrine (worst); 1-hexanol for metoprolol (fourth best) 
and synephrine (fifth best); 2-hexanol for metoprolol (best); cyclohexanol for 
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Figure 4.4.  Effect of cosurfactant identity on the separation of atenolol enantiomers 
using chiral MEEKC.  Other conditions as in Figure 4.2. 
  
128 
 
 
 
Figure 4.5.  Effect of cosurfactant identity on the separation of atenolol enantiomers 
using chiral MEEKC.  Other conditions as in Figure 4.3.
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pseudoephedrine (fifth best), atenolol (fourth best), and synephrine (fourth best); and 
cyclopentanol for N-methyl ephedrine (second best). 
 
4.3.4 Methylene Selectivity 
Microemulsions with different cosurfactants were also analyzed for variations in 
methylene selectivity.  Methylene selectivity demonstrates how well the aggregate can 
separate analytes differing in their number of methylene (CH2) groups.  The use of 
alcohols with different structures (primary versus secondary, straight chain versus cyclic, 
and varying length of alkyl chain) showed changes in the ability to distinguish between 
similar analytes (alkylphenone homologs).  The order for decreasing methylene 
selectivity was 1H > 2H > 1P > 2P ≥ CH ≥ 1B > CP with a range of 2.731-2.475, see 
Table 4.7 and Figure 4.6.  The microemulsion formulated with the longest chain primary 
alcohol (1-hexanol) provided the largest methylene selectivity.  The next highest result 
was obtained with the secondary alcohol having the longest chain (2-hexanol).  
Methylene selectivity continued to decrease with primary alcohol chain length (1-
pentanol) followed by the secondary alcohol (2-pentanol).  The cyclic and shortest chain 
cosurfactants (cyclopentanol, cyclohexanol, and 1-butanol) resulted in the lowest 
methylene selectivities.  The cosurfactant 1-butanol had a methylene selectivity value in 
between those of the cyclic alcohols.  The methylene selectivities for 2-pentanol, 
cyclohexanol, and 1-butanol are not statistically different from each other, demonstrating 
that the hydrophobic nature of these microemulsion formulations is very similar.  These 
results indicate that the cosurfactant plays a vital role in the analyte partition mechanism.  
There are two potential contributing factors to explain the impact of cosurfactant on the 
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Table 4.7.  Methylene selectivity observed with different cosurfactants. 
 
Cosurfactant αmetha) 
Cyclopentanol 2.475 ± 0.005 
1-Butanol 2.496 ± 0.015 
Cyclohexanol 2.498 ± 0.019 
2-Pentanol 2.505 ± 0.023 
1-Pentanol 2.528 ± 0.032 
2-Hexanol 2.632 ± 0.011 
1-Hexanol 2.731 ± 0.004 
 
a) Values based on an average of 15-26 injections.
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Figure 4.6.  Effect of cosurfactant identity on the separation of alkylphenones using chiral 
MEEKC.  A) 1-butanol (1.20% v/v); B) 1-pentanol (1.40% v/v); C) 2-pentanol (1.40% 
v/v); D) 1-hexanol (1.65% v/v); E) 2-hexanol (1.65% v/v); F) Cyclopentanol (1.19% 
v/v); and G) Cyclohexanol (1.39% v/v).  Other conditions as in Figure 4.2. 
  
132 
PSP characteristics:  the ability to partition into the interior of the microemulsion and the 
aggregate polarity.  In terms of the first factor, the longer alkyl chain enhances the ability 
of hydrophobic compounds to penetrate into the aggregate.  When the chain is shortened 
or the steric hindrance of the alcohol increases, the analyte cannot easily access the 
interior portion of the microemulsion.  The cyclic alcohols further inhibited the depth to 
which the alkylphenones could partition, thereby reducing the capability of the 
microemulsion to separate similar compounds.  The other contributor to the observed 
trend is the PSP hydrophobicity.  Since the aqueous phase remained constant for all of the 
systems studied, 50 mM phosphate buffer pH 7, and the microemulsion formulations 
were identical with respect to the functional groups, the methylene selectivity can be used 
as a measure of PSP polarity.  Higher values for methylene selectivity signify a more 
nonpolar, hydrophobic aggregate and vice-versa.  The hydrophobicity is also a sign of 
water penetration into the aggregate.  As previously discussed, the secondary and cyclic 
alcohols would allow more water to partition into the microemulsion, increasing the 
polarity and decreasing the methylene selectivity. 
 
4.4 Concluding Remarks 
The results of this study clearly demonstrate the importance of optimizing the 
cosurfactant identity to obtain the greatest enantioselectivity, efficiency, resolution, and 
methylene selectivity.  The seven alcohols investigated included primary and secondary 
alcohols with varying chain lengths as well, as cyclic structures.  Enantioselectivity 
analysis showed that, overall, secondary or cyclic alcohols enable better separation of 
chiral analytes, with the exception of 1-butanol.  Cyclopentanol gave the best 
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enantioselectivity for ephedrine, atenolol, and metoprolol.  Pseudoephedrine and 
synephrine had the largest enantioselectivity with 1-butanol.  The best enantioselectivity 
for the sixth compound, N-methyl ephedrine, was achieved with the cosurfactant 2-
pentanol. 
 
In contrast to the trends in enantioselectivity, efficiency and resolution results were 
analyte dependent.  Average efficiencies obtained with 1-hexanol were the highest for 
three compounds (pseudoephedrine, metoprolol, and synephrine).  The other three pairs 
of enantiomers required different cosurfactants for the best efficiency:  1-pentanol for 
ephedrine, 2-hexanol for N-methyl ephedrine, and cyclopentanol for atenolol.  The 
efficiency values varied by as much as 50% with the alcohols tested.  Four different 
cosurfactants resulted in the best enantiomer resolution values:  cyclohexanol (ephedrine 
and N-methyl ephedrine), cyclopentanol (atenolol and synephrine), 2-pentanol 
(pseudoephedrine), and 2-hexanol (metoprolol).  Atenolol was the only compound where 
the highest and second highest enantioselectivity, efficiency, and resolution were 
achieved with the same alcohol (cyclopentanol and 1-butanol, respectively).  In several 
instances, the cosurfactant rank was the same for two chromatographic figures of merit.   
 
Another characteristic of the chromatographic figures of merit analyzed was the change 
in resolution with respect to the optimal retention factor.  When retention approaches the 
optimal value, resolution should increase.  In this study, a loose correlation between kopt 
and Rs was observed in which some compounds exhibited increased resolution when 
retention was closest to optimum and decreased resolution when retention was less 
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optimal.  There is a complex relationship when improving enantioselectivity, efficiency, 
or resolution in terms of microemulsion cosurfactant identity where the analyte identity 
must also be considered. 
 
The performance of each microemulsion in separating compounds differing only in the 
number of methylene groups (alkylphenone homologs) varied with cosurfactant structure.  
A correlation was evident between higher methylene selectivity values and alcohol 
substituent position (primary versus secondary) and chain length.  The longest chain 
primary alcohol, 1-hexanol, provided better discrimination between the homologs with 
the secondary alcohol of this base alkane coming in second, 2-hexanol.  The worst 
methylene selectivities were obtained with the cyclic alcohols (cyclopentanol and 
cyclohexanol) and the shortest primary alcohol (1-butanol).  
 
Overall, the results of this study clarify the cosurfactant role in chiral MEEKC 
separations using the chiral surfactant DDCV.  Alcohols that increase the space between 
surfactant headgroups and the water content of the aggregate (i.e., bulkier, non-straight 
chain) enhance the interaction of chiral analytes with the chiral selectand, increasing 
enantioselectivity.  Improvements in methylene selectivity can be accomplished by using 
a longer chain primary alcohol as the cosurfactant, in effect increasing the 
hydrophobicity.  Thus, the specific analytes to be separated must be considered when 
selecting a cosurfactant. 
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Chapter 5:  Two-Chiral-Component Microemulsion Electrokinetic 
Chromatography—Chiral Surfactant and Chiral Oil, Part 1:  Dibutyl Tartrate 
 
 
 
5.1 Introduction 
A wide variety of surfactants, cosurfactants, and oils have been used in microemulsion 
formulations for MEEKC [1].  Significantly fewer options are available when a chiral 
microemulsion is being prepared.  The chiral surfactant dodecoxycarbonylvaline (DDCV) 
has been used in a number of MEEKC studies as the sole chiral contributor for the 
separation of enantiomers [2-6].  There has been one report where chiral cosurfactants 
with an achiral surfactant and oil effectively differentiated chiral pharmaceutical 
compounds [7].  Another chiral MEEKC study incorporated the chiral oil dibutyl L-
tartrate into a microemulsion with an achiral surfactant and cosurfactant; it was effective 
in separating the enantiomers of ephedrine [8].  In the first and only publication of its 
kind to date, we detailed the combination of multiple chiral components in a 
microemulsion formulation [9].  A chiral surfactant, DDCV (R- and S-), and a chiral 
cosurfactant, S-2-hexanol, were used to separate the enantiomers of N-methyl ephedrine 
and pseudoephedrine.  A synergistic effect was found with this dual-chirality system.  In 
our current research, we examined two-chiral-component microemulsions assembled 
with the chiral surfactant DDCV (R- and S-) and the chiral oil dibutyl tartrate (D- and L-) 
for the separation of pharmaceutical enantiomers.  Chiral tartrates have been used in 
chiral liquid-liquid extraction methods (didodecyl L-tartrate [10]), as well as in chiral 
liquid chromatography (dibutyl L-tartrate [11-13]).  In addition, racemic dibutyl tartrate 
has been employed as the oil in non-chiral MEEKC work [14, 15].   
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In this study, four microemulsion formulations with two chiral components were 
prepared; all systems contained racemic 2-hexanol as the cosurfactant and 50 mM 
phosphate buffer at a pH of 7.  Results from these PSPs, covering all possible 
combinations of R- or S-DDCV with dibutyl D- or dibutyl L-tartrate, were evaluated in 
comparison with one-chiral-component microemulsions (chiral surfactant only or chiral 
oil only) for changes in enantioselectivity, efficiency, resolution, methylene selectivity, 
and Gibb’s free energy differences.  The data show improvements in enantioselectivity 
and resolution when using DDCV/dibutyl tartrate dual-chirality microemulsions over the 
single component formulations.  Efficiency and methylene selectivity decreased when the 
oil stereochemistry was changed from racemic to chiral.  The trends varied depending on 
the analyte identity.  The ephedrine derivatives (ephedrine, pseudoephedrine, and N-
methyl ephedrine) had higher enantioselectivities when the chiral surfactant and chiral oil 
stereochemical configurations were opposite of each other.  One compound, atenolol, 
could not be separated with any of the dibutyl tartrate formulations, although it has been 
minimally resolved with similar ethyl acetate microemulsions (previously reported [16]).  
Synergies from using a chiral surfactant in conjunction with a chiral oil were found for all 
but one compound (five out of six).  These findings are consistent with those from the 
first study of dual-chirality microemulsions in which both the surfactant and cosurfactant 
components were chiral. 
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5.2 Results and Discussion 
5.2.1 Microemulsion Formulations and Stability 
The overall formulation for the dual-chirality microemulsions in this study was adapted 
from the previously reported system in which ethyl acetate was utilized as the oil [16].  
The millimolar concentration of oil was held constant, but the identity was changed. 
Comparing ethyl acetate and dibutyl tartrate, the former is a low-interfacial-tension oil 
while the latter is more hydrophobic and of higher density.  The difference was readily 
apparent during microemulsion preparation with dibutyl tartrate settling to the bottom 
and forming large droplets.  The hydrophobicity of this oil required longer sonication 
times to create clear solutions.  Once solubilized, the microemulsions were stable over 
several months.  
 
The chiral surfactant and chiral oil were obtained in both stereochemical configurations:  
R- and S-DDCV, and dibutyl L-tartrate (RR = “R”) and dibutyl D-tartrate (SS = “S”).  
The cosurfactant was racemic 2-hexanol.  A total of six microemulsions were tested, 
including four with both chiral components, one with only the chiral surfactant (50/50 
(w/w) mixture of dibutyl R- and dibutyl S-tartrate, total concentration 1.23% (v/v)), and 
one with only the chiral oil (50/50 (w/w) mixture of R- and S-DDCV, total concentration 
of 2% (w/v)), see Table 5.1.  The microemulsions are identified by a three-letter 
abbreviation with the first letter signifying the surfactant stereochemical configuration, 
the second letter the cosurfactant, and the last letter for the oil; the letter X represents a 
racemic component.  The baselines obtained with the dibutyl formulations were not as 
consistent as those from previous ethyl acetate studies.  In particular, within the first six  
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Table 5.1.  Microemulsion compositionsa), abbreviationsb), and elution ranges. 
 
 
DDCV 
Stereochemistry 
Dibutyl Tartrate 
Stereochemistryc) 
Microemulsion 
Abbreviation 
 
Elution range 
R R RXR 3.6 
S R SXR 3.4 
X R XXR 3.4 
R S RXS 3.3 
S S SXS 3.3 
R X RXX 3.0 
 
a) Surfactant (DDCV) concentration was 2.00% w/v (60.7 mM); racemic 
cosurfactant (2-hexanol) concentration was 1.65% v/v (131 mM); oil (dibutyl 
tartrate) concentration was 1.23% v/v (51.2 mM); and buffer was 50 mM 
phosphate at a pH of 7.0. 
b) The first letter signifies surfactant configuration, followed by cosurfactant, and 
then oil.  The letter X is for racemic components. 
c) The configurations (abbreviations) of dibutyl L-tartrate and dibutyl D-tartrate are 
2R, 3R- (R) and 2S, 3S- (S), respectively.
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minutes of a run, the baseline became erratic even though the current was steady and 
Joule heating was near the expected value.  This situation necessitated a sequence of 
several short runs and multiple conditionings.  Once a steady baseline was achieved, the 
separations proceeded without incident. 
  
5.2.2 Effect of Microemulsion Component Stereochemistry on Retention Factor 
and Elution Range 
 
Retention factors for each pair of enantiomers varied minimally with microemulsion 
component stereochemistry; data reported here are the average retention factors for the 
five pairs of enantiomers.  Metoprolol showed the greatest change, with the lowest 
retention factor of 3.14 observed using RXR compared to the highest retention factor of 
3.28 observed using SXS.  The average retention factor ranges for the remaining analytes 
were:  1.61 to 1.66 for ephedrine (XXR to RXX/SXS); 1.41 to 1.48 for pseudoephedrine 
(XXR to RXX); 1.48 to 1.57 for N-methyl ephedrine (SXR to RXX); and 0.59 to 0.62 for 
synephrine (SXR to XXR).  The ephedrine derivatives had the most retention with the one-
chiral-component microemulsion RXX.   
 
In contrast to the very small changes in retention factors observed with the different 
microemulsion stereochemistries, the elution range changed moderately as the 
microemulsion component stereochemistry was varied (Table 5.1).  The smallest elution 
range (3.0), determined using the microemulsion marker octanophenone, was obtained 
with RXX.  The RXR microemulsion provided the largest elution range (3.6).  Elution 
ranges were almost identical between the octanophenone and alkylphenone methods; the 
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largest difference was 0.2.  Since octanophenone had been added to the samples in the 
later stages of experimentation, it was used to estimate the elution range and to calculate 
retention factors.  In addition, RXX and RXR had the smallest and largest elution ranges, 
respectively, regardless of the marker compound(s). 
   
5.2.3 Effect of Microemulsion Component Stereochemistry on Enantioselectivity 
The ability of a chiral selectand to discriminate between enantiomers is measured via the 
enantioselectivity value, αenant.  Of the six chiral analytes tested, the three ephedrine 
derivatives experienced greater overall changes in enantioselectivity.  The enantiomeric 
pair of one compound, atenolol, could not be separated using any of the dibutyl tartrate 
microemulsions.  In some instances, there was a hint of separation, but it could not be 
properly integrated and was not reproducible.  When analyzed with the ethyl acetate 
version of this PSP, atenolol had the smallest enantioselectivity (identical sample set), 
αenant = 1.027, and was not baseline resolved [16].  Therefore, atenolol was excluded from 
the remainder of this discussion. 
 
Enantioselectivity data are summarized in Table 5.2 along with the microemulsion 
rankings; values are arranged in decreasing order by microemulsion stereochemistry (left 
to right) and by compound (top to bottom).  All separations were performed on three 
separate days; the percent RSD was less than 0.5% for all microemulsions except N-
methyl ephedrine with XXR (0.6% RSD).  Notably, the elution order for a pair of 
enantiomers changed only when the stereochemical configuration of the surfactant was 
changed. 
  
143 
  
Table 5.2. Effect of microemulsion component stereochemistry (surfactant and oil) on enantioselectivity.a)  
 
 
 
Compound \ αenant 
 
RXS 
 
SXR 
 
RXX 
 
RXR 
 
SXS 
 
XXRb) 
Compound 
Meanc) 
 
Microemulsion Rankingd) 
Pseudoephedrine 1.111 1.109 1.107 1.102 1.098 1.009 1.105 RXS > SXR ≈ RXX > RXR > SXS >> XXR > 1 
N-methyl ephedrine 1.075 1.072 1.067 1.062 1.059 1.009 1.067 RXS > SXR > RXX > RXR > SXS >> XXR > 1 
Ephedrine 1.070 1.071 1.064 1.062 1.055 1.005 1.064 SXR ≈ RXS > RXX > RXR > SXS >> XXR > 1 
Metoprolol 1.042 1.041 1.044 1.047 1.046 < 1.02 1.044 RXR > SXS > RXX > RXS > SXR > XXR ≈ 1 
Synephrine 1.038 1.036 1.038 1.038 1.040 < 1.02 1.038 SXS ≈ RXX ≈ RXS ≈ RXR ≈ SXR > XXR ≈ 1 
         
Arithmetic mean 1.067 1.066 1.064 1.062 1.060 < 1.01 N/A N/A 
Geometric mean 1.067 1.065 1.064 1.062 1.059 < 1.01 N/A N/A 
 
a) Microemulsion composition as in Table 5.1. 
b) Individual enantiomers were analyzed separately for ephedrine, N-methyl ephedrine, and pseudoephedrine, but were not 
available for metoprolol and synephrine; the enantioselectivity inequalities reported for the latter 2 compounds reflect the 
minimum enantioselectivity needed to achieve a minimum observable separation.  
c) XXR enantioselectivities were excluded in the compound mean statistics because values for all 5 compounds were not 
available. 
d) The greater than symbol, >, indicates a statistically significant difference and the approximately equal symbol, ≈, indicates 
a small difference (0.002 and less) that is not statistically significant.
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Among the ephedrine-related compounds, the highest enantioselectivities were observed 
for pseudoephedrine, ranging from 1.111 to 1.009.  Interestingly, the racemic surfactant 
formulation (XXR) was ineffective in resolving any of the pairs of the ephedrine-related 
compounds (ephedrine, pseudoephedrine, and N-methyl ephedrine), therefore the 
individual enantiomers were injected separately and a t-test was performed to confirm 
that the results were statistically different from 1.  This finding conflicts qualitatively 
with that reported in 1993 by Aiken and Huie [8], where a selectivity value of 2.6 was 
obtained for ephedrine with a microemulsion of SDS/1-butanol/dibutyl L-tartrate; Aiken 
and Huie’s results could not be reproduced in our laboratory using their experimental 
protocol.  Although the surfactant identity and concentrations of microemulsion 
components differ somewhat in the two studies, it is nonetheless surprising that the 
enantioselectivity could be so different for two similar microemulsions (similar anionic 
surfactants, similar co-surfactant) in which the only chiral component—the chiral oil—
was the same.   
 
The second highest enantioselectivities were observed for N-methyl ephedrine, and they 
varied from 1.075 to 1.009.  The ranking was the same as for pseudoephedrine, except 
that the enantioselectivities using the RXS and SXR microemulsions were also statistically 
different.  Finally, for ephedrine the enantioselectivities ranged from 1.071 to 1.005.  
Representative electrokinetic chromatograms for ephedrine are shown in Figure 5.1.  
Although acceptable results were obtained with each microemulsion, subtle changes were 
achieved by changing stereochemical combinations.   
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Figure 5.1.  Effect of surfactant and oil stereochemical configurations on the separation 
of ephedrine.  (A) RXX microemulsion, (B) RXR microemulsion, (C) SXR microemulsion, 
(D) RXS microemulsion, and (E) SXS microemulsion.  Surfactant concentration = 2.00% 
w/v; cosurfactant concentration = 1.65% v/v; oil concentration = 1.23% v/v; 50 mM 
phosphate buffer, pH 7.0.  Capillary dimensions:  Ltot = 32 cm, Leff = 23.6 cm, i.d. = 50 
µm.  Detection wavelength was 215 ± 5 nm, injections were performed 
hydrodynamically for 2 seconds with 25 mbar pressure, and the applied voltage was 11.5 
kV.
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The final two analytes, metoprolol and synephrine, did not exhibit as dramatic a change 
in enantioselectivity with the various microemulsions as the ephedrine series.  Metoprolol 
had a range of 1.047 to <1.02.  Racemic metoprolol exhibited no hint of separation with 
XXR, and because the individual enantiomers were not available for separate testing, the 
enantioselectivity is reported as <1.02, the smallest enantioselectivity needed to achieve a 
minimally observable separation.  For synephrine, the enantioselectivity ranged from 
1.040 to <1.02.  As with metoprolol, the microemulsion with racemic surfactant (XXR) 
did not separate synephrine and the individual enantiomers were not available for 
separate testing.   
 
Further examination of the enantioselectivity data in Table 5.2, excluding XXR, revealed 
several additional trends.  First, the dual-chirality microemulsions provided both the 
largest and smallest enantioselectivities for the analytes of the present study.  RXS 
provided the highest or comparable enantioselectivity for all compounds except for 
metoprolol for which it ranked fourth.  SXS ranked lowest for all three ephedrine 
derivatives, while SXR gave the lowest values for metoprolol and synephrine.  Finally, an 
interesting trend was noted for the ephedrine-related compounds (ephedrine, 
pseudoephedrine, and N-methyl ephedrine):  the dual-chiral microemulsions with the 
surfactant and oil in opposite stereochemical configurations (RXS and SXR) provided 
higher enantioselectivities than the single-chiral microemulsion RXX, whereas the dual-
chiral microemulsions with the surfactant and oil in the same stereochemical 
configurations (RXR and SXS) provided lower enantioselectivities than RXX.   
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In summary, the differences in enantioselectivity observed with the various DDCV-2-
hexanol-dibutyl tartrate microemulsions demonstrated that altering the stereochemical 
combinations of chiral components can have an important and often analyte-specific 
effect on enantioselectivity.  Interestingly, the enantioselectivity achieved for most 
enantiomers with the best two-chiral-component microemulsion was slightly better than 
that achieved with the best one-chiral-component microemulsion.   
 
5.2.4 Effect of Microemulsion Component Stereochemistry on Efficiency and 
Resolution  
 
The average efficiencies and resolution values at half-height were evaluated to further 
elucidate the influence of multiple chiral components in a microemulsion on chiral 
separations.  Results are summarized in Tables 5.3 and 5.4, and are ranked in decreasing 
order of Navg or Rs by microemulsion stereochemistry (left to right) and by compound 
(top to bottom).  The rankings for each parameter are also included in Tables 5.3 and 5.4.  
 
The most striking result for the efficiency data of Table 5.3 is the two distinct groups of 
efficiencies based on the stereochemistry of the chiral oil.  When racemic dibutyl tartrate 
and dibutyl D-tartrate were employed (RXX, RXS, and SXS), the efficiencies (averaged 
over all compounds) clustered in a narrow range from 127,000 to 134,000, with the one-
chiral-component microemulsion (RXX) slightly outperforming the dual-chiral-
microemulsions.  In contrast, when dibutyl L-tartrate was employed (RXR, SXR, and 
XXR), the efficiencies again clustered but were significantly lower, ranging from 100,000 
to 105,000.   A similar clustering is observed when the efficiency results for synephrine, a  
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Table 5.3. Effect of microemulsion component stereochemistry (surfactant and oil) on efficiency.a)   
 
 
 
Compound \ Navg 
 
RXX 
 
RXS 
 
SXS 
 
RXR 
 
SXR 
 
XXRb) 
Compound 
meanc) 
 
Microemulsion Rankingd) 
Ephedrine 146000 139000 154000 116000 110000 116000 133000 SXS ≥ RXX ≥ RXS > RXR ≥ SXR 
N-methyl ephedrine 148000 135000 128000 128000 120000  88000 132000 RXX > RXS ≥ RXR ≈ SXS ≥ SXR 
Pseudoephedrine 141000 132000 140000 112000 120000  95000 129000 RXX ≈ SXS ≥ RXS > SXR ≥ RXR 
Metoprolol 129000 153000 126000 102000  99000 NR 122000 RXS > RXX ≥ SXS > RXR ≥ SXR 
Synephrine 106000   87000   92000   66000    66000 NR  84000 RXX ≥ SXS ≥ RXS > RXR ≈ SXR 
         
Arithmetic mean 134000 129000 127000 105000 103000 100000 N/A N/A 
Geometric mean 133000 127000 125000 102000 101000  99000 N/A N/A 
 
a) Microemulsion composition as in Table 5.1. 
b) Metoprolol and synephrine enantiomers were not resolved (NR) with the XXR microemulsion.   
c) XXR efficiencies were excluded in the compound mean statistics because values for all 5 compounds were not available. 
d) The greater than symbol, >, indicates a statistically significant difference; greater than or equal to, ≥, indicates a large 
difference (3,000 and greater) that is not statistically significant; and the approximately equal symbol, ≈, indicates a small 
difference (less than 3,000) that is not statistically significant.
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Table 5.4. Effect of microemulsion component stereochemistry (surfactant and oil) on resolution.a) 
 
 
Compound \ Rs 
 
RXS 
 
RXX 
 
SXR 
 
SXS 
 
RXR 
Compound 
mean 
 
Microemulsion Rankingb) 
Pseudoephedrine 3.19 2.97 2.95 2.84 2.73 2.94 RXS > RXX ≈ SXR ≥ SXS ≥ RXR 
N-methyl ephedrine 2.21 1.94 1.96 1.70 1.85 1.93 RXS > SXR ≈ RXX ≥ RXR > SXS 
Ephedrine 2.15 1.84 1.91 1.73 1.81 1.89 RXS > SXR ≥ RXX ≈ RXR ≥ SXS 
Metoprolol 1.30 1.10 1.00 1.25 1.24 1.18 RXS ≈ SXS ≈ RXR ≥ RXX ≥ SXR 
Synephrine 0.69 0.72 0.54 0.72 0.59 0.65 RXX ≈ SXS ≈ RXS > RXR ≈ SXR 
        
Arithmetic mean 1.91 1.72 1.67 1.65 1.64 N/A N/A 
 
a) Microemulsion composition as in Table 5.1. 
b) The greater than symbol, >, indicates a statistically significant difference; greater than or equal to, ≥, indicates a large 
difference (greater than 0.05) that is not statistically significant; and the approximately equal symbol, ≈, indicates a small 
difference (less than 0.05) that is not statistically significant.
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potential outlier, are excluded.  Although Navg is satisfactory for both groups, the 
difference in Navg between groups is statistically significant and the reason for this is 
currently being investigated.   
 
Within the group of higher efficiency microemulsions (RXX, RXS, and SXS), the single-
chiral-component formulation, RXX, yielded the highest efficiency for three out of the 
five compounds analyzed (pseudoephedrine, N-methyl ephedrine, and synephrine) and 
the second highest for the remaining analytes.  The dual-chiral-component 
microemulsions RXS and SXS each yielded the highest efficiency for one of the two 
remaining compounds analyzed (metoprolol and ephedrine, respectively).  
 
Additional differences in efficiency were compound-specific.  In the case of ephedrine, 
the average efficiency for the enantiomers ranged from 154,000 to 110,000.  The ranges 
for pseudoephedrine and N-methyl ephedrine were 141,000 to 112,000 and 148,000 to 
120,000, respectively.  Metoprolol and synephrine had ranges of 153,000 to 99,000 and 
106,000 to 66,000, respectively.  The lower efficiency for synephrine resulted from a 
slightly non-ideal peak shape that may have been due to its elution just after the EOF 
marker; such elution is possible for moderately retained compounds with a positive 
mobility (charge).   
 
From the microemulsion rather than the compound perspective, comparisons were made 
between two-chiral-component microemulsions that: (i) differed only in oil 
stereochemistry (SXR/SXS and RXR/RXS), (ii) differed only in surfactant stereochemistry 
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(RXS/SXS and RXR/SXR), and (iii) differed in both oil and surfactant stereochemistry 
(RXR/SXS and RXS/SXR).  Statistically significant differences in Navg for category (i) 
were observed for the following compounds:  ephedrine, pseudoephedrine, metoprolol, 
and synephrine.  For (ii), significant differences in Navg were observed only for the 
RXS/SXS microemulsion pair, and only for the compounds ephedrine and metoprolol.  
Finally, for (iii), statistically significant differences in Navg were observed for all 
compounds between the RXS and SXR microemulsions, and for all compounds except N-
methyl ephedrine between the RXR and SXS microemulsions. 
  
Resolution data obtained in this study are shown in Table 5.4 and were examined for 
trends in the same manner as enantioselectivity and efficiency.  Besides the commonly 
observed result in chiral separations of beta-blockers and agonists (that the highest 
enantiomeric resolution was achieved for pseudoephedrine), the most interesting result 
was that on average, the two-chiral-component RXS microemulsion provided 
significantly better resolution than the remaining one- and two-chiral component 
microemulsions for the ephedrine group of compounds, but only slightly better or 
equivalent resolution for the non-ephedrine compounds.   
 
Excluding the above RXS results, significantly different outcomes between sequentially 
ranked microemulsions were found only in two instances.  First, in the case of N-methyl 
ephedrine enantiomers, the resolution ranged from 2.21 to 1.70 with the following 
ranking: RXS > SXR ≈ RXX ≥ RXR > SXS.  Second, for the synephrine enantiomers, the 
resolution varied from 0.72 to 0.54 with an order of RXX ≈ SXS ≈ RXS > RXR ≈ SXR. 
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On a compound-by-compound basis, the four dual-chirality PSPs provided statistically 
different resolution in the following instances:  SXS vs. SXR for all analytes except 
pseudoephedrine; RXS vs. RXR for ephedrine, pseudoephedrine, N-methyl ephedrine, and 
synephrine; RXR vs. SXR for metoprolol; RXS vs. SXS for ephedrine, pseudoephedrine, 
and N-methyl ephedrine; RXR vs. SXS for N-methyl ephedrine and synephrine; and RXS 
vs. SXR for all five compounds.  Comparing the resolution provided by the two-chiral-
component microemulsions with RXX: (i) the resolution provided by RXS was 
statistically different than RXX for all analytes except synephrine, (ii) the resolution 
provided by SXS was different than RXX for N-methyl ephedrine resolution, and (iii) both 
SXR and RXR yielded a resolution for synephrine that was different from that provided by 
RXX.   
 
The larger resolution values obtained for some analytes with some dual-chirality 
microemulsions is explained through the fundamental resolution equation for chiral EKC: 
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The elution range was the smallest with the RXX formulation and increased with all dual-
chirality systems.  Larger elution ranges resulted from either a decrease in EOF 
(increased solution viscosity or decreased charge on the capillary wall) or increased PSP 
mobility (decreased EOF or more compact aggregate).  These increases in the elution 
range were the principal reason for the observed changes in resolution.  For 
pseudoephedrine and N-methyl ephedrine, however, increases in enantioselectivity also 
contributed to higher resolution values (increased chiral recognition).  In the case of 
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metoprolol, larger efficiencies obtained with selected two-chiral-component 
microemulsions also helped enhance the resolution.   
 
Another potential factor for the resolution improvements is the ratio of the average 
retention factor to the optimal retention factor (kavg/kopt), where kopt is given by: 
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The resolution that is achievable decreases when kavg/kopt deviates significantly from unity 
[17].  For the five analytes tested, kavg/kopt was closest to unity with the RXX 
microemulsion for all but one compound (metoprolol).  However, kavg/kopt differed only 
slightly among all the microemulsions and was therefore not a contributing factor to the 
observed changes in resolution (data not shown).   
 
In summary, the addition of a second chiral component creates a more complex system in 
terms of analyte/selectand associations because the enantiomers can interact with two 
different chiral species within the microemulsion.  Based on our results, the improvement 
in resolution achieved by using specific dual-chirality microemulsions more than 
compensates for the slight loss in efficiency that is occasionally observed.  Although the 
ephedrine-based enantiomers were consistently baseline resolved (values of 1.7 and 
greater), the data demonstrate that varying the oil identity is a valid means to fine-tune 
chiral MEEKC separations.  Another aspect to consider is the implementation of chiral 
separations in regulated industries such as pharmaceuticals.  Under such circumstances, 
resolution greater than baseline (Rs > 1.5) can be required for newly developed methods 
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and method transfers.  In cases where quantitation of trace chiral impurities is being 
performed, a resolution of 1.5 has been shown to be inadequate [18-20].   
 
5.2.5 Effect of Two-Chiral-Component Microemulsion Stereochemistry on 
Hydrophobic (Methylene) Selectivity 
 
The combinations of chiral surfactant and/or chiral oil were also examined for their 
effects on methylene selectivity.  Methylene selectivity defines how well a 
chromatographic system can separate compounds that differ in the number of methylene 
(CH2) groups, and it is also widely accepted as a general measure of how well a 
chromatographic system can separate compounds that vary slightly in their 
hydrophobicity based on non-methylene group differences.   
 
The microemulsion prepared with the chiral surfactant and racemic oil, RXX, provided 
the largest methylene selectivity (Table 5.5).  The range observed for αmeth was 2.872 to 
2.713 and decreased in the following sequence of microemulsions:  RXX > SXS ≥ RXS ≥ 
SXR ≥ XXR > RXR.  
 
As a consequence of the aqueous phase being held constant at 50 mM phosphate buffer 
(pH 7.0) and the microemulsion formulations being identical with respect to functional 
groups, the methylene selectivity is a fairly direct measure of PSP polarity in this study.  
Higher values indicate a more nonpolar, hydrophobic aggregate and vice-versa.  
Although the differences in methylene selectivity among the microemulsions studied 
were often statistically significant, the results span only a narrow range of values and one 
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Table 5.5.  Effect of microemulsion component stereochemistry (surfactant and oil) on 
methylene selectivity. 
 
 
Microemulsiona) αmethb) 
RXR 2.713 ± 0.028 
XXR 2.792 ± 0.022 
SXR 2.807 ± 0.040 
RXS 2.822 ± 0.037  
SXS 2.836 ± 0.028 
RXX 2.872 ± 0.052 
 
a) Microemulsion composition as in Table 5.1. 
b) Values based on a minimum of 15 injections.
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must conclude that the stereochemistry of one or more components of a chiral PSP will 
often have little effect on αmeth or the overall hydrophobicity of the aggregate.  Given that 
αmeth is measured with achiral compounds (typically homologs with good detectability), 
the small but often statistically significant variations observed in αmeth may be due to 
minor differences in the content of water or other polar molecules in the microemulsion 
resulting from slight differences in solvation.  
 
5.2.6 Thermodynamic Analysis of Synergies in Enantioselectivity  
In the previous two-chiral-component microemulsion publication that utilized a chiral 
surfactant, a chiral cosurfactant, and an achiral oil, enantioselective synergies were shown 
to exist through an analysis of differences in Gibb’s free energy changes for enantiomers 
(ΔΔG˚ = ΔG˚2 - ΔG˚1), where ∆∆G˚ corresponds to the energetic difference in the transfer 
of a pair of enantiomers (“1” and “2”) from the mobile phase to the microemulsion (PSP) 
[9].  
 
In the present study, ∆∆G˚ was calculated for two-chiral-component microemulsions 
comprised of a chiral surfactant, an achiral cosurfactant, and a chiral oil using 
experimentally measured enantioselectivities and equation 2.7; the data are shown in 
Table 5.6.  In all cases, analytes partitioning into the microemulsion is 
thermodynamically favorable (k > 0, ∆G˚ < 0, data not shown), although for metoprolol 
and synephrine enantiomers with the XXR microemulsion it is a nonselective partitioning 
(ΔΔG˚ = 0).   
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Table 5.6.  Analysis of synergies in enantioselectivity for dual-chiral microemulsion electrokinetic chromatography with a chiral 
surfactant and a chiral oil.   
 
 
 
Microemulsiona) 
Ephedrine 
ΔΔG˚ b) 
Pseudoephedrine 
ΔΔG˚ b) 
N-methyl ephedrine 
ΔΔG˚ b) 
Metoprolol 
ΔΔG˚ b) 
Synephrine 
ΔΔG˚ b) 
RXX -0.153 -0.253 -0.160 -0.107 -0.093 
  SXXc) -0.153 -0.253 -0.160 -0.107 -0.093 
XXR -0.012 -0.022 -0.022  0.000  0.000 
  XXSc) -0.012 -0.022 -0.022  0.000  0.000 
RXR -0.149 -0.241 -0.149 -0.115 -0.091 
SXR -0.170 -0.257 -0.173 -0.099 -0.088 
RXS -0.168 -0.262 -0.178 -0.103 -0.094 
SXS -0.132 -0.231 -0.143 -0.112 -0.097 
      
ΔΔG°RXR – (ΔΔG°RXX + ΔΔG°XXR)  0.016 0.034 0.034 -0.008  0.002 
ΔΔG°SXR – (ΔΔG°SXX + ΔΔG°XXR) -0.005 0.018 0.010  0.008  0.005 
ΔΔG°RXS – (ΔΔG°RXX + ΔΔG°XXS) -0.003 0.014 0.004  0.004  0.000 
ΔΔG°SXS – (ΔΔG°SXX + ΔΔG°XXS)  0.033 0.044 0.039 -0.005 -0.004 
 
a) Microemulsion composition as in Table 5.1. 
b) See equation 2.7 in Chapter 2.   
c) SXX and XXS microemulsions not prepared.  Using the opposite stereochemistry in a single-chirality formulation will give 
same enantioselectivity with reversal in elution order.
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In order to perform a thermodynamic analysis for enantioselective synergies, the 
contributions by the individual chiral components to enantioselectivity must be 
determined.  In this study, the chiral surfactant contribution was obtained from RXX data 
and the chiral oil contribution from XXR.  Enantioselectivity measurements for one- 
chiral-component microemulsions containing S-DDCV (SXX) or dibutyl L-tartrate (XXS) 
were not necessary because they would simply differ from the RXX or XXR results in 
elution order [21].   
 
Assuming no synergistic interactions between the chiral components (surfactant and oil), 
the sum of the Gibb’s free energy changes for the chiral surfactant-only and chiral oil-
only microemulsions should be equal to the value calculated for the corresponding dual-
chiral microemulsions.  For example, the sum of ΔΔG˚RXX and ΔΔG˚XXR should equal 
ΔΔG˚RXR if no synergism is occurring.  Equivalently, in more general terms for this study,  
∆∆G˚chiral surf & chiral oil – (∆∆G˚chiral surf + ΔΔG˚chiral oil) = 0     (5.1) 
 if no synergy is occurring due to the simultaneous presence of a chiral surfactant and a 
chiral oil in a microemulsion (surfactant abbreviated as “surf”).  Alternatively, if a 
synergy is occurring, then eqn. 5.1 would be false and one of the inequalities below 
would be true: 
∆∆G˚chiral surf & chiral oil – (∆∆G˚chiral surf + ΔΔG˚chiral oil) < 0     (5.2a) 
∆∆G˚chiral surf & chiral oil – (∆∆G˚chiral surf + ΔΔG˚chiral oil) > 0     (5.2b) 
If eqn. 5.2a is observed to be true for a given analyte/two-chiral-component 
microemulsion system, then a beneficial synergy for enantioselectivity is being induced 
  
159 
by the concurrent usage of chiral surfactant and chiral oil.  In other words, the dual-chiral 
enantioselectivity is higher than what would be predicted from the enantioselectivities 
provided by the individual chiral components, i.e., higher than predicted from eqn. 5.3:  
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Conversely, if eqn. 5.2b rather than eqn. 5.2a is true, then a detrimental synergy for 
enantioselectivity is occurring and the dual-chiral enantioselectivity is lower than what 
would be predicted from eqn. 5.3. 
 
Shown in the bottom half of Table 5.6 are the results of the enantioselectivity synergy 
analysis.  Out of 20 possible combinations of 5 pairs of enantiomers with 4 dual-chiral 
microemulsions (RXR, SXR, RXS, SXS), a complete lack of enantioselectivity synergy 
(eqn. 5.1) was observed for only 2 combinations (absolute values of 0.002 and less, as 
established in Chapter 3).  Of the remaining 18 combinations, a beneficial synergy (eqn. 
5.2a) in the enantioselectivity was observed for 5 combinations and a detrimental synergy 
(eqn. 5.2b) was observed for the other 13.  The largest, albeit negative, synergies in 
enantioselectivity were observed for the ephedrine-related compounds with the RXR and 
SXS microemulsions.  The smallest non-zero enantioselective synergies were observed 
for non-ephedrine compounds with the RXS and SXS microemulsions.   
 
Although the thermodynamic nature of enantioselectivity greatly facilitates a quantitative 
analysis of enantioselective synergies with dual-chiral pseudostationary phases, it has 
proven challenging to develop a detailed explanation for the observed trends.  For 
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example, the synergies for RXR and SXS were expected to be symmetrical, but were not. 
The purity of the reagents was investigated via polarimetry and did indicate some 
decreased enantiopurity for R-DDCV.  However, corrections based on the optical rotation 
difference failed to compensate for the observed discrepancy.  The cause of the 
asymmetrical synergy data is still being investigated.  It is certainly clear, however, that 
the exact nature and magnitude of these synergies in enantioselectivity are both analyte 
and microemulsion dependent, as were the synergies observed for the efficiency and 
resolution described earlier in this study. 
 
In a previous report on chiral MEEKC that examined possible synergies between a chiral 
surfactant and chiral cosurfactant [9], two types of interactions were proposed as possible 
ways to explain the observed phenomena: (i) a two-way interaction between the two 
chiral microemulsion constituents, resulting in either an increase or decrease in the 
overall chirality of the microemulsion for the analyte to then experience; or (ii) a three-
way interaction between the two chiral microemulsion constituents and the analyte.  
Given the probable separate locations of surfactant and oil in a microemulsion, scenario 
(i) can presumably be disregarded, while scenario (ii) is perhaps still plausible provided 
that the analyte experiences both the surfactant and oil regions of the chiral 
microemulsion.  According to scenario (ii), hydrophilic compounds that reside at or near 
the surface of the microemulsion (i.e., away from the oil core) would be unlikely to 
experience any enantioselective synergy, as would highly hydrophobic compounds that 
reside in the oil core or at its surface (i.e., away from the outward-facing stereoselective 
center of the surfactant).  In contrast, compounds of intermediate hydrophobicity 
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(polarity) that could spend significant amounts of time in contact with both the chiral 
surfactant and chiral oil would be the most likely to experience some enantioselective 
synergy, as was the case with the moderately retained ephedrine-based analytes.   
 
5.3   Concluding Remarks 
The data for dual-chirality MEEKC reported here provide numerous examples of the 
synergy observed for the enantioselectivity, efficiency, and resolution through the use of 
two chiral components in a microemulsion instead of one.  The observed synergies were 
largely enantiomer- and microemulsion-specific and although they were often 
detrimental, the enantioselectivity achieved for most enantiomers with the best two-
chiral-component microemulsion was slightly better than that achieved with the best one-
chiral-component microemulsion.  Moreover, the resolution achieved for most 
enantiomers with the best two-chiral-component microemulsion was significantly better 
than that achieved with the best one-chiral-component microemulsion of the present 
study.  Enantioselectivity increased for most of the compounds when the PSP contained 
both a chiral surfactant and a chiral oil.  In particular, the ephedrine derivatives had larger 
values when the surfactant and oil were both chiral and of opposite stereochemistry.  On 
a negative note, efficiencies decreased slightly when the microemulsion oil was changed 
from racemic dibutyl tartrate to enantiopure dibutyl tartrate.  A key observation for 
efficiency was the distinct division between the higher values observed with racemic 
dibutyl tartrate and dibutyl D-tartrate and the lower values observed with dibutyl L-
tartrate; the underlying cause of these differences is currently under investigation.  The 
number of chiral components in the microemulsion formulation also impacted the 
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resolution of the enantiomers.  Significant improvements in resolution for ephedrine-
based compounds were observed in this study with the combination of R-DDCV, racemic 
2-hexanol, and dibutyl D-tartrate to form a microemulsion.  In general, the slight to 
moderate differences in resolution observed with microemulsions of different 
stereochemistry were due largely, but not exclusively, to slight differences in the elution 
range.  Whereas synergies for all chromatographic figures of merit in the fundamental 
resolution equation (equation 1.6) could be examined directly, the relationship of 
enantioselectivity to Gibb’s free energy (equation 2.7) facilitated a more extensive 
analysis of enantioselective synergisms.  Evaluation of the differences in Gibb’s free 
energies of transfer revealed the existence of such synergisms in eighteen out of twenty 
cases for the combination of chiral surfactant and chiral oil in an aggregate structure.  The 
nature of these synergies was found to be detrimental almost 80% of the time (beneficial 
for the remaining 20%).  The largest synergistic effects were observed for ephedrine, 
pseudoephedrine, and N-methyl ephedrine, all of which have two stereogenic centers. 
Lastly, a comparison of the results reported here to those obtained using a R-
DDCV/racemic 2-hexanol/ethyl acetate microemulsion [16] revealed overall decreases in 
enantioselectivity and resolution when ethyl acetate was replaced by dibutyl tartrate 
(racemic or chiral), while efficiency and methylene selectivity increased.  
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Chapter 6:  Two-Chiral-Component Microemulsion Electrokinetic 
Chromatography—Chiral Surfactant and Chiral Oil, Part 2:  Diethyl Tartrate 
 
 
 
6.1 Introduction 
 
The development of novel chiral separation methods and the optimization of existing 
techniques such as chiral high performance liquid chromatography (HPLC) and chiral 
capillary electrophoresis (CE) continue to be areas of focus in academic and industrial 
laboratories [1].  Chiral products in pharmaceuticals [2-6], agrochemicals [7], and food 
additives [8, 9] are providing the driving force behind this research with recent examples 
being the CE analyses of the chiral drug etomidate [10], chiral organophosphorus 
pesticides [11], and amino acids in vinegar [12].  Specifically, the design, production, and 
analysis of enantiopure formulations, instead of racemates, are becoming more important 
due to inherent differences in activity between the enantiomers and the potential adverse 
side effects from one of the enantiomers [13].  In some cases, one stereochemical 
configuration of a compound gives the desired result, whereas the other configuration 
could be toxic or may impede the beneficial action of the product.  The most common 
methods of chiral testing are HPLC and CE, with a great deal of interest in CE having 
developed over the past twenty years.  
 
In our latest chiral MEEKC studies, two chiral microemulsion components were 
employed simultaneously to form a dual-chiral PSP.  First, we combined a chiral 
surfactant (DDCV) and a chiral cosurfactant (S-2-hexanol) with an achiral oil (ethyl 
acetate) [14].  Next, in part one of this evaluation, we integrated a chiral surfactant 
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(DDCV), an achiral cosurfactant (2-hexanol), and a chiral oil (dibutyl tartrate) into a 
microemulsion formulation [15].  Both of these dual-chirality systems demonstrated 
synergism and separation variability that was dependent upon the stereochemical 
combinations of the microemulsion components.  Our current research continues to focus 
on two-chiral-component microemulsions consisting of a chiral surfactant (DDCV) and a 
chiral oil (diethyl tartrate), the difference being the chiral oil identity.  This is the first 
reported use to date of diethyl-D-tartrate or diethyl-L-tartrate as an oil phase in MEEKC 
(chiral or achiral).  Herein we examine the impact of surfactant stereochemistry (DDCV, 
R- or S-) in conjunction with oil stereochemistry (diethyl tartrate, D- or L-) on efficiency, 
resolution, enantioselectivity, enantioselective synergism, and methylene selectivity.  Six 
pairs of pharmaceutical enantiomers were used to probe the enantioselective 
characteristics of the PSPs.  Synergistic effects were revealed for this mixture of chiral 
microemulsion constituents.     
 
6.2 Results and Discussion 
6.2.1 Microemulsion Stereochemistry 
The two chiral microemulsion components, surfactant and oil, were obtained in both 
stereochemical configurations:  R- and S-DDCV, and diethyl L-tartrate (RR = “R”) and 
diethyl D-tartrate (SS = “S”).  This study included six microemulsion formulations (see 
Table 6.1):  four with chiral surfactant and chiral oil, one with chiral surfactant only 
(racemic oil, 50/50 (w/w) mixture of diethyl R- and diethyl S-tartrate, total concentration 
0.88% (v/v)), and one with chiral oil only (racemic surfactant, 50/50 (w/w) mixture of R- 
and S-DDCV, total concentration of 2.0% (w/v)).  The microemulsions are identified by
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Table 6.1.  Microemulsion stereochemical compositionsa) and abbreviationsb). 
 
DDCV 
Stereochemistry 
Diethyl Tartrate 
Stereochemistryc) 
Microemulsion 
Abbreviation 
R R RXR 
S R SXR 
X R XXR 
R S RXS 
S S SXS 
R X RXX 
 
a) Surfactant (DDCV) concentration was 2.00% w/v (60.7 mM), racemic 
cosurfactant (2-hexanol) concentration was 1.65% v/v (131 mM), oil (diethyl 
tartrate) concentration was 0.88% v/v (51.2 mM), and buffer was 50 mM 
phosphate at a pH of 7.0. 
b) The first letter signifies surfactant configuration, followed by cosurfactant, and 
then oil.  The letter X represents racemic components. 
c) The configurations (abbreviations) of diethyl L-tartrate and diethyl D-tartrate are 
2R, 3R- (R) and 2S, 3S- (S), respectively.
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a three-letter abbreviation with the first letter denoting the surfactant stereochemical 
configuration, the cosurfactant by the second letter (racemic 2-hexanol in all cases), and 
the last letter for the oil; racemic components are represented by an X.  
 
Although a microemulsion with only one chiral component (the chiral oil) was prepared 
and tested (XXR), it did not resolve any of the six racemic chiral analytes in the study.  
Enantioselectivity values for the XXR system were determined for ephedrine, N-methyl 
ephedrine, and pseudoephedrine from analyses of individual enantiomers: they were not 
statistically different from unity (no enantioresolution).  Therefore, the XXR 
microemulsion was excluded from further statistical analysis and discussion.  Elution 
order reversal for each enantiomer pair was observed only with changes in surfactant 
stereochemistry.  Furthermore, the RXR and SXS microemulsions should, in theory (from 
symmetry arguments), provide equivalent results for all chromatographic figures of merit 
but experimentally they did not.  This unexpected result is still being investigated and 
may be due, in part, to differences in the enantiomeric purity of the R- and S-DDCV (see 
section 6.2.6). 
 
6.2.2 Efficiency:  Results and Trends with Diethyl Tartrate Microemulsions 
Average efficiency values for pairs of enantiomers varied depending on the 
microemulsion component stereochemical configurations.  The magnitude and order of 
decreasing efficiency was a function of chiral analyte identity; data for each pair of 
enantiomers as well as a mean and range are given in Table 6.2 along with 
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Table 6.2.  Effect of microemulsion component stereochemistry (surfactant and oil) on efficiency.a)   
 
 
Compound \ Navg 
 
RXS 
 
RXR 
 
RXX 
 
SXR 
 
SXS 
Compound 
Mean 
 
Range 
 
Stereochemical Rankingb) 
Atenololc) 111300  95100 126100 115400  91100 107600 21900 RXX ≥ SXR ≥ RXS > RXR ≥ SXS 
Metoprolol 117600 115100  99200  89800 104900 105300 27800 RXS ≥ RXR > SXS ≥ RXX > SXR 
N-methyl ephedrine  97300  94900  85500  81100  76600  87100 20700 RXS ≥ RXR > RXX ≥ SXR ≥ SXS 
Ephedrine  92600  93100  86700  80800  74500  85500 18600 RXR ≈ RXS > RXX > SXR > SXS 
Synephrine  83000  82300  79800  67600  79800  78500 15400 RXS ≈ RXR ≥ RXX ≈ SXS > SXR 
Pseudoephedrine  80800  71800  72400  84700  69300  75800 11500 SXR ≥ RXS > RXX ≈ RXR ≥ SXS 
          
Arithmetic mean  97100  92100  91600  86600  82700 N/A 19300 N/A 
         
Arithmetic mean 
excluding Atenolol  94300  91400  84700  80800  81000 N/A 18800 N/A 
 
a) Microemulsion composition as in Table 6.1. 
b) Statistical differences between adjacent values are shown with the use of a greater than sign (>), and the absence of a 
statistically significant difference by an approximately equal sign (≈, difference less than 2,000) or a greater than or equal 
to sign (≥, difference greater than 2,000). 
c) Atenolol efficiencies listed for completeness but cannot be considered accurate due to the use of half-height values with 
low resolution.
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microemulsion rankings.  Representative separations for pseudoephedrine are depicted in 
Figure 6.1.  Although this compound experienced the smallest range of efficiencies, the 
variation with microemulsion stereochemistry was apparent.  In contrast to ephedrine, 
pseudoephedrine did not show as many statistical differences among adjacent values.  
The best efficiency for N-methyl ephedrine was obtained with RXS and decreased in the 
same order as ephedrine (range of 97,300 to 76,600).  As with pseudoephedrine, N-
methyl ephedrine had only one statistically significant difference among neighboring 
values.  Atenolol efficiency was found to range from 126,100 to 91,100.  The last two 
compounds, metoprolol and synephrine, had efficiencies that decreased in a similar order.  
Values for metoprolol varied the most with changes in PSP stereochemistry and had two 
significant differences in the rankings.  Synephrine efficiencies, in one case, had adjacent 
values that were statistically different and ranged from 67,600 to 83,000.  There was only 
one compound, atenolol, where the single-chirality microemulsion outperformed the 
dual-chirality microemulsions in terms of efficiency.  Several commonalities can be 
observed in the rankings among the six analytes studied.  One such similarity is in the 
position of RXX efficiency, which is found to be the middle performer for four out of six 
compounds (ephedrine, pseudoephedrine, N-methyl ephedrine, and synephrine; all of 
which have shorter side chains on the benzene ring, showing a dependence on structure).  
Ephedrine, N-methyl ephedrine, metoprolol, and synephrine all had their top two average 
efficiency values with either the RXS or RXR.  The entire set of enantiomer pairs had the 
placement of S-DDCV two-chiral-component microemulsions at the bottom (worst 
efficiency).  In four out of six cases, SXS gave the lowest average efficiency. 
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Figure 6.1. Effect of surfactant and oil stereochemical configurations on the efficiency of 
pseudoephedrine enantiomers. (A) SXS microemulsion, (B) RXR microemulsion, (C) RXX 
microemulsion, (D) RXS microemulsion, and (E) SXR microemulsion.  Surfactant 
concentration = 2.00% w/v; cosurfactant concentration = 1.65% v/v; oil concentration = 
0.88% v/v; 50 mM phosphate buffer, pH 7.0.  Capillary dimensions:  Ltot = 32 cm, Leff = 
23.6 cm, i.d. = 50 µm.  Detection wavelength was 215 ± 5 nm, injections were performed 
hydrodynamically for 2 seconds with 25 mbar pressure, and the applied voltage was 11.5 
kV.
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Examination of the average efficiencies for each microemulsion in conjunction with the 
methylene selectivity data (section 6.2.7) reveals a correlation:  higher efficiencies are 
achieved with more polar aggregates.  The root cause of this behavior is the PSP 
flexibility; more hydrophilic nanodroplets most likely contain more water molecules, 
increasing the distance between surfactant head groups and improving mass transfer. 
 
Efficiency data were also analyzed for trends in statistical differences among 
microemulsions with the same surfactant stereochemical configuration (opposite oil 
stereochemistry), the same oil stereochemical configuration (opposite surfactant 
configuration), and opposite stereochemistry for both chiral components.  Comparison of 
results from microemulsions with opposite diethyl tartrate stereochemical configurations 
(RXR vs. RXS and SXR vs. SXS) revealed a dissimilarity for R- and S-DDCV.  Two chiral 
analytes had unequal efficiencies with RXR/RXS, pseudoephedrine and atenolol, whereas 
five out of six pairs of enantiomers had statistical differences for SXR/SXS, N-methyl 
ephedrine being the exception.  For the systems that were identical except in surfactant 
stereochemistry (RXR vs. SXR and RXS vs. SXS), only one compound, synephrine for 
RXS/SXS, did not have significantly varying values.  PSPs with completely opposing 
stereochemical configurations (RXR vs. SXS and RXS vs. SXR) provided statistically 
different efficiencies for half (ephedrine, N-methyl ephedrine, and metoprolol) and two-
thirds of the analytes (ephedrine, N-methyl ephedrine, metoprolol, and synephrine), 
respectively.  These findings demonstrate that microemulsion stereochemistry can have a 
direct impact on efficiency. 
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In addition, the dual-chirality microemulsions were compared to RXX (single-chirality) 
for significant inequalities.  Ephedrine had the most instances of efficiencies differing 
from that of RXX, where two of these aggregate systems gave better results (RXR and 
RXS), and the other two gave worse results (SXR and SXS).  Synephrine displayed only 
one statistical difference in average efficiency from the value obtained with RXX, SXR 
(lower efficiency).  The remaining four pairs of enantiomers had either two or three two-
chiral-component microemulsions that produced results with statistical differences from 
RXX.  For pseudoephedrine, the two systems that performed significantly better than RXX 
were SXR and RXS.  Three PSPs were found to be statistically different from RXX for N-
methyl ephedrine and metoprolol:  RXS and RXR with improved efficiencies for both 
compounds and reduced efficiencies with SXS for N-methyl ephedrine and SXR for 
metoprolol.  Finally, atenolol had two cases where microemulsions with lower 
efficiencies than RXX were significantly different:  RXR and SXS.  Thus, incorporation of 
a second chiral microemulsion component can either improve or degrade efficiency 
depending on the specific analyte. 
 
6.2.3 Enantioselectivity Variations with Two-Chiral-Component Microemulsions 
 
The ability of each microemulsion to distinguish between enantiomers was measured 
through enantioselectivity values (the ratio of retention factors).  The formulation 
containing only the chiral oil, XXR, did not provide any evidence of separation for the six 
compounds when tested as racemates.  Individual enantiomers for ephedrine, 
pseudoephedrine, and N-methyl ephedrine were analyzed separately on two days.  The 
enantioselectivities calculated were less than 1.002 and were not statistically different 
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from unity, i.e., zero enantioresolution, and were therefore omitted from this discussion 
(see Table 6.3 for values and rankings).  Ephedrine-based compounds did not show 
statistical differences between neighboring values.  Metoprolol and synephrine had 
identical microemulsion rankings with some variation in statistical differences.  The 
improvement in synephrine chiral selectivity with a dual-chirality selector is shown in 
Figure 6.2 (this was one of two compounds that could not be baseline resolved, but it 
does illustrate the variations in enantioselectivity with microemulsion stereochemistry).  
Chiral separations utilizing the SXS microemulsion resulted in the largest 
enantioselectivities for three out of six compounds (atenolol, metoprolol, and synephrine; 
all having one chiral center).  Another observation was that RXX provided the best 
enantioselectivity for two of the three ephedrine derivatives tested (pseudoephedrine and 
N-methyl ephedrine).  On the lower end of values, all enantiomers had their worst 
enantioselectivity with microemulsions composed of chiral surfactant and chiral oil in 
opposing stereochemical configurations (SXR for pseudoephedrine, N-methyl ephedrine, 
metoprolol, and synephrine; RXS for ephedrine and atenolol).  In four out of six cases-
ephedrine, atenolol, metoprolol, and synephrine-the one-chiral-component 
microemulsion (RXX) provided the second worst result. 
 
Despite the relatively small variations in enantioselectivity, there were some interesting 
differences among the dual-chirality systems.  For PSPs containing the same 
configuration of surfactant but opposite stereochemistry in the oil, ephedrine and atenolol 
had statistically different values for R-DDCV (RXR vs. RXS) and pseudoephedrine, N-
methyl ephedrine, metoprolol, and synephrine had unequal values with 
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Table 6.3.  Effect of microemulsion component stereochemistry (surfactant and oil) on enantioselectivity.a)  
 
Compound \ αenantb)c) SXS RXR RXX RXS SXR Compound Mean Stereochemical Rankingd) 
Pseudoephedrine 1.139 1.139 1.141 1.137 1.135 1.138 RXX ≈ RXR ≈ SXS ≈ RXS ≈ SXR 
Ephedrine 1.077 1.078 1.075 1.074 1.079 1.077 SXR ≈ RXR ≈ SXS ≈ RXX ≈ RXS 
N-methyl ephedrine 1.077 1.076 1.078 1.076 1.075 1.076 RXX ≈ SXS ≈ RXS ≈ RXR ≈ SXR 
Metoprolol 1.057 1.054 1.053 1.055 1.052 1.054 SXS > RXS ≈ RXR > RXX ≈ SXR 
Synephrine 1.057 1.051 1.050 1.053 1.050 1.052 SXS > RXS ≈ RXR ≈ RXX ≈ SXR 
Atenolol 1.025 1.024 1.022 1.021 1.024 1.023 SXS ≈ SXR ≈ RXR ≈ RXX ≈ RXS 
        
Arithmetic mean 1.072 1.070 1.070 1.069 1.069 N/A N/A 
Arithmetic mean 
excluding Atenolol 1.081 1.080 1.079 1.079 1.078 N/A N/A 
 
a) Microemulsion composition as in Table 6.1. 
b) RSD less than 0.5%. 
c) Enantioselectivity with XXR microemulsion < 1.02 in all cases. 
d) Statistical differences between adjacent values are shown with the use of a greater than sign (>) and the absence of a 
statistically significant difference by an approximately equal sign (≈, difference less than 0.004).
  
177 
 
 
 
Figure 6.2.  Effect of surfactant and oil stereochemical configurations on the 
enantioselectivity of synephrine enantiomers.  (A) RXX microemulsion, (B) SXR 
microemulsion, (C) RXR microemulsion, (D) RXS microemulsion, and (E) SXS 
microemulsion.  Conditions as in Figure 6.1.
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S-DDCV (SXR vs. SXS).  Pseudoephedrine and metoprolol had statistically significant 
changes in enantioselectivity when the RXR and SXR aggregates were compared 
(opposing surfactant stereochemical configuration).  More compounds had significant 
differences with the microemulsions formed from diethyl D-tartrate and each surfactant 
enantiomer, RXS vs. SXS:  ephedrine, atenolol, metoprolol, and synephrine.  The last 
pairs of two-chiral-component microemulsions that were evaluated had opposing 
stereochemistry for both the surfactant and the oil.  Metoprolol and synephrine 
enantioselectivities were significantly different for the comparison between RXR and SXS 
microemulsions.  In the case of RXS vs. SXR, four out of six analytes gave different 
values (ephedrine, atenolol, metoprolol, and synephrine).  Comparison of 
enantioselectivities achieved with the one-chiral-component microemulsion (RXX) versus 
those with the two-chiral-component systems gave the following statistical differences:  
RXR for ephedrine, N-methyl ephedrine, and metoprolol; SXR for ephedrine, 
pseudoephedrine, and N-methyl ephedrine; RXS for pseudoephedrine, metoprolol, and 
synephrine; and SXS for metoprolol and synephrine. 
 
The addition of a second chiral species to a microemulsion formulation impacts the chiral 
separations differently depending on the analyte.  In general, dual-chirality PSPs were 
found to modestly improve enantioselectivity for half of the analytes studied (ephedrine, 
metoprolol, and synephrine).  Two compounds, pseudoephedrine and N-methyl 
ephedrine, were negatively affected by an increase in the number of chiral microemulsion 
components.  The change in microemulsion from single-chirality to dual-chirality did not 
influence the enantioselectivity for the least retained pair of enantiomers, R- and S-
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atenolol.  The data show that chiral discrimination with MEEKC can be fine-tuned by 
incorporating a second chiral element into the aggregate recipe.   
 
6.2.4 Resolution Changes from Microemulsion Stereochemical Configuration 
Resolution values for each pair of enantiomers are shown in Table 6.4 with 
microemulsion rankings.  Fewer statistical differences were observed for this 
chromatographic figure of merit for adjacent values or microemulsion pairs with opposite 
surfactant and/or oil stereochemical configuration.  Ephedrine, pseudoephedrine, and N-
methyl ephedrine resolutions did not show significant changes among the five PSPs 
tested (insignificant F-ratio).  The impact of microemulsion formulation on ephedrine 
resolution is shown in Figure 6.3; although the values are not statistically different the 
effect of microemulsion stereochemistry is evident.  Unlike ephedrine and 
pseudoephedrine, which were best resolved with RXR, N-methyl ephedrine resolution 
was slightly better with the SXR microemulsion.  The highest resolution for the final three 
analytes was obtained with the SXS aggregate.  Some general trends in the microemulsion 
rankings for resolution were observed.  The largest values were obtained with 
microemulsions containing both the chiral surfactant and chiral oil with identical 
stereochemical configurations (SXS or RXR for five out of six enantiomers, N-methyl 
ephedrine being the exception).  For half of the analytes, RXX provided the smallest 
resolution (pseudoephedrine, metoprolol, and synephrine).  The other three compounds 
were most poorly resolved with the RXS formulation. 
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Table 6.4.  Effect of microemulsion component stereochemistry on resolution.a) 
 
Compound \ Rs SXS SXR RXR RXS RXX Compound Mean Stereochemical Rankingb) 
Pseudoephedrine 3.53 3.56 3.57 3.56 3.48 3.54 RXR ≈ SXR ≈ RXS ≈ SXS ≈ RXX 
Ephedrine 2.20 2.24 2.26 2.04 2.23 2.19 RXR ≈ SXR ≈ RXX ≈ SXS ≥ RXS 
N-methyl ephedrine 2.18 2.24 2.17 2.16 2.17 2.18 SXR ≈ SXS ≈ RXX ≈ RXR ≈ RXS 
Metoprolol 2.00 1.65 1.63 1.76 1.59 1.73 SXS > RXS ≥ SXR ≈ RXR ≈ RXX 
Synephrine 1.15 0.95 0.98 1.03 0.94 1.01 SXS ≥ RXS ≈ RXR ≈ SXR ≈ RXX 
Atenolol 0.65 0.62 0.61 0.53 0.59 0.60 SXS ≈ SXR ≈ RXR ≈ RXX ≈ RXS 
        
Arithmetic mean 1.95 1.88 1.87 1.85 1.83 N/A N/A 
Arithmetic mean 
excluding Atenolol 2.21 2.13 2.12 2.11 2.08 N/A N/A 
 
a) Microemulsion composition as in Table 6.1. 
b) Statistical differences between adjacent values are shown with the use of a greater than sign (>) and the absence of a 
statistically significant difference by an approximately equal sign (≈, difference less than 0.10) or a greater than or equal to 
sign (≥, difference greater than 0.10).
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Figure 6.3. Effect of surfactant and oil stereochemical configurations on the resolution of 
ephedrine enantiomers.  (A) RXS microemulsion, (B) SXS microemulsion, (C) RXX 
microemulsion, (D) SXR microemulsion, and (E) RXR microemulsion.  Conditions as in 
Figure 6.1.
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Analysis of the resolution data between the various dual-chirality microemulsions did not 
reveal as many differences as found with the efficiency data.  As previously stated, the 
ephedrine derivatives did not show statistical differences for any of the PSPs. Atenolol 
had significant variations in resolution for the following pairs of microemulsions:  
RXS/SXS and RXS/SXR.  Metoprolol values were unequal for two-  
chiral-component systems of RXS vs. SXS, SXR vs. SXS, and RXR vs. SXS; and one- 
versus two-chiral component microemulsions of RXX vs. RXS and RXX vs. SXS.  Lastly, 
synephrine had statistically different resolutions for SXR/SXS, RXR/SXS, and RXX/SXS 
(one vs. two chiral microemulsion entities).  The reasons for the differences in resolution 
are explained below. 
 
6.2.5 Analysis of Resolution Changes via the Fundamental Resolution Equation 
The fundamental resolution equation shown below expresses resolution in terms of four 
factors:  efficiency, enantioselectivity, retention factors, and elution range. 
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The changes in efficiency and enantioselectivity with the five microemulsion 
formulations have been described in sections 6.2.2 and 6.2.3.  One approach to evaluate 
the effect of retention factor changes on resolution is via the ratio of average retention 
factor to optimal retention factor (kavg/kopt, kopt formula given in equation 1.8).  
! 
kopt =
µeo
µme
1+
µep
µeo
" 
# 
$ 
% 
& 
'         (1.8) 
  
183 
As the average retention factor for a pair of enantiomers nears the calculated optimum 
(kavg/kopt approaching unity), resolution improves because analytes interact more 
optimally with the PSP.  As kavg/kopt moves away from unity, the maximum achievable 
resolution decreases [16].  The retention factor ratios of kavg/kopt are shown in Table 6.5.  
Overall, the RXS formulation provided retention factors closest to their optimal (average 
kavg/kopt of 0.69).  In terms of individual enantiomers, RXS did in fact allow retention 
factor ratios for ephedrine, pseudoephedrine, N-methyl ephedrine, and synephrine to 
come closest to one.  Atenolol had a more favorable value of average retention with the 
SXR system.  The average retention factor for metoprolol was furthest from optimal with 
RXS; the SXR, SXS, and RXR microemulsions all gave more optimum conditions for this 
analyte.  The last portion of the fundamental resolution equation is, in essence, the elution 
range.  The PSP marker, octanophenone, was used to determine the microemulsion 
mobility, which in turn was used to calculate the elution range.  The values obtained for 
each aggregate system are given in Table 6.5.  The largest elution range was obtained 
with SXS and decreased with an order of SXS ≈ RXR ≥ RXX ≥ RXS ≈ SXR (range of 4.5 to 
5.7). 
 
An examination of each analyte, with respect to the four contributing factors for 
resolution, was conducted by calculating resolution via eqn. 1.6 and then varying 
individual parameters using the values from the best and worst performing 
microemulsions (changes in the underlying chemical phenomena were explained in 
previous chapters).  Ephedrine was best resolved with the RXR microemulsion, although 
its average retention factor was furthest from optimum.  The other three factors positively 
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Table 6.5.  Effect of microemulsion component stereochemistry (surfactant and oil) on kavg/kopt and elution rangea). 
 
 
 
Microemulsion 
 
 
Ephedrine 
kavg/kopt 
 
 
Pseudoephedrine 
kavg/kopt 
 
N-methyl 
ephedrine 
kavg/kopt 
 
 
Atenolol 
kavg/kopt 
 
 
Metoprolol 
kavg/kopt 
 
 
Synephrine 
kavg/kopt 
 
 
Average 
kavg/kopt 
Average 
kavg/kopt 
excluding 
Atenolol 
  
 
Elution 
Rangeb) 
RXS 0.76 0.67 0.72 0.32 1.41 0.26 0.69 0.76  4.6 
SXR 0.66 0.67 0.65 0.33 1.24 0.24 0.63 0.69  4.5 
RXX 0.66 0.63 0.64 0.28 1.26 0.24 0.62 0.69  4.9 
SXS 0.67 0.61 0.64 0.28 1.24 0.25 0.62 0.68  5.8 
RXR 0.65 0.58 0.61 0.23 1.24 0.25 0.59 0.67  5.7 
 
a) Microemulsion composition as in Table 6.1. 
b) Determined via µeo/µme using octanophenone data. 
  
185 
impacted the resolution (largest efficiency, second largest enantioselectivity, and second 
highest elution range), thus overcoming the poor value of kavg/kopt.  Quantitatively, the 
increase in elution range contributed the most to the increase in ephedrine resolution from 
the RXS to RXR system.  A similar situation was observed in the case of 
pseudoephedrine:  despite having the worst kavg/kopt, the best resolution was obtained with 
the RXR system.  Pseudoephedrine had its second highest enantioselectivity with this PSP 
and as stated above, the elution range was second best with RXR.  The efficiency was 
lower for pseudoephedrine with RXR, however its impact on resolution is decreased due 
to the square root.  Overall, the increase in elution range was responsible for the better 
resolution with RXR over RXX.  N-methyl ephedrine resolution was slightly better with 
the SXR formulation due to its ranking for kavg/kopt (second best).  Based on the trends 
from the other aggregates, the RXR system would have been predicted to provide the best 
resolution for N-methyl ephedrine (largest elution range), however it resulted in the 
second lowest resolution.  The values for resolution were very similar for these two 
microemulsions; it is therefore reasonable to assume experimental variation caused SXR 
to outrank RXR.  Resolution calculations revealed that the change in retention factor to a 
more optimal value impacted N-methyl ephedrine resolution the most.  Atenolol was best 
resolved with SXS.  The underlying factors making this the best performer are 
enantioselectivity (highest value) and elution range (highest value).  The other two 
portions of the fundamental resolution equation, efficiency and retention factors, although 
ranked lower did not outweigh the positive influence of the other two parts.  
Mathematically, the improvements in enantioselectivity contributed the most to the 
increase in resolution with SXS.  The remaining compounds, metoprolol and synephrine, 
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had largest resolution values with the SXS microemulsion as well.  In addition to the 
increased elution range, metoprolol and synephrine enantioselectivities were the best with 
SXS.  Those two factors contributed the most to improvements in resolution.  The 
retention factor ratios (kavg/kopt) were in the middle (synephrine) to upper (metoprolol) 
rankings with this microemulsion.  Efficiencies with SXS were mid-range for these two 
compounds.  Based on predicted resolution values, the elution range impacted metoprolol 
resolution the most, whereas enantioselectivity was a bigger factor for the improvements 
achieved in synephrine resolution.   
 
6.2.6 Gibb’s Free Energy Changes and Potential Synergies 
Evaluation of Gibb’s free energy changes (ΔΔG° = ΔG°2 - ΔG°1) for each pair of 
enantiomers with the various microemulsions provided thermodynamic data that were 
used to identify potential synergies in dual-chirality systems [14, 15].  The free energy 
value ΔΔG° signifies the energetic difference between the chiral enantiomers for their 
incorporation into the PSP from the mobile phase.  Partitioning into the aggregate is 
favored when ΔΔG° is positive.  Conversely, negative free energy changes indicate an 
analyte preference for the mobile phase with minimal retention in the microemulsion.  
The calculated ΔΔG° values are given in Table 6.6.  The contribution of each chiral 
microemulsion component on its own was determined from the single-chirality 
formulations (RXX for the chiral surfactant and XXR for the chiral oil).  As previously 
stated, the system containing only the chiral oil did not result in any appreciable 
enantioselectivity, therefore testing with an XXS microemulsion was unnecessary.  The 
free energy changes for XXR and XXS are reported as zero.  The one-chiral-component 
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Table 6.6.  Analysis of synergies in enantioselectivity for dual-chiral microemulsion electrokinetic chromatography with a chiral 
surfactant and a chiral oil.   
 
 
Microemulsiona)/ΔΔG°b) 
 
Ephedrine 
 
Pseudoephedrine 
N-methyl 
ephedrine 
 
Atenolol 
 
Metoprolol 
 
Synephrine 
RXX -0.179 -0.327 -0.185 -0.055 -0.128 -0.121 
SXXc) -0.179 -0.327 -0.185 -0.055 -0.128 -0.121 
XXR  0.000  0.000  0.000  0.000  0.000  0.000 
XXSd)  0.000  0.000  0.000  0.000  0.000  0.000 
RXR -0.187 -0.322 -0.181 -0.058 -0.131 -0.123 
SXR -0.187 -0.314 -0.179 -0.059 -0.126 -0.120 
RXS -0.176 -0.319 -0.182 -0.051 -0.134 -0.129 
SXS -0.185 -0.322 -0.183 -0.062 -0.137 -0.138 
       
ΔΔG°RXR – (ΔΔG°RXX + ΔΔG°XXR) -0.008 0.004 0.004 -0.004 -0.003 -0.002 
ΔΔG°SXR – (ΔΔG°SXX + ΔΔG°XXR) -0.008 0.013 0.006 -0.004  0.002  0.001 
ΔΔG°RXS – (ΔΔG°RXX + ΔΔG°XXS)  0.004 0.008 0.003  0.004 -0.006 -0.008 
ΔΔG°SXS – (ΔΔG°SXX + ΔΔG°XXS) -0.005 0.005 0.002 -0.007 -0.009 -0.018 
 
a) Microemulsion composition as in Table 6.1. 
b) ΔΔG° = ΔG°2 - ΔG°1, kJ/mol 
c) SXX microemulsion not prepared.  Using the opposite stereochemistry in a single-chirality formulation will give the same 
enantioselectivity with reversal in elution order. 
d) XXS not tested because zero enantioselectivity was achieved with XXR.
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microemulsion SXX was not analyzed due to the fact that it would differ from RXX only 
in elution order [17]. 
 
Theoretically, the free energy changes from the individual chiral microemulsion 
components are additive and should total to the free energy changes observed with the 
two-chiral-component systems, as shown in eqn. 5.1 below.   
∆∆G˚chiral surf & chiral oil – (∆∆G˚chiral surf + ΔΔG˚chiral oil) = 0          (5.1) 
Therefore, when the subtraction of the single-chirality ΔΔG° values from the dual-
chirality values yielded non-zero quantities, it was reasoned that a synergetic effect was 
present.  As shown in Table 6.6, potential synergies exist for every two-chiral-component 
microemulsion.  The magnitude and sign of this synergism varies by compound and 
aggregate system.  Beneficial and detrimental synergies are defined by equations 5.2a and 
5.2b, respectively.  
∆∆G˚chiral surf & chiral oil – (∆∆G˚chiral surf + ΔΔG˚chiral oil) < 0     (5.2a) 
∆∆G˚chiral surf & chiral oil – (∆∆G˚chiral surf + ΔΔG˚chiral oil) > 0     (5.2b) 
In the majority of cases, 20 out of 24, non-zero differences in free energy changes were 
found (values of 0.002 kJ/mol and smaller were deemed insignificant, as established in 
Chapter 3).  The remaining synergies were divided almost evenly between beneficial and 
detrimental (11 beneficial synergies and 9 detrimental).  Interestingly, the largest 
deviations from zero, whether beneficial or detrimental, were obtained with either SXR or 
SXS.  Another important observation is the compound groupings:  the ephedrine 
derivatives had maximum synergies with SXR (ephedrine had equal values for RXR and 
SXR) and the non-ephedrine analytes displayed higher values with SXS.  Among the 
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ephedrine-based enantiomers, only ephedrine experienced a beneficial synergistic effects 
(3 out of 4 microemulsions, RXS being the exception).  For the most part, atenolol, 
metoprolol, and synephrine had beneficial synergisms.  In addition, the synergies for RXR 
and SXS were expected to be symmetrical, but were not.  We investigated the purity of 
our reagents via polarimetry and did discover some decreased enantiopurity for R-DDCV 
(specific rotation of +7.2 versus -7.7 for S-DDCV at a concentration of 60.7 mM in 0.1 M 
NaOH).  However, corrections based on the optical rotation difference failed to 
compensate for the observed discrepancy.  The cause of the asymmetrical synergy data is 
still being investigated. 
 
The underlying causes of the synergistic effects were first postulated in our chiral 
surfactant-chiral cosurfactant-achiral oil study [14] to be due to a) an increase or decrease 
in the overall microemulsion chirality from the interaction of the chiral microemulsion 
components, and/or b) association of the analytes with both chiral microemulsion 
components.  In our second study on dual-chirality MEEKC using a chiral surfactant and 
a chiral oil (dibutyl tartrate) [15], the first possible reason, a), was eliminated due to the 
spatial limitations for microemulsion component locations.  Thus, the data reported here 
further support proposal b) as the root cause of synergism in two-chiral-component 
microemulsions.  Analytes that are highly hydrophilic or highly hydrophobic would not 
partition into the aggregate optimally to form temporary diastereomeric bonds with each 
chiral component.  Therefore, enantiomers with intermediate polarity (hydrophobicity) 
would have the potential to interact with both the chiral surfactant and the chiral oil, 
resulting in a synergistic effect.   
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6.2.7 Aggregate Hydrophobicity Changes with the Incorporation of a Second 
Chiral Microemulsion Component 
 
The final analysis performed on the single- and dual-chirality microemulsions containing 
the oil diethyl tartrate was the determination of methylene selectivity (αmeth, the ability of 
an aggregate to differentiate between analytes with similar hydrophobicities).  The αmeth 
values, shown in Table 6.7, span a relatively narrow range from a high of 2.683 to a low 
of 2.568.  Only one statistical difference was found for adjacent values:  SXR > XXR ≥ 
SXS ≥ RXR ≥ RXX ≥ RXS.  
 
In general, this information on methylene group discrimination would be used to 
establish microemulsion polarity differences provided the aqueous phase was held 
constant among systems, as was the case in this study.  Larger values of αmeth represent an 
aggregate with increased hydrophobicity (non-polarity), whereas smaller values indicate 
an increase in hydrophilicity (polarity).  Despite there being statistical differences 
between the one- and two-chiral-component microemulsions, the minor extent of these 
changes demonstrates the negligible impact of stereochemical combinations on the 
overall hydrophobic nature of the aggregate. 
 
6.2.8 Comparison of Results to DDCV Formulations with Different Oils (Achiral 
and Chiral) 
 
The results from this study were compared to those from a previous study that utilized 
ethyl acetate as the microemulsion oil core (otherwise identical BGE) [18] to provide a 
different perspective on the current data, see Table 6.8.  Average efficiencies increased 
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Table 6.7.  Effect of microemulsion component stereochemistry (surfactant and oil) on 
methylene selectivity. 
 
Microemulsiona) αmethb) 
RXS 2.568 ± 0.029 
RXX 2.582 ± 0.027 
RXR 2.592 ± 0.020 
SXS 2.610 ± 0.010 
XXR 2.613 ± 0.020 
SXR 2.683 ± 0.040 
 
a) Microemulsion composition as in Table 6.1. 
b) Values based on a minimum of 15 injections.
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Table 6.8.  Comparison of chromatographic figures of merit in chiral MEEKC with changes in oil configuration and identity. 
 
  Microemulsion Stereochemistry  
Parametera) Oilb) RXR RXS RXX SXR SXS Mean 
Ethyl Acetate N/A N/A 76000 N/A N/A 76000 
Diethyl Tartrate 91400 94300 84700 80800 81000 86400 Navg 
Dibutyl Tartrate 105000 129000 134000 103000 127000 119600 
        
Ethyl Acetate N/A N/A 1.082 N/A N/A 1.082 
Diethyl Tartrate 1.080 1.079 1.079 1.078 1.081 1.079  αenant 
Dibutyl Tartrate 1.062 1.067 1.064 1.066 1.060 1.064 
        
Ethyl Acetate N/A N/A 0.68 N/A N/A 0.68 
Diethyl Tartrate 0.67 0.76 0.69 0.69 0.68 0.70 kavg/kopt 
Dibutyl Tartrate 0.73 0.81 0.88 0.76 0.83 0.80 
        
Ethyl Acetate N/A N/A 2.24 N/A N/A 2.24 
Diethyl Tartrate 2.12 2.11 2.08 2.13 2.21 2.13 Rs 
Dibutyl Tartrate 1.64 1.91 1.72 1.67 1.65 1.72 
        
Ethyl Acetate N/A N/A 2.632 N/A N/A 2.632 
Diethyl Tartrate 2.592 2.568 2.582 2.683 2.610 2.607 αmeth 
Dibutyl Tartrate 2.713 2.822 2.872 2.807 2.863 2.815 
  
 
a) Values averaged for ephedrine, N-methyl ephedrine, pseudoephedrine, metoprolol, and synephrine (atenolol excluded). 
b) Oil concentrations are equimolar (51.2 mM).  Data for the achiral oil ethyl acetate were previously published [18] and those 
for the chiral oil dibutyl tartrate [15] are in press. 
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when the achiral oil identity was changed from ethyl acetate to diethyl tartrate for five out 
of six analytes, pseudoephedrine being the exception.  The average efficiency across all 
analytes was 78,300 for R-DDCV/2-hexanol/ethyl acetate and 91,600 for R-DDCV/2-
hexanol/racemic diethyl tartrate (76,000 vs. 84,700 for ethyl acetate and diethyl tartrate, 
respectively, when values for atenolol are excluded).  The opposite effect was observed 
for resolution with four enantiomers showing a decrease in values, pseudoephedrine and 
N-methyl ephedrine had very small increases.  The overall average resolutions for each 
aggregate were 1.99 for the ethyl acetate formulation and 1.83 for the racemic diethyl 
tartrate system (2.24 vs. 2.08 when atenolol is excluded).  Enantioselectivities achieved 
with these two microemulsions varied modestly for most of the compounds (maximum 
difference of 0.007 with ephedrine, no difference for N-methyl ephedrine) with the 
average for each system being nearly identical (1.073 vs. 1.070 with atenolol and 1.082 
vs. 1.079 without atenolol for ethyl acetate and diethyl tartrate, respectively).  The higher 
resolution observed with ethyl acetate was due to the larger elution range (6.8 versus 4.9 
with diethyl tartrate) and its greater influence on resolution than the moderate decrease in 
efficiency (comparable enantioselectivity and kavg/kopt).  Lastly, the similarity in 
methylene selectivities (2.632 vs. 2.582 for ethyl acetate and racemic diethyl tartrate, 
respectively) demonstrates that these microemulsions have approximately equivalent 
hydrophobicities.  All in all, the replacement of ethyl acetate with racemic diethyl tartrate 
resulted in more efficient separations. 
 
The initial experiments conducted for dual-chirality MEEKC with the combination of a 
chiral surfactant and a chiral oil utilized dibutyl tartrate as the second chiral 
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microemulsion component (submitted for publication, [15]).  The main difference 
between dibutyl tartrate and diethyl tartrate is hydrophobicity: the higher interfacial 
tension with dibutyl tartrate required longer sonication times for solubilization.  
Methylene selectivities reflected this with larger values obtained for all dibutyl tartrate 
formulations (range of 2.713 to 2.872) over those with diethyl tartrate (range of 2.568 to 
2.683).  The trends found for efficiency, resolution, enantioselectivity, and changes in 
Gibb’s free energy differed for the dual-chirality microemulsions with dibutyl tartrate and 
diethyl tartrate, and were not contrasted in detail.  Importantly, the dibutyl tartrate 
formulations were completely ineffective in separating atenolol, whereas diethyl tartrate 
aggregates did produce an observable separation.  The higher hydrophobicity of the 
dibutyl tartrate aggregates most likely prevented this hydrophilic analyte from adequately 
partitioning into the PSP to interact with the chiral selectand.  Average efficiencies for all 
pairs of enantiomers decreased with the use of a less hydrophobic oil (80,800 to 94,300 
for diethyl tartrate without atenolol and 100,000 to 134,000 for dibutyl tartrate).  In the 
dibutyl tartrate report, two distinct groups of efficiency values were noted based on oil 
stereochemistry.  This was not observed with the diethyl tartrate microemulsions.  
Resolution and enantioselectivity values for the two studies demonstrated an increase in 
analyte averages across all microemulsions when the oil diethyl tartrate was used.  In 
addition, the stereochemical combinations that provided the worst average 
enantioselectivities in the dibutyl tartrate study (RXR and SXS) gave the best values with 
diethyl tartrate.  Comparison of enantioselective synergies achieved with each chiral oil 
revealed smaller magnitudes with diethyl tartrate (maximum values of -0.018 and 0.044 
kJ/mol for diethyl and dibutyl tartrate, respectively).  The ephedrine-based enantiomers 
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had increased synergism with the SXR combination of diethyl tartrate and the SXS version 
of dibutyl tartrate.  Lastly, synephrine experienced an enhanced synergistic effect with 
the less hydrophobic chiral oil, diethyl tartrate.  The oil identity in two-chiral-component 
microemulsions has a direct impact on the quality of chromatography with oil and 
analyte-dependent trends that would allow optimization. 
  
6.3 Concluding Remarks 
The combination of two chiral selectors into one PSP has proven to be a unique way to 
modify a MEEKC analysis to achieve improved enantioseparations.  We discovered 
distinct variations in efficiency, resolution, enantioselectivity, and enantioselective 
synergies depending on the exact stereochemical configurations of the chiral surfactant 
and chiral oil, in addition to the enantiomer identity.  The chiral oil identity, as well as 
stereochemistry, impacts how each analyte responds to dual-chirality microemulsions.   
 
Average efficiencies improved when a second chiral component was added to the PSP for 
the majority of test compounds, with formulations containing R-DDCV giving the best 
results.  In general, resolution values were not greatly impacted by the introduction of a 
chiral oil to an existing chiral microemulsion.  However, dual-chirality systems did 
provide slightly better enantioresolutions.  Enantioselectivities increased modestly when 
two-chiral-component aggregates were employed.  The potential for the chiral 
enantiomers to interact with two different chiral species in the microemulsion created 
enantioselective synergies that were beneficial or detrimental depending on the analyte 
and PSP.   
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In comparison to the oil ethyl acetate, utilization of racemic diethyl tartrate enhanced 
efficiencies but reduced resolutions.  These two systems had similar enantioselectivities 
and methylene selectivities due to their comparable hydrophobic nature.  The chiral oil 
used in part one of this study, dibutyl tartrate, performed better than diethyl tartrate in 
terms of efficiency and gave larger magnitude synergies.  Diethyl tartrate increased 
enantioselectivities and resolutions over those obtained with dibutyl tartrate.  The 
methylene selectivities for these two chiral oils (greater values with dibutyl tartrate) 
reflected the apparent differences in hydrophobicity.  It is hypothesized that this factor is 
responsible for changes in chromatographic figures of merit for the dual-chirality 
microemulsions with the same chiral surfactant but different chiral oils. 
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Chapter 7:  Influence of Microemulsion Chirality on Chromatographic Figures of 
Merit and Enantioselective Synergisms in Electrokinetic Chromatography:  Results 
with Novel Three-Chiral-Component Microemulsions and Comparison with One- 
and Two-Chiral-Component Microemulsions 
 
 
 
7.1 Introduction 
The field of chiral MEEKC (where the microemulsion is chiral) has yet to gain 
widespread interest as evidenced by the small body of literature (eleven publications to 
date) noted in three recent reviews of MEEKC [1-3].  Most of this work has focused on 
the chiral surfactant dodecoxycarbonylvaline (DDCV).  Our group first introduced a 
system containing DDCV, 1-butanol, and ethyl acetate in 2002 [4].  Subsequent DDCV 
microemulsion studies explored the effect of oil identity [5], addition of a cyclodextrin 
[6], effect of surfactant concentration and buffer identity [7], effect of temperature [8], 
differences between micelles and microemulsions [9], and cosurfactant identity [10].  In 
addition to these single-chiral-component microemulsion reports, dibutyl tartrate has 
been incorporated as a chiral oil (achiral surfactant and achiral cosurfactant) [11] and 
chiral cosurfactants have been shown to produce enantioselectivity (achiral surfactant and 
achiral oil) [12].  We were the first to demonstrate the simultaneous combination of two 
chiral microemulsion components with DDCV and S-2-hexanol with an achiral oil for the 
separation of pharmaceutical enantiomers [13].  Enantioselective synergies were found 
with dual-chirality systems, and the combination of S-DDCV with S-2-hexanol provided 
higher efficiencies and resolution than R-DDCV and S-2-hexanol.  Next, we investigated 
two-chiral-component microemulsions formed from a chiral surfactant (R- or S-DDCV), 
an achiral cosurfactant (racemic 2-hexanol), and a chiral oil (dibutyl tartrate [14] or 
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diethyl tartrate [15]).  Dibutyl-tartrate-containing systems were shown to have higher 
efficiencies but lower enantioselectivities and resolution.  Both dual-chirality aggregates 
displayed enantioselective synergies. 
 
In the present study, the potential of using three chiral microemulsion components 
simultaneously—chiral surfactant + chiral cosurfactant + chiral oil— was explored for 
the first time using R- or S-DDCV (surfactant), S-2-hexanol (cosurfactant), and R- or S-
diethyl tartrate (oil).  Out of four possible combinations of these three reagents,  three 
produced stable aggregates whereas R-DDCV/S-2-hexanol/R-diethyl tartrate did not, 
presumably due to incompatible stereochemistry.  Six chiral pharmaceutical compounds 
were tested with the novel microemulsions (atenolol, ephedrine, metoprolol, N-methyl 
ephedrine, pseudoephedrine, and synephrine).  Although only modest differences were 
observed between the triple- and dual-chirality microemulsion pseudostationary phases 
(PSPs), they provided higher enantioselectivities and resolution than any of the one-
chiral-component microemulsion PSPs.  Separation characteristics of the one-, two-, and 
three-chiral-component microemulsions are compared using the following 
chromatographic figures of merit:  enantioselectivity, efficiency, resolution, methylene 
selectivity, and enantioselective synergy.  Overall, improved chiral MEEKC analyses 
were obtained when the number of chiral microemulsion reagents was increased. 
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7.2 Results and Discussion 
7.2.1 Novel Multi-Chirality-Microemulsion Formulations 
Microemulsions containing one, two, and three chiral components were examined in this 
study.  Two of the chiral microemulsion components, surfactant and oil, were obtained in 
both stereochemical configurations:  R- and S-DDCV and diethyl L-tartrate (RR = “R”) 
and diethyl D-tartrate (SS = “S”), respectively.  The chiral cosurfactant, S-2-hexanol, 
was obtained in only one stereochemical configuration.  Four dual-chirality and four 
triple-chirality microemulsions are reported for the first time with results compared to 
previously reported one- and two-chiral-component systems, see Table 7.1.  The 
microemulsions are identified by a three-letter abbreviation with the first letter denoting 
the surfactant stereochemical configuration, the second letter the cosurfactant, and the 
last letter for the oil; racemic components are represented by an X.   
 
Microemulsions that did not include the chiral surfactant (XXR, XSR, and XSS) failed to 
provide any enantioresolution for racemic mixtures.  Enantioselectivity values were 
determined for ephedrine, N-methyl ephedrine, and pseudoephedrine from analyses of 
individual enantiomers and were statistically different from unity (t-test with α=0.05) in 
only two cases:  XSS for ephedrine (αenant = 1.006) and XSR for N-methyl ephedrine (αenant 
= 1.004).  Additionally, the combination or R-DDCV, S-2-hexanol, and diethyl L-tartrate 
was unstable; initially it gave erratic baselines and subsequently it precipitated from 
solution.  Therefore, these microemulsions (XSS, XSR, XXR, and RSR (diethyl tartrate 
only)) were excluded from further statistical analysis and discussion.  
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Table 7.1.  Microemulsion stereochemical compositionsa) and abbreviationsb). 
 
DDCV 
Stereochemistry 
2-Hexanol 
Stereochemistry 
Diethyl Tartrate 
Stereochemistryc) 
Microemulsion 
Abbreviation 
R X X RXXd) 
X X R XXRd) 
R S X RSXe) 
S S X SSXe) 
X S R XSRe) 
X S S XSSe) 
R X R RXRd) 
S X R SXRd) 
R X S RXSd) 
S X S SXSd) 
R S R RSRe) 
S S R SSRe) 
R S S RSSe) 
S S S SSSe) 
 
a) Surfactant (DDCV) concentration was 2.00% w/v (60.7 mM); racemic 
cosurfactant (2-hexanol) concentration was 1.65% v/v (131 mM); oil (diethyl 
tartrate) concentration was 0.88% v/v (51.2 mM); and buffer was 50 mM 
phosphate at a pH of 7.0. 
b) The first letter signifies surfactant configuration, followed by cosurfactant, and 
then oil.  The letter X represents racemic components. 
c) The configurations (abbreviations) of diethyl L-tartrate and diethyl D-tartrate are 
2R, 3R- (R) and 2S, 3S- (S), respectively. 
d) Previously reported formulations [14]. 
e) Newly prepared formulations.
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7.2.2 Enantioselectivity, Efficiency, Resolution, and Methylene Selectivity with 
Triple-Chirality Microemulsions 
 
Variation in microemulsion stereochemical composition was found to cause minor to 
moderate changes in enantioselectivity as shown in Table 7.2.  In all cases, the triple- 
chirality systems afforded better enantioresolution than the single-chirality 
microemulsion RXX, due to a better environment for chiral recognition for the 
compounds of interest.  Synephrine experienced the largest increase, with RSS giving a 
net improvement of 0.009 over RXX (see Fig. 7.1).  The next largest difference in 
enantioselectivity was observed for pseudoephedrine where the SSR aggregate provided a 
0.006 net increase (see Fig. 7.2).  The remaining four pairs of enantiomers all had SSS as 
the top-ranking microemulsion.  Additionally, three out of these four compounds (N-
methyl ephedrine, metoprolol, and atenolol) displayed rankings that decreased in an 
identical order.  The results for ephedrine were improved by 0.005 by simultaneously 
incorporating three chiral components into the microemulsion.  Metoprolol and atenolol 
both demonstrated a net improvement of 0.004 whereas N-methyl ephedrine was least 
affected by aggregate composition with an overall increase in enantioselectivity of just 
0.002. 
 
The average enantioselectivity for each microemulsion across all compounds yielded 
similar values for the three stable all-chiral systems.  When data for the analyte with the 
smallest enantioselectivity (atenolol) are excluded, the triple-chirality aggregates provide 
the same overall average result.  The data demonstrate that enantiomer discrimination 
remains constant when the stereochemistry of the microemulsion constituents is changed. 
  
204 
 
Table 7.2. Effect of microemulsion component stereochemistry (surfactant, cosurfactant, and oil) on enantioselectivity.a)  
 
 
Compound \ αenantb) SSR SSS RSS RXXc) Compound Mean Stereochemical Rankingd) 
Pseudoephedrine 1.147 1.142 1.142 1.141 1.143 SSR > SSS ≈ RSS ≈ RXX 
N-methyl ephedrine 1.080 1.080 1.079 1.078 1.079 SSS ≈ SSR ≈ RSS ≈ RXX 
Ephedrine 1.077 1.080 1.078 1.075 1.078 SSS ≈ RSS ≈ SSR ≈ RXX 
Metoprolol 1.057 1.057 1.055 1.053 1.056 SSS ≈ SSR > RSS > RXX 
Synephrine 1.055 1.056 1.059 1.050 1.055 RSS > SSS ≈ SSR > RXX 
Atenolol 1.025 1.026 1.025 1.022 1.025 SSS ≈ SSR ≈ RSS > RXX 
       
Arithmetic mean 1.074 1.073 1.073 1.070 N/A N/A 
Arithmetic mean 
excluding Atenolol 1.083 1.083 1.083 1.079 N/A N/A 
 
a) Microemulsion composition as in Table 7.1. 
b) RSD less than 0.5%. 
c) Previously reported [15]. 
d) Statistical differences between adjacent values are shown with the use of a greater than sign (>) and the absence of a 
statistically significant difference by an approximately equal sign (≈, difference less than 0.004).
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Figure 7.1.  Effect of microemulsion stereochemical composition on synephrine 
enantioselectivity.  (A) RXX microemulsion, (B) SSR microemulsion, and (C) RSS 
microemulsion.  Surfactant concentration = 2.00% w/v; cosurfactant concentration = 
1.65% v/v; oil concentration = 1.23% v/v; 50 mM phosphate buffer, pH 7.0.  Capillary 
dimensions:  Ltot = 32 cm, Leff = 23.6 cm, i.d. = 50 µm.  Detection wavelength was 215 ± 
5 nm, injections were performed hydrodynamically for 2 seconds with 25 mbar pressure, 
and the applied voltage was 11.5 kV.
  
206 
 
 
 
Figure 7.2.  Effect of microemulsion stereochemical composition on pseudoephedrine 
enantioselectivity.  (A) RXX microemulsion, (B) SSS microemulsion, and (C) SSR 
microemulsion.  Conditions as in Fig. 7.1.  
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In contrast to the uniformly beneficial influence of multiple chiral microemulsion 
components on enantioselectivity, the effect on efficiency when the cosurfactant and oil 
were chiral instead of racemic was solute-dependent, decreasing for three out of the six 
test compounds and increasing for the three others.  As is evident in Table 7.3, atenolol 
efficiency decreased the most (difference of 32,700 between RXX and best triple-chirality 
system of SSS, 26% reduction).  It must be noted that half-width efficiency values for 
poorly resolved peaks, like those of atenolol, are known to be inaccurate and as such 
serve only as qualitative indicators of microemulsion performance.  Ephedrine displayed 
the next largest drop with values going from 86,700 with RXX to 77,700 with SSR (10% 
reduction).  Another ephedrine-based compound, N-methyl ephedrine, also suffered a 
minor efficiency loss with increased number of chiral microemulsion components (see 
Fig. 7.3).  However, this small decrease of 2% from RXX to the most efficient triple-
chirality PSP of SSR was not statistically significant. 
 
The other pairs of enantiomers examined in this study had larger average efficiencies 
with three-chiral-component aggregates.  Metoprolol and synephrine both had better 
results with all the triple-chirality systems tested.  The improvement was greater for 
metoprolol:  24,200 more plates with RSS than with RXX, a 24% increase.  A more 
modest increase of 8% was achieved for synephrine with SSR.  Lastly, pseudoephedrine 
exhibited the largest percentage gain in efficiency with a difference of 20,500 between 
RXX and RSS (28%, see Fig 7.4). 
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Table 7.3. Effect of microemulsion component stereochemistry (surfactant, cosurfactant, and oil) on efficiency.a)   
 
 
 
Compound \ Navg 
 
RXXb) 
 
RSS 
 
SSS 
 
SSR 
Compound 
Mean Stereochemical Ranking
c) 
Metoprolol 99200 123400 115200 100900 109700 RSS ≥ SSS > SSR ≈ RXX 
Atenolold) 126100 86000 93400 82900 97100 RXX > SSS ≥ RSS ≥ SSR 
Synephrine 79800 83300 81200 85900 82600 SSR ≥ RSS ≥ SSS ≈ RXX 
N-methyl ephedrine 85500 80500 73300 83400 80700 RXX ≥ SSR ≥ RSS > SSS 
Pseudoephedrine 72400 92900 74300 66400 76500 RSS > SSS ≈ RXX ≥ SSR 
Ephedrine 86700 71000 69200 77700 76200 RXX > SSR > RSS ≈ SSS 
       
Arithmetic mean 91600 89500 84400 82900 N/A N/A 
Arithmetic mean 
excluding Atenolol 84700 90200 82600 82900 N/A N/A 
 
 
a) Microemulsion composition as in Table 7.1. 
b) Previously reported [15]. 
c) Statistical differences between adjacent values are shown with the use of a greater than sign (>) and the absence of a 
statistically significant difference by an approximately equal sign (≈, difference less than 2,000) or a greater than or equal 
to sign (≥, difference greater than 2,000). 
d) Atenolol efficiencies listed for completeness but cannot be considered accurate due to the use of half-height values with 
low resolution. 
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Figure 7.3.  Effect of microemulsion stereochemical composition on N-methyl ephedrine 
efficiency.  (A) RXX microemulsion, (B) SSS microemulsion, and (C) SSR 
microemulsion.  Conditions as in Fig. 7.1.
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Figure 7.4.  Effect of microemulsion stereochemical composition on pseudoephedrine 
efficiency.  (A) RXX microemulsion, (B) SSR microemulsion, and (C) RSS 
microemulsion.  Conditions as in Fig. 7.1.
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For half of the analytes, the SSS microemulsion ranked second and RSS ranked fourth.  
Among the multi-chirality microemulsions, RSS performed the best, even outperforming 
RXX when atenolol is excluded.  Examining the enantioselectivity and efficiency data 
from single- (RXX) and triple-chirality systems, it can be seen that higher efficiency is 
generally correlated to lower enantioselectivity.  Minor exceptions to this generalization 
are found for metoprolol and synephrine where the smallest enantioselectivity and 
efficiency are obtained with the same microemulsion formulation.  However, it can be 
hypothesized that an enhanced ability to distinguish between enantiomers will lead to 
decreased efficiency via slower mass transfer, the underlying cause being the time 
duration required to form the three necessary interactions for chiral recognition.  It is 
improbable that this network of associations will occur simultaneously, thereby 
decreasing the rate of analyte movement between the mobile phase and chiral PSP.  Thus 
increasing the contribution of band broadening and reducing the number of theoretical 
plates.  Furthermore, this can be extended to postulate that achiral separations will give 
larger efficiencies than chiral separations due to the absence of three-point interactions. 
 
Similar to the enantioselectivity findings, resolution increased when microemulsions 
containing all chiral reagents were employed.  The data for this chromatographic figure 
of merit are given in Table 7.4 along with the microemulsion stereochemical rankings.  
The majority of analytes, four out of six, were worst resolved with the single-chirality 
system (RXX).  The other two compounds, N-methyl ephedrine and ephedrine, had RXX 
ranked third.  Two aggregates provided the highest resolution values for three compounds 
each:  RSS and SSR.  Ephedrine had the lowest percentage difference, 2%, between the 
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Table 7.4. Effect of microemulsion component stereochemistry (surfactant, cosurfactant, and oil) on resolution.a) 
 
 
Compound \ Rs RSS SSR SSS RXXb) Compound Mean Stereochemical Rankingc) 
Pseudoephedrine 4.11 3.62 3.54 3.48 3.69 RSS > SSR ≈ SSS ≈ RXX 
N-methyl ephedrine 2.23 2.42 2.15 2.17 2.24 SSR ≥ RSS ≈ RXX ≈ SSS 
Ephedrine 2.14 2.28 2.27 2.23 2.23 SSR ≈ SSS ≈ RXX ≈ RSS 
Metoprolol 2.03 1.94 1.89 1.59 1.86 RSS ≈ SSR ≈ SSS > RXX 
Synephrine 1.23 1.19 1.03 0.94 1.10 RSS ≈ SSR > SSS ≈ RXX 
Atenolol 0.61 0.64 0.60 0.59 0.61 SSR ≈ RSS ≈ SSS ≈ RXX 
       
Arithmetic mean 2.06 2.02 1.91 1.83 N/A N/A 
Arithmetic mean 
excluding Atenolol 2.35 2.29 2.18 2.08 N/A N/A 
 
a) Microemulsion composition as in Table 7.1. 
b) Previously reported [15]. 
c) Statistical differences between adjacent values are shown with the use of a greater than sign (>) and the absence of a 
statistically significant difference by an approximately equal sign (≈, difference less than 0.10) or a greater than or equal to 
sign (≥, difference greater than 0.10).
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best triple-chirality microemulsion and RXX.  The range between the highest and lowest 
resolution was 0.14 (SSR to RSS).  The smallest range between the best and worst 
microemulsions was found with atenolol, a 0.05 range in resolution and an 8% 
improvement over RXX.  The resolution values for N-methyl ephedrine spanned 0.27 
units (SSR to SSS) with a 0.25 difference between SSR and RXX (12% increase).  
Pseudoephedrine displayed the greatest variation in resolution, a 0.63 difference between 
RSS and RXX (18% enhancement).  The final two pairs of enantiomers showed the largest 
relative increases in resolution by incorporating all chiral components into a single PSP:  
28% and 31% improvements for metoprolol and synephrine, respectively, over RXX (see 
Fig. 7.5 and 7.6).   
 
The data illustrate that microemulsion constituent stereochemistry has a considerable 
influence on resolution regardless of the fact that most of the test analytes were better 
than baseline resolved (Rs > 1.5).  The ability to further increase resolution is vital in 
cases where other analyte peaks may overlap or quantitation of minor components is 
being performed.  It has been well documented that a resolution of 1.5 is insufficient for 
the analysis of low-level analytes in samples with high concentrations of other 
constituents [16-18].  Importantly, the triple-chirality systems investigated herein were 
able to significantly enhance the resolution between metoprolol enantiomers.  
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Figure 7.5.  Effect of microemulsion stereochemical composition on metoprolol 
resolution.  (A) RXX microemulsion, (B) SSS microemulsion, and (C) RSS 
microemulsion.  Conditions as in Fig. 7.1.
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Figure 7.6.  Effect of microemulsion stereochemical composition on synephrine 
resolution.  (A) RXX microemulsion, (B) SSS microemulsion, and (C) RSS 
microemulsion.  Conditions as in Fig. 7.1.
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Changes in resolution can be understood by assessing the factors within the fundamental 
resolution equation: 
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As described previously in this section, enantioselectivity and resolution increased while 
efficiency decreased with triple-chirality microemulsions.  The role of retention factor 
changes in resolution improvement can be evaluated using the ratio of the average 
retention factor to the optimal retention factor (kavg/kopt, kopt formula given in eqn. 1.8). 
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As this ratio approaches unity (retention becoming more optimal), resolution improves.  
As kavg/kopt diverges from unity, the maximum obtainable resolution will decrease [19].  
The retention factor ratios of kavg/kopt are shown in Table 7.5 in addition to the principal 
component of the last term in equation 1.6, the elution range, (t0/tpsp)-1.  Based on these 
data, kavg/kopt does not contribute to the resolution improvements as the values change 
minimally with the different microemulsions, and the small differences in elution range 
exert only a minor effect.  The key element to the observed resolution enhancement for 
most of the compounds is the increase in enantioselectivity.  Higher efficiencies for 
pseudoephedrine and metoprolol with triple-chirality PSPs also aided in increasing their 
resolution. 
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Table 7.5.  Effect of microemulsion component stereochemistry (surfactant, cosurfactant, and oil) on kavg/kopt and elution range. 
 
 
Microemulsiona) Ephedrine 
 
kavg/kopt 
Pseudoephedrine 
 
kavg/kopt 
N-methyl 
ephedrine 
kavg/kopt 
Atenolol 
 
kavg/kopt 
Metoprolol 
 
kavg/kopt 
Synephrine 
 
kavg/kopt 
Average  
 
kavg/kopt 
 Elution 
Rangeb) 
SSR 0.67 0.63 0.64 0.27 1.23 0.24 0.61  6.0 
RSS 0.67 0.61 0.63 0.26 1.24 0.23 0.61  5.6 
SSS 0.61 0.60 0.61 0.27 1.36 0.23 0.61  5.3 
RXXc) 0.66 0.63 0.64 0.28 1.26 0.24 0.62  4.9 
 
a) Microemulsion composition as in Table 7.1. 
b) Determined via µeo/µme using octanophenone data. 
c) Previously reported [15].
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Finally, the hydrophobic character of the newly developed triple-chirality aggregates was 
examined and compared to the RXX system.  Methylene selectivity, αmeth, is a measure of 
the discriminating capacity of an aggregate for analytes with similar hydrophobicities 
(alkylphenone homologs differing in number of methylene groups). When the aqueous 
phase is identical, as was the case in this study, αmeth can be used to determine polarity 
differences among microemulsion solutions.  Non-polar systems (higher hydrophobicity) 
correspond to larger values of αmeth and smaller values signify more polar systems (higher 
hydrophilicity).  Although statistical differences exist between RXX and the triple-
chirality microemulsions (see Table 7.6), and also among the latter, the overall range of 
values is relatively small and as such indicates that changing the stereochemical 
configuration of the aggregate components does not significantly affect hydrophobicity. 
 
7.2.3 Enantioselective Synergisms with Three-Chiral-Component Microemulsions 
As with the prior studies conducted on multi-chirality microemulsions, the existence of 
synergetic effects was established using Gibb’s free energy changes (ΔΔG° = ΔG°2 - 
ΔG°1) for each pair of enantiomers [13-15].  This thermodynamic term represents the free 
energy difference between chiral enantiomers for partitioning into the microemulsion 
from the mobile phase.  A positive value denotes that inclusion in the PSP is favorable, 
whereas a negative value demonstrates a greater affinity for the mobile phase.  The 
calculated free energy values are given in Table 7.7.  In order to delineate the 
involvement of individual chiral microemulsion components in the overall free energy 
difference, single-chirality formulations of RXX for the chiral surfactant, XSX for the 
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Table 7.6.  Effect of microemulsion component stereochemistry (surfactant, cosurfactant, 
and oil) on methylene selectivity. 
 
 
Microemulsiona) αmeth 
SSR 2.639 ± 0.046 
RSS 2.610 ± 0.018 
SSS 2.605 ± 0.009 
RXXb) 2.582 ± 0.027 
 
a) Microemulsion composition as in Table 7.1. 
b) Previously reported [15].
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Table 7.7. Analysis of synergies in enantioselectivity for three-chiral-component microemulsion electrokinetic chromatography 
with a chiral surfactant, a chiral cosurfactant, and a chiral oil.   
 
 
 
Microemulsiona)/ΔΔG°b) 
 
Ephedrine 
 
Pseudoephedrine 
N-methyl 
ephedrine 
 
Atenolol 
 
Metoprolol 
 
Synephrine 
RXXc) -0.179 -0.327 -0.185 -0.055 -0.128 -0.121 
SXXc) -0.179 -0.327 -0.185 -0.055 -0.128 -0.121 
XXRc)  0.000  0.000  0.000  0.000  0.000  0.000 
XXSc)  0.000  0.000  0.000  0.000  0.000  0.000 
XSXc) 0.000 0.000 0.000 0.000 0.000 0.000 
RSRd) N/A N/A N/A N/A N/A N/A 
SSR -0.184 -0.340 -0.190 -0.062 -0.138 -0.133 
RSS -0.187 -0.329 -0.187 -0.062 -0.132 -0.143 
SSS -0.190 -0.329 -0.190 -0.063 -0.138 -0.134 
       
SSR Synergisme) -0.005 -0.014 -0.005 -0.007 -0.010 -0.013 
RSS Synergismf) -0.008 -0.002 -0.002 -0.007 -0.004 -0.022 
SSS Synergismg) -0.011 -0.003 -0.005 -0.008 -0.010 -0.013 
 
a) Microemulsion composition as in Table 7.1. 
b) ΔΔG° = ΔG°2 - ΔG°1, kJ/mol. 
c) Previously reported [15]. 
d) RSR microemulsion was not stable, no data collected. 
e) ΔΔG°SSR = ΔΔG°SSR – (ΔΔG°SXX + ΔΔG°XSX + ΔΔG°XXR). 
f) ΔΔG°RSS = ΔΔG°RSS – (ΔΔG°RXX + ΔΔG°XSX + ΔΔG°XXS). 
g) ΔΔG°SSS  ΔΔG°SSS – (ΔΔG°SXX + ΔΔG°XSX + ΔΔG°XXS).
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chiral cosurfactant, and XXR for the chiral oil were previously tested.  In the previously 
completed studies, it was found that XSX and XXR did not give any discernable 
enantioselectivity, thereby precluding contributions from the cosurfactant or oil.  The 
one-chiral-component microemulsion SXX was not analyzed because it has the opposite 
stereochemistry from RXX and as such should differ only in elution order [20].  However, 
an investigation conducted following the dual-chirality study with diethyl tartrate  
(Chapter 6) to elucidate the asymmetrical synergies for microemulsions with opposite 
stereochemistries (RXR/SXS and RXS/SXR) revealed larger enantioselectivities with the 
single-chirality microemulsion containing S-DDCV over an equivalent formulation with 
R-DDCV (racemic 2-hexanol and ethyl acetate incorporated as the cosurfactant and oil). 
Four of six analytes had statistically different values with R- and S-DDCV although the 
difference was less than 0.5% (data in Appendix D).  Polarimetry confirmed the 
discrepancy between R- and S-DDCV and potential correction factors were developed 
using the MEEKC and specific rotation data.  These correction factors were unable to 
align the synergies for stereochemically opposite microemulsion formulations and were 
not employed for the final data analysis.  One problematic aspect of this dissimilarity is 
that the percent difference in enantioselectivity provided by R- versus S-DDCV varies 
from compound to compound (a non-systematic bias), making the development of a 
suitable correction factor difficult.  The data presented here have not been adjusted 
because possible impurities in R-DDCV are still being explored and the cosurfactant 
stereochemistry was limited to either racemic or S- configurations, and as such precludes 
the formation of stereochemically opposite aggregates.  
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In the absence of any cooperativity between chiral microemulsion components, the 
individual free energy changes should equal the total triple-chirality free energy changes, 
as expressed in equation 7.1 below.   
∆∆G˚triple-chirality – (∆∆G˚chiral surfactant + ΔΔG˚chiral cosurfactant + ΔΔG˚chiral oil) = 0   (7.1) 
In cases where equation 7.1 did not hold true, the origin of the discrepancy was 
concluded to be a synergy from the simultaneous use of multiple chiral microemulsion 
reagents.  The nature of the synergistic effects, beneficial (higher than expected 
enantioselectivity) or detrimental (lower than expected enantioselectivity), is defined in 
equations 7.2a and 7.2b, respectively.  
∆∆G˚triple-chirality – (∆∆G˚chiral surfactant + ΔΔG˚chiral cosurfactant + ΔΔG˚chiral oil) < 0   (7.2a) 
∆∆G˚triple-chirality – (∆∆G˚chiral surfactant + ΔΔG˚chiral cosurfactant + ΔΔG˚chiral oil) > 0   (7.2b) 
As shown in Table 7.7, potential synergies that vary depending on the exact 
microemulsion and analyte were identified for each multi-chirality system tested.  As 
established in Chapter 3, any values lower in magnitude than 0.002 kJ/mol were 
considered to be insignificant (observed for two combinations).  For the remaining 16 
combinations, the synergies were all beneficial.  For the majority of enantiomers, 
excluding ephedrine and pseudoephedrine, nearly equivalent synergies were found for 
SSR and SSS.  The largest and second largest synergetic effects were found for 
synephrine with RSS and pseudoephedrine with SSR, respectively.  No other apparent 
trends in these data were identified. 
 
The basis for synergism in multiple-chiral-component microemulsions was first proposed 
in our chiral surfactant-chiral cosurfactant-achiral oil study [13] to be either:  a) the 
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alteration of microemulsion chirality from the interaction of the chiral microemulsion 
components, and/or b) the association of enantiomers with both chiral microemulsion 
components.  In our second study on dual-chirality MEEKC using a chiral surfactant and 
a chiral oil (dibutyl tartrate) [14], the first postulate, a), was ruled out due to the spatial 
separation of the chiral components within the microemulsion droplet.  This was also 
supported by our subsequent dual-chirality system containing the same chiral surfactant 
and a different chiral oil (diethyl tartrate).  Due to the complexity of the novel triple-
chirality microemulsions, it is difficult to more precisely pinpoint the exact cause of 
synergy.  However, only compounds that have intermediate hydrophobicity would most 
likely partition optimally into the microemulsion, forming temporary diastereomeric 
bonds with each chiral component (surfactant, cosurfactant, and oil), and experience the 
triple enantioselective synergies.  
 
7.2.4 Comparison of Two Types of Dual-Chirality Microemulsions  
In conjunction with the triple-chirality microemulsions, dual-chirality experiments for the 
combination of chiral surfactant and chiral cosurfactant were conducted with racemic 
diethyl tartrate as the oil (earlier studies of this dual-chiral surfactant/cosurfactant system 
used ethyl acetate as the achiral oil [13]).  Data comparing the two categories of dual-
chirality microemulsions are given in Table 7.8.  The results for chiral surfactant-achiral 
cosurfactant-chiral oil aggregates were previously reported in Chapter 6 and in the 
literature [15]. 
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Table 7.8.  Comparison of results from two varieties of dual-chirality microemulsions.a) 
 
 Chiral Surfactant + 
Chiral Cosurfactant 
Chiral Surfactant + Chiral Oilb) 
Parameter and Compound RSX SSX RXS SXS RXR SXR 
Enantioselectivity, αenantc) 
Atenolol 
Ephedrine 
Metoprolol 
N-methyl ephedrine 
Pseudoephedrine 
Synephrine 
 
1.026 
1.082 
1.056 
1.079 
1.143 
1.058 
 
1.024 
1.076 
1.057 
1.076 
1.149 
1.056 
 
1.021 
1.074 
1.055 
1.076 
1.137 
1.053 
 
1.025 
1.077 
1.057 
1.077 
1.139 
1.057 
 
1.024 
1.078 
1.054 
1.075 
1.139 
1.051 
 
1.024 
1.079 
1.052 
1.075 
1.135 
1.050 
αenant microemulsion means 1.074 1.073 1.069 1.072 1.070 1.069 
αenant category means  1.073 1.070 
Efficiency, Navg 
Atenolol 
Ephedrine 
Metoprolol 
N-methyl ephedrine 
Pseudoephedrine 
Synephrine 
 
104300 
 76600 
110400 
 84800 
 80000 
 94700 
 
104100 
 84200 
107100 
 83200 
 68100 
 71700 
 
110200 
 92600 
117600 
 97300 
 80800 
 83000 
 
 91100 
 74500 
104900 
 76600 
 69300 
 79800 
 
 95100 
 93100 
115100 
 94900 
 71800 
 82300 
 
115400 
 80800 
 89800 
 81100 
 84700 
 67600 
Navg microemulsion means  91800  86400  96900  82700  92100  86600 
Navg category means 89100 89600 
Resolution, Rs 
Atenolol 
Ephedrine 
Metoprolol 
N-methyl ephedrine 
Pseudoephedrine 
Synephrine 
 
0.82 
2.45 
2.16 
2.46 
4.06 
1.32 
 
0.68 
2.12 
1.87 
2.07 
3.71 
1.02 
 
0.55 
2.04 
1.76 
2.16 
3.56 
1.03 
 
0.65 
2.20 
2.00 
2.18 
3.53 
1.15 
 
0.61 
2.26 
1.63 
2.17 
3.57 
0.98 
 
0.62 
2.24 
1.65 
2.24 
3.56 
0.95 
Rs microemulsion means 2.21 1.91 1.85 1.95 1.87 1.88 
Rs category means 2.06 1.89 
Enantioselective Synergy 
Atenolol 
Ephedrine 
Metoprolol 
N-methyl ephedrine 
Pseudoephedrine 
Synephrine 
 
-0.009 
-0.015 
-0.006 
-0.004 
-0.004 
-0.020 
 
-0.003 
-0.002 
-0.010 
 0.004 
-0.018 
-0.014 
 
 0.004 
 0.004 
-0.006 
 0.003 
 0.008 
-0.008 
 
-0.007 
-0.005 
-0.009 
 0.002 
 0.005 
-0.018 
 
-0.004 
-0.008 
-0.003 
 0.004 
 0.004 
-0.002 
 
-0.004 
-0.008 
 0.002 
 0.006 
 0.013 
 0.001 
αmeth 2.580 2.622 2.568 2.610 2.592 2.683 
αmeth category means 2.601 2.613 
 
a) Microemulsion composition as in Table 7.1. 
b) Previously reported [15]. 
c) RSD less than 0.5%.
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In terms of enantioselectivity, RSX provided higher values for all but two compounds 
(metoprolol and pseudoephedrine).  As apparent by the averages for each two-chiral-
component microemulsion, both chiral surfactant/cosurfactant combinations (RSX and 
SSX) gave better results than any of the surfactant/oil dual-chirality microemulsions.  The 
higher enantioselectivities observed for the combination of a chiral cosurfactant and a 
chiral surfactant instead of a chiral oil/chiral surfactant indicates that a more selective 
chiral interaction can take place when two chiral components are near the surface of the 
PSP. 
 
Average efficiencies were equivalent for the two types of dual-chiral microemulsions, but 
there was a greater variation among the surfactant/oil dual-chirality systems (trends 
discussed in Chapter 6).  Comparison of averages for individual two-chiral-component 
microemulsions reveals the highest efficiency with RXS, nearly equivalent results for RSX 
and RXR as well as for SSX and SXR, and the lowest with SXS.  On a compound-to-
compound basis, only one compound displayed better efficiency when the aggregate 
contained both a chiral surfactant and a chiral cosurfactant:  synephrine with RSX. 
 
In stark contrast to the similarities in enantioselectivity and efficiency, a major difference 
was observed when resolution was examined.  The RSX microemulsion, by far, exceeded 
the averages for the other aggregates in addition to providing the best value for each 
individual analyte.  Altogether, the combination of a chiral surfactant and a chiral 
cosurfactant allowed for resolution improvements over the other dual-chirality category 
(see Figures 7.7 and 7.8).  The main factor behind this dramatic inequality for two-chiral- 
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Figure 7.7.  Effect of different dual-chirality microemulsion (chiral surfactant plus chiral 
cosurfactant vs. chiral surfactant plus chiral oil) on atenolol resolution.  (A) RXS 
microemulsion, (B) SXS microemulsion, and (C) RSX microemulsion.  Conditions as in 
Fig. 7.1.
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Figure 7.8.  Effect of different dual-chirality microemulsions (chiral surfactant plus chiral 
cosurfactant vs. chiral surfactant plus chiral oil) on ephedrine resolution.  (A) RXS 
microemulsion, (B) SXR microemulsion, and (C) RSX microemulsion.  Conditions as in 
Fig. 7.1.
  
228 
component microemulsions was a moderate increase in elution range (values of 6.8 and 
5.3 for RSX and SSX, respectively, compared to 4.6, 5.8, 5.7, and 4.5 for RXS, SXS, RXR, 
and SXR).  
 
The last two sets of data included in Table 7.8 are enantioselective synergies and 
methylene selectivities.  Briefly, for the former, values varied depending on analyte and 
microemulsion composition.  It was observed that generally beneficial synergisms were 
obtained with chiral surfactant/chiral cosurfactant PSPs compared to an almost perfect 
balance of beneficial and detrimental synergies observed for the chiral surfactant/chiral 
oil aggregates.  An unresolved aspect of these data is the lack of symmetry between the 
data for stereochemically opposite microemulsions (i.e., RSX/SSX, RXR/SXS, RXS/SXR).   
At this point in time, surfactant impurities are being explored as the primary cause of this 
discrepancy, but another possibility is that the theoretical hypothesis is not entirely 
correct as these types of studies have not been performed before and the experimental 
data did not give the expected synergy trends.  Finally, the nanodroplets were shown to 
have very similar hydrophobicities as per their methylene selectivities.  Thus, the use of a 
chiral instead of racemic reagent does not greatly influence the PSP water content.  
Therefore, the differences in enantioselectivity, efficiency, and resolution do not result 
from variations in aggregate polarity. 
 
As mentioned at the beginning of this section, the first dual-chirality microemulsion 
studies were conducted with chiral surfactant/cosurfactant formulations containing the 
achiral oil ethyl acetate for the analysis of pseudoephedrine and N-methyl ephedrine 
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enantiomers (Chapter 3).  Comparison of these data with those obtained using racemic 
diethyl tartrate (RSX and SSX aggregates) showed opposite trends for most parameters 
that depended on analyte identity.  Enantioselectivity was essentially unchanged for N-
methyl ephedrine among PSPs with the same oil, regardless of the stereochemical 
combination of surfactant and cosurfactant; diethyl tartrate provided a very small 
improvement over ethyl acetate (1.08 vs. 1.07).  Pseudoephedrine enantioselectivity was 
the largest with the RS combination with ethyl acetate and the smallest with the SS 
system of the same oil.  There was less of a difference between the stereochemical 
combinations with racemic diethyl tartrate and the trend was opposite of that for ethyl 
acetate-based PSPs where SSX gave a slight improvement over RSX.  Efficiencies for 
both analytes varied less with racemic diethyl tartrate dual-chirality systems with values 
for N-methyl ephedrine being nearly equal with RSX and SSX and between those for the 
ethyl acetate versions.  Pseudoephedrine again had an opposite trend for dual-chirality 
surfactant/cosurfactant microemulsions with different achiral oils:  RSX provided higher 
values than SSX (racemic diethyl tartrate) and the highest value equaled that obtained 
with ethyl acetate.  Similarly, resolution did not change as much when the surfactant 
stereochemistry was switched from R to S with racemic diethyl tartrate compared to the 
variation found with ethyl acetate, and lower values were obtained with the SSX system 
(opposite of the observations for ethyl acetate).  Pseudoephedrine resolution was larger 
with both racemic diethyl tartrate systems, whereas N-methyl ephedrine values decreased 
with an order of RSX diethyl tartrate > SSX ethyl acetate > SSX diethyl tartrate > RSX 
ethyl acetate (statistical differences not tested). 
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The identity of the achiral oil also had an effect on the synergies for dual-chirality 
microemulsions.  N-methyl ephedrine experienced a larger detrimental synergistic effect 
with ethyl acetate that was nearly equivalent for RSX and SSX aggregates.  However, 
racemic diethyl tartrate systems resulted in much smaller synergies for this pair of 
enantiomers with values of equal magnitude but opposite signs obtained.  
Pseudoephedrine demonstrated asymmetrical synergies for stereochemically opposite 
dual-chirality microemulsions for both achiral oils.  The SSX system with ethyl acetate 
did not result in a synergistic effect, but the same surfactant/cosurfactant combination 
with diethyl tartrate did reveal a synergy.  The opposite PSP stereochemistry (RSX) 
demonstrated a large beneficial synergy when the oil was ethyl acetate and a small 
beneficial synergy when racemic diethyl tartrate was employed.  The differences found 
for changes in achiral oil identity for dual-chirality microemulsions illustrated the 
importance of this component:  even though oils of similar hydrophobicity were 
employed, their structures varied enough that the values and trends for the 
chromatographic figures of merit were impacted.  
 
7.2.5 Impact of Microemulsion Chirality: One- vs. Two- vs. Three-chiral-
Components 
 
In order to assess the effect of increasing the number of chiral microemulsion 
components, results for all of the two- and three-chiral-component systems were 
separately averaged for each compound and compared with those from the only single-
chiral-component microemulsion explored in detail (as explained earlier), RXX.  The 
chromatographic figures of merit from the fundamental resolution equation of 
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electrokinetic chromatography are discussed here in the following order:  
enantioselectivity, efficiency, retention (kavg/kopt), elution range, and resolution.   
 
Shown in Table 7.9 are the average enantioselectivity values and statistical rankings for 
all of the chiral microemulsions containing a chiral surfactant (R- or S- DDCV), 2-
hexanol (racemic or S-), and diethyl tartrate (R-, S-, or racemic).  First, it can be observed 
that all compounds except N-methyl ephedrine and pseudoephedrine experienced an 
increase in average enantioselectivity with the addition of a second chiral microemulsion 
reagent; enantioselectivity increases were seen for all enantiomers with specific dual-
chirality systems.  A further increase was observed for all analytes except ephedrine 
when the third microemulsion component was also chiral.  The enantioselectivities 
averaged over all of the compounds increased with increasing number of chiral aggregate 
elements (both with and without atenolol results).  Examination of the rankings revealed 
several similarities for the chiral compounds tested:  highest values were achieved with 
either a surfactant/cosurfactant dual-chirality PSP or a triple- chirality PSP, the worst 
values were obtained with surfactant/oil dual-chirality systems, and the single chirality 
microemulsion did not rank higher than 5th for any analyte (rank of 9th for four pairs of 
enantiomers).  These results clearly indicate that improvements in enantioselectivity can 
be accomplished by using multiple chiral reagents in microemulsion formulations.  
 
Efficiency data from the different chirality PSPs were evaluated in the same manner as 
enantioselectivity.  As displayed in Table 7.10, going from one chiral constituent to two 
caused the plate count to increase for four analytes and decrease for two.  Comparison of 
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Table 7.9.  Enantioselectivity changes based on the number of chiral microemulsion components.a)b) 
 
 Microemulsion Type  
 
Analyte 
One-Chiral-
Component 
Two-Chiral-
Componentsc) 
Three-Chiral-
Components 
 
Rankingsd)e) 
Atenolol 1.022 1.024 1.025 RSX ≈ SSS ≈ SSR ≈ SXS ≈ RSS ≈ SXR ≈ RXR ≈ SSX ≈ RXX ≈ RXS 
Ephedrine 1.075 1.078 1.078 RSX ≈ SSS ≈ SXR ≈ RSS ≈ RXR ≈ SXS ≈ SSR ≈ SSX ≈ RXX ≈ RXS 
Metoprolol 1.053 1.055 1.056 SSS ≈ SSX ≈ SSR ≈ SXS > RSX ≈ RXS ≈ RSS ≈ RXR > RXX ≈ SXR 
N-methyl ephedrine 1.078 1.076 1.079 SSS ≈ SSR ≈ RSX ≈ RSS ≈ RXX ≈ SXS ≈ RXS ≈ SSX ≈ RXR ≈ SXR 
Pseudoephedrine 1.141 1.140 1.144 SSX ≈ SSR > RSX ≈ SSS ≈ RSS ≈ RXX ≈ RXR ≈ SXS ≈ RXS ≈ SXR 
Synephrine 1.050 1.054 1.057 RSS ≈ RSX ≈ SXS ≈ SSX ≈ SSS ≈ SSR ≈ RXS ≈ RXR ≈ RXX ≈ SXR 
Arithmetic Mean 1.070 1.071 1.073 N/A 
Arithmetic Mean 
excluding Atenolol 1.079 1.081 1.083 N/A 
 
a) Microemulsion composition as in Table 7.1. 
b) Microemulsion categories correspond to:  RXX for one-chiral-component; average of RSX, SSX, RXS, SXS, RXR, and RXS for two-chiral-
components; and average of SSR, RSS, and SSS for three-chiral-components. 
c) See Table 7.8 for a breakdown of two-chiral-component data into categories for chiral surfactant/cosurfactant and chiral surfactant/oil. 
d) Statistical differences between adjacent values are shown with the use of a greater than sign (>) and the absence of a statistically significant 
difference by an approximately equal sign (≈, difference less than 0.004). 
e) Statistical differences among non-adjacent values: 
Atenolol:  RSX vs. SSX, RXS, and RXR; SSX vs. RXS, SSR, SSX, and SSS; RXS vs. SXS, RXR, SXR, SSR, RSS, and SSS; RXX vs. RSX, SSR, RSS, and 
SSS. 
Ephedrine:  RSX vs. all except SSS; SSX vs. RSX, RXR, SXR, RSS, and SSS; RXS vs. all except SSX and RXX; SSR vs. SSS; RXX vs. RXR, SXR, RSS, 
and SSS. 
Metoprolol:  RSX vs. all except RXS and RSS; SSX vs. all except SXS, SSR, and SSS. 
N-methyl ephedrine:  RSX vs. SSX, RXS, SXS, RXR, and SXR; SSX vs. SSR, RSS, and SSS; RXS vs. SSR, RSS, and SSS; SXS vs. SXR, SSR, RSS, and 
SSS; RXR vs. SSR, RSS, and SSS; SXR vs. SSR, RSS, and SSS; SSR vs. SSS; RXX and RSX, RXR, SXR, RSS, and SSS. 
Pseudoephedrine:  RSX vs. all except RSS, SSS, and RXX; SSX vs. all except SSR; RXS vs. SSR, RSS, and SSS; SXS vs. SXR, SSR, RSS, and SSS; 
RXR vs. SXR, SSR, and SSS; SXR vs. SSR, RSS, and SSS; RXX vs. SSX, RXS, SXR, and SSR. 
Synephrine:  RSX vs. RXS, RXR, SXR, SSR, and SSS; SSX vs. RXR, SXR, and RSS; RXS vs. SXS, SXR, and RSS; SXS vs. RXR and SXR; RXR vs. 
SSR, RSS, and SSS; SXR vs. SSR, RSS, and SSS; RXX vs. all except RXR and SXR. 
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Table 7.10.  Efficiency changes based on the number of chiral microemulsion componentsa)b). 
 
 Microemulsion Type  
 
Analyte 
One-Chiral-
Component 
Two-Chiral-
Componentsc) 
Three-Chiral-
Components 
 
Rankingsd) 
Atenolol 126100 103400 87400 RXX ≥ SXR ≥ RXS ≥ RSX ≈ SSX ≥ RXR ≈ SSS ≥ SXS ≥ RSS ≥ SSR 
Ephedrine 86700 83600 72600 RXR ≈ RXS ≥ RXX ≥ SSX ≥ SXR ≥ SSR ≈ RSX ≥ SXS ≥ RSS ≈ SSS 
Metoprolol 99200 107500 113200 RSS ≥ RXS ≥ SSS ≈ RXR ≥ RSX ≥ SSX ≥ SXS ≥ SSR ≈ RXX ≥ SXR 
N-methyl ephedrine 85500 86300 79100 RXS ≥ RXR > RXX ≈ RSX ≈ SSR ≈ SSX ≥ SXR ≈ RSS ≥ SXS ≥ SSS 
Pseudoephedrine 72400 75800 77900 RSS ≥ SXR ≥ RXS ≈ RSX ≥ SSS ≈ RXX ≈ RXR ≥ SXS ≈ SSX ≈ SSR 
Synephrine 79800 79900 83500 RSX > SSR ≥ RSS ≈ RXS ≈ RXR ≈ SSS ≈ RXX ≈ SXS > SSX ≥ SXR 
Arithmetic Mean 91600 89400 85600 N/A 
Arithmetic Mean 
excluding Atenolol 84700 86600 85200 N/A 
 
a) Microemulsion composition as in Table 7.1. 
b) Microemulsion categories correspond to:  RXX for one-chiral-component; average of RSX, SSX, RXS, SXS, RXR, and RXS 
for two-chiral-components; and average of SSR, RSS, and SSS for three-chiral-components. 
c) See Table 7.8 for a breakdown of two-chiral-component data into categories for chiral surfactant/cosurfactant and chiral 
surfactant/oil. 
d) Statistical differences between adjacent values are shown with the use of a greater than sign (>) and the absence of a 
statistically significant difference by an approximately equal sign (≈, difference less than 2,000) or a greater than or equal 
to sign (≥, difference greater than 2,000).
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dual- and triple-chirality microemulsion results displayed an efficiency increase for half 
of the compounds.  The averages for each type of aggregate revealed an overall decrease 
with each additional chiral reagent.  As discussed in section 7.2.2, as enantioselectivity 
values increase, efficiency should decrease due to the longer time involved in chiral 
interactions.  This expected trend is indeed observed for the overall one-, two-, and three-
chiral-component systems when atenolol is included, but changes when it is excluded 
with similar values for the three categories.  In terms of rankings, the single-chirality 
microemulsion (RXX) gave the highest efficiency for one pair of enantiomers, the dual-
chirality microemulsions the highest Navg for three pairs of enantiomers, and the triple-
chirality microemulsions the largest efficiency for the remaining two pairs.  Multi-
chirality PSPs performed the worst for all compounds (four with triple-chirality and two 
with dual-chirality).  The one-chiral-component aggregate ranking varied depending on 
the analyte.  
 
Last and most importantly, resolution was found to improve as more chiral components 
were incorporated into a single PSP nanodroplet, see Table 7.11.  The driving force 
behind these increases was in most cases due to larger enantioselectivities.  As previously 
discussed, efficiency, retention factors, and elution ranges also influenced the resolution.  
Five out of six pairs of enantiomers had larger values with the dual-chirality 
microemulsions compared to the one-chiral-component system.  The remaining analyte 
showed an insignificant decrease.  When all microemulsion components are chiral, 
resolution was generally higher than with other systems, both with and without atenolol 
results.  However, resolution for atenolol showed a slight decrease with three-chiral-  
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Table 7.11.  Resolution changes based on the number of chiral microemulsion componentsa)b). 
 
 Microemulsion Type  
 
Analyte 
One-Chiral-
Component 
Two-Chiral-
Componentsc) 
Three-Chiral-
Components 
 
Rankingsd) 
Atenolol 0.59 0.66 0.62 RSX > SSX ≈ SXS ≈ SSR ≈ SXR ≈ RXR ≈ RSS ≈ SSS ≈ RXX ≈ RXS 
Ephedrine 2.23 2.22 2.23 RSX ≥ SSR ≈ SSS ≈ RXR ≈ SXR ≈ RXX ≈ SXS ≈ RSS ≈ SSX ≈ RXS  
Metoprolol 1.59 1.85 1.95 RSX ≥ RSS ≈ SXS ≈ SSR ≈ SSS ≈ SSX ≥ RXS ≥ SXR ≈ RXR ≈ RXX 
N-methyl ephedrine 2.17 2.21 2.27 RSX ≈ SSR ≥ SXR ≈ RSS ≈ SXS ≈ RXX ≈ RXR ≈ RXS ≈ SSS ≈ SSX 
Pseudoephedrine 3.48 3.67 3.76 RSS ≈ RSX > SSX ≈ SSR ≈ RXR ≈ SXR ≈ RXS ≈ SSS ≈ SXS ≈ RXX  
Synephrine 0.94 1.08 1.15 RSX ≈ RSS ≈ SSR ≈ SXS ≥ RXS ≈ SSS ≈ SSX ≈ RXR ≈ SXR ≈ RXX 
Arithmetic Mean 1.83 1.95 2.00 N/A 
Arithmetic Mean 
excluding Atenolol 2.08 2.20 2.27 N/A 
 
a) Microemulsion composition as in Table 7.1. 
b) Microemulsion categories correspond to:  RXX for one-chiral-component; average of RSX, SSX, RXS, SXS, RXR, and RXS 
for two-chiral-components; and average of SSR, RSS, and SSS for three-chiral-components. 
c) See Table 7.8 for a breakdown of two-chiral-component data into categories for chiral surfactant/cosurfactant and chiral 
surfactant/oil. 
d) Statistical differences between adjacent values are shown with the use of a greater than sign (>) and the absence of a 
statistically significant difference by an approximately equal sign (≈, difference less than 0.10) or a greater than or equal to 
sign (≥, difference greater than 0.10).
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components compared to that with two.  Additionally, ephedrine resolution remained 
essentially the same regardless of the number of chiral reagents in the microemulsion.  
Although the microemulsion averages were all greater than baseline, they steadily 
increased as the components were switched from racemic to enantiopure.  The dual-
chirality microemulsion RSX outperformed all other microemulsion formulations for 
almost the entire compound set (pseudoephedrine being the exception).  The lowest 
values were obtained with either the single-chirality or dual-chirality microemulsions (3 
analytes each).  RXX did not rank higher than 6th for any compound.  As with 
enantioselectivity, it is clear that an increase in the number of chiral PSP constituents 
provides better resolution. 
 
Enhancements in resolution with the incorporation of additional chiral reagents into the 
microemulsion formulation were evaluated with respect to the fundamental resolution 
equation (eqn. 1.6).  Altering the number of chiral components in the aggregate did not 
result in kavg/kopt changes (the third term in eqn. 1.6).  For each individual pair of 
enantiomers, this ratio had a variation of 0.02 among the three types of chiral 
microemulsions.  Additionally, the averages with and without atenolol, were essentially 
the same for all three types of nanodroplets (0.62, 0.61, and 0.62 for one-, two-, and 
three-chiral-component systems with atenolol and 0.69, 0.68, and 0.69, respectively 
without atenolol).  Therefore, resolution increases were not due to more optimal retention 
factors.  The last term in the fundamental resolution equation (elution range) showed a 
moderate increase with dual-chirality microemulsions over the single-chirality version 
(4.9 versus 5.5) and a negligible difference between dual- and triple-chirality aggregates 
  
237 
(5.5 versus 5.6).  The larger elution range for multi-chirality microemulsions contributed 
to the improvement in resolution along with larger enantioselectivities.  
 
Within each category of chiral microemulsion (one-, two-, and three-chiral components), 
the best average enantioselectivities were achieved with RXX (αenant=1.070), RSX 
(αenant=1.074), and SSR (αenant=1.074), respectively (with atenolol).  The only differences 
with the exclusion of atenolol were increases in the overall averages (αenant=1.079 and 
1.084 for RXX and RSX, respectively) and an equal overall average for all triple-chirality 
systems (αenant=1.083).  A comparison of these values reveals that dual- and triple-
chirality microemulsions outperform the single-chirality formulation to a similar degree.  
Efficiencies for each type of aggregate with atenolol were 91,600 (RXX), 96,900 (RXS), 
and 89,500 (RSS), where the two-chiral-component microemulsion provides the highest 
value followed by the one-chiral-component and then the three-chiral-component 
aggregates.  The order and averages change when atenolol is excluded, with the triple-
chirality microemulsion performing better than RXX (94,300 with RXS, 90,200 with RSS, 
and 84,700 with RXX).  Resolution with the best individual microemulsions from each 
type decreased from the dual-chirality formulation (RSX, Rs=2.21 with atenolol and 2.49 
without) to the triple-chirality aggregate (RSS, Rs=2.06 with atenolol and 2.35 without) to 
the single-chirality nanodroplet (RXX, Rs=1.83 with atenolol and 2.08 without).  Based on 
this comparison, multi-chirality systems offer improvements in chromatographic figures 
of merit over those containing just a chiral surfactant with two-chiral-components 
providing the highest values. 
 
  
238 
7.3 Concluding Remarks 
 
Novel microemulsions made from all chiral reagents were successfully prepared and 
employed as PSPs in chiral MEEKC.  Interestingly, the combination of R-DDCV, S-2-
hexanol, and diethyl R-tartrate was incompatible as the solution separated within days of 
preparation.  Possible explanations are that the steric hindrance was greater for this 
particular mixture of chiral entities or that the typical concentrations of surfactant, 
cosurfactant, and oil were non-optimal for these stereochemistries.  The three other triple-
chirality microemulsion formulations were stable and demonstrated superior performance 
in terms of resolution compared to the single-chirality system.  Additionally, 
enantioselectivities improved with the use of three-chiral-component aggregates.  
However, somewhat lower efficiencies were observed using the newly introduced triple-
chirality PSPs.  This trend was hypothesized to be a consequence of the enhanced chiral 
selectivity:  chiral recognition requires a three (or more)-point interaction and these 
individual chemical associations will probably not occur simultaneously or at exactly the 
same rate, essentially lengthening the time enantiomers spend with the selectand and thus 
increasing band broadening.  Enantioselectivity differences among the three triple-
chirality aggregates were also observed but were not as dramatic as those from RXX.  
Enantioselective synergisms were identified for the combination of a chiral surfactant, a 
chiral cosurfactant, and a chiral oil.  All analytes displayed beneficial synergies that 
varied in magnitude depending on microemulsion composition. 
 
Recent chiral MEEKC research in our group has explored the effects of combining two or 
three chiral reagents in microemulsion formulations.  The dual-chirality nanodroplets are 
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divided into three classes: chiral surfactant plus chiral cosurfactant, chiral surfactant plus 
chiral oil, and chiral cosurfactant plus chiral oil.  As demonstrated by the lack of 
sufficient or consistent enantioseparations with the last combination, the chiral surfactant 
is the dominant chiral selector in our systems.  That being stated, it was shown that 
addition of a chiral cosurfactant or chiral oil to a microemulsion PSP containing chiral 
surfactant alters its selectivity and performance.  Specifically, these two varieties of dual-
chirality microemulsions displayed different advantages, with the dual-chiral 
surfactant/cosurfactant offering better enantioselectivity and resolution and the dual-
chiral surfactant/oil providing higher efficiency.  Evaluation of the data obtained from 
one-, two-, and three-chiral-component microemulsion experiments revealed slight to 
moderate differences in terms of enantioselectivity, resolution, and efficiency.  
Improvements in enantioselectivity and resolution can be realized by incorporation of 
additional chiral aggregate elements at the cost of a slight to moderate decrease in 
efficiency.  The findings illustrate the  importance of optimizing not only the identity but 
also the stereochemistry of microemulsion components for the target analytes. 
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Chapter 8:  Conclusions and Recommendations for Future Chiral MEEKC 
Research 
 
 
 
The wide variety and sheer number of publications detailing novel chiral selectors and 
applications of existing chiral selectors that have appeared over the past two years 
unequivocally establishes the importance of this field of separation science.  The ability 
to successfully develop and validate chiral EKC methods has been illustrated more 
frequently in recent years, with approved methods now in place for regulated 
environments such as pharmaceuticals (i.e., USP and EP).  As research continues in 
chiral EKC, additional chiral agents will undoubtedly be discovered for especially 
challenging analyses.  Additional studies on recognition mechanisms can serve to further 
the knowledge base and lead to faster method development.  
 
In an effort to advance the specialized field of chiral MEEKC, the studies reported herein 
focused on the impact of microemulsion formulations on the enantioresolution of 
pharmaceutical enantiomers.  The results demonstrate the importance of both the identity 
and stereochemistry of each of the three microemulsion components:  surfactant, 
cosurfactant, and oil.  Although it is difficult to predict the exact effect each PSP change 
will have on a chiral separation, some general guidelines for improving DDCV-based 
microemulsions can be given, see Table 8.1.  
 
One open issue for the data presented in this thesis is that of surfactant purity.  The source 
of the discrepancy between R- and S-DDCV-based microemulsions needs to be further 
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Table 8.1.  Guidelines for the selection of a cosurfactant and oil for DDCV-
microemulsions. 
 
 
 
Cosurfactanta) 
Desired Outcome Recommended Type of Reagent(s) 
Increased αenant Achiral alcohol with short alkyl chain such as 1-butanol 
Increase Navg Achiral primary alcohol with longer alkyl chain such as 1-
hexanol 
Increase Rs Achiral alcohol with short alkyl chain such as 1-butanol 
Increase αmeth Achiral primary alcohol with longer alkyl chain such as 1-
hexanol 
  
Oilb) 
Desired Outcome Recommended Type of Reagent(s) 
Increased αenant More hydrophilic oil such as diethyl tartrate or ethyl acetate 
Increase Navg More hydrophobic oil such as dibutyl tartrate 
Increase Rs More hydrophilic oil such as ethyl acetate 
Increase αmeth More hydrophobic oil such as dibutyl tartrate 
  
Cosurfactant and Oil 
Desired Outcome Recommended Type of Reagent(s) 
Greater increase in 
resolution 
Both chiral:  S-2-hexanol and diethyl S-tartrate with R-
DDCV 
  
 
 
a) Chiral alcohols are currently high priced; therefore alterations using achiral 
alcohols should be tested first. 
b) Racemic tartrates (dibutyl and diethyl) are not commercially available.  Due to the 
minimal cost of enantiopure tartrates, alterations in oil identity should be 
performed with the chiral versions of these reagents.
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investigated and the exact impact on chiral CE separations determined.  Based on our 
initial findings, it appears that the lower purity of R-DDCV has a minimal influence on 
chiral MEEKC results.  Potentially, more analytical analyses, such as HPLC, LC-MS, or 
CE, could be performed on the surfactant itself to determine how many contaminants 
may be present and their identity.  We have been in contact with Waters Corporation to 
gain more insight into possible side products and contaminants.  At this point in time, it is 
plausible that achiral contaminants are present in the surfactant from either the raw 
materials or synthesis that cannot be removed with the manufacturer’s purification 
process.   
 
As with most scientific endeavors, a good research idea does not lead to a completed 
project but instead fosters many new ideas and approaches.  Due to the minimal research 
in chiral MEEKC, a variety of avenues have yet to be explored.  For instance, as an 
alternative to using an alcohol as a cosurfactant, amines could be investigated for this role 
because of their similarity to alcohols in that they possess a hydrophilic functionality.  
Amines could provide an easy way to modify selectivity, and chiral amines could perhaps 
be incorporated as a second or third chiral component in the microemulsion formulation.  
Aliphatic alcohols and amines have similar UV transparencies (typical UV cutoffs around 
200-220 nm), thus PSP transparency would not be greatly impacted by this cosurfactant 
change.  On the other hand, the amine group would be ionized at pH values less than ~8.5 
(depending on the exact amine) and would therefore contribute to Joule heating and 
require lower applied voltages to be used.     
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A potential drawback to the widespread usage of DDCV-microemulsions as PSPs is the 
cost of enantiopure surfactant.  One way to reduce this expense would be to replace some 
of the chiral selector with a less expensive achiral surfactant.  The minimum amount of 
DDCV required to provide adequate enantioselectivity and resolution would have to be 
determined.  Initially, sodium dodecyl sulfate (SDS) could be incorporated to maintain 
the overall surfactant concentration as the DDCV concentration is reduced.  However, a 
unique method of altering selectivity and aggregate character could be changing the 
substitute surfactant identity.  Along the same lines, the cosurfactant does not have to be 
just one substance.  Mixtures of different alcohols (or amines) could be used.  It is 
possible that this type of change would give another option for fine-tuning chiral 
separation characteristics.  Another interesting mixture approach for chiral MEEKC 
would be to combine two microemulsion systems with vastly different EKC properties.  
This step would have to occur immediately before the solution was to be used because of 
the dynamic nature of surfactant aggregates.  The existence of two types of nanodroplets 
in the separation buffer could act either cooperatively or antagonistically. 
 
Limited studies have been conducted on the effect of oil identity.  Two extremes can be 
found in the literature with researchers using very hydrophobic reagents such as octane 
and heptane or more hydrophilic compounds such as ethyl acetate.  Our group did 
investigate a few low-interfacial-tension oils, but a larger range of hydrophobicities 
should be chosen for a systematic approach.  The differences found between dibutyl 
tartrate and diethyl tartrate suggest that the oil core composition can have a significant 
influence on efficiency in addition to methylene selectivity.  With regard to the data 
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presented for dibutyl and diethyl tartrate as microemulsion oils, analyzing PSPs prepared 
with equal volume/volume percentages instead of equimolar concentrations would be 
worthwhile.  Specifically, increasing the concentration of diethyl tartrate could increase 
the size of the oil core, thereby increasing the droplet size and fluidity, which would most 
likely improve efficiencies. 
 
The effect of organic modifiers has been reported in the literature for the three classes of 
surfactant aggregates (micelles, vesicles, and microemulsions).  Obviously, the exact 
impact of such modifiers will vary depending on the PSP composition.  Organic 
modifiers can improve separations by altering solution viscosity, EOF, analyte 
partitioning (providing more optimal retention factors), and aid in sample solubility.  To 
date, an examination of this nature has not been performed with DDCV-microemulsions.  
An important question to answer would be what the maximum concentration of organic 
modifier could be before the microemulsion equilibrium is disrupted causing droplet 
disintegration.  Particle size data could aid in assessing whether or not most of the 
modifier remains in the bulk phase or becomes part of the microemulsion. 
 
Step gradient analyses (where the mobile phase composition changes) are commonly 
found in HPLC methods, but are almost non-existent in CE.  The ability to change the 
electrolyte during the separation allows for more optimal retention of the analytes.  One 
of the difficulties, in our experience, has been defining the best change (i.e., % CD) and 
minimizing zone effects such as stacking or destacking (i.e., maintaining a constant 
current).  A particularly challenging issue was discovered during HS-CD step gradient 
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trials (see Appendix B) in that the mobility of the selectand could not be determined, 
therefore giving results which could not be fully interpreted.  An appropriate marker 
compound for cyclodextrins needs to be identified in order for a thorough investigation of 
this technique to be conducted.  A step gradient might also be investigated for MEEKC 
where a parameter such as surfactant concentration could be modified throughout the run. 
 
A continuing obstacle in developing superior PSPs for enantiomeric separations is the 
lack of an approach for assessing the overall chiral discriminating power of the aggregate.  
If a series of chiral homologs could be identified or created, a chiral index could be 
calculated (similar to the concept of methylene selectivity).  This parameter would allow 
a fast and simple means of determining whether or not a certain combination of 
microemulsion components is going to enhance or degrade the separation.  Currently, 
researchers analyze a set of test compounds (selected based on their own needs) and then 
examine the results for changes in enantioselectivity, efficiency, and/or resolution.  A 
clear picture of the microemulsion chiral recognition capacity may not be obtained since 
analyte structures can vary significantly thereby obscuring overall trends.  The homolog 
set could contain several pairs of enantiomers differing only in the location of the chiral 
center, or pairs of enantiomers with an identical chiral center differing in alkyl chain 
length. 
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Appendix A:  Preparation of Electropherogram Figures for Presentations and 
Publications 
 
 
 
It is of utmost importance to have high quality figures for both presentations and 
publications.  In the case of electropherograms (electrophoretic chromatograms) simply 
copying the selected figure from the instrument software (ChemStation) and directly 
pasting it into the desired file (PowerPoint or Word) results in poor quality.  For 
instance, the axis labels are too small to be legible and the baseline trace is very light.  
The following steps should be followed to correct these problems. 
 
Notes:   
• If multiple electropherograms are to be stacked in the same figure, make sure all 
individual electropherograms have the same run time.  
• Each file must be processed separately. 
 
In ChemStation: 
1. Load the appropriate file in ChemStation.  Although multiple files can be loaded and 
copied from ChemStation, doing this will not allow the axis labels and baselines to 
be altered. 
2. Select the pre-determined x-axis scale (time) in the Graphics/Signal Options menu. 
3. Remove all integration. 
4. Omit the title, which displays the file name and wavelength, by clicking on the 
button that shows a title (12th button from the top when the annotation buttons are 
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present. If these buttons do not appear select one of the annotation options under the 
Graphics menu). 
5. Copy the electropherogram (Graphics/Copy to clipboard). 
 
In PowerPoint:   
6. Open PowerPoint and select a blank presentation page.  Select “Paste Special” under 
the Edit menu.  The data must be pasted as an “enhanced meta file,” select this 
option and click ok. 
7. Right click on the electropherogram and select “Ungroup” from the grouping menu.  
A message will appear asking if you want to convert the figure to an Office picture, 
click ok.  The baseline trace will become noticeably darker and thicker. 
8. Right click on the electropherogram again and ungroup again.  Now each portion of 
the figure can be changed individually. 
 
Increasing the axes font size: 
9. Select all of the y-axis labels (hold the shift key and click on each number, including 
the unit mAu).  Change the font size to 12 point.  The larger font will cause the 
numbers to overlap the axis itself, click the left arrow three times to move all of the 
numbers over. 
10. Select all of the x-axis labels and change the font size to 12 point. 
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Adjust the size of the box surrounding the figure: 
11. Select the box around the figure and make it large enough to contain both axes.  
Make it a little larger than needed, particularly on the bottom, as subsequent sizing 
will most likely result in an overlap of the box and axis labels. 
 
Change the color of the trace from blue to black: 
12. Select all portions of the baseline/chromatogram trace and under “Format 
Autoshapes” change the line color from blue to black. 
 
Regroup the figure: 
13. The major changes to the figure have been completed.  Right click somewhere on the 
figure and select “Regroup” from the Grouping menu.  Alternatively, under the Edit 
menu, select “Select All” then regroup. 
 
Finalize the figure: 
14. Repeat steps 1 through 13 for each electropherogram. 
15. If multiple electropherograms are stacked, move the desired portions of the figure to 
the same PowerPoint slide.   
a. Adjust the size so that they are all equal.  This may cause the outer box to 
overlap the x-axis requiring an ungroup, adjust, and regroup sequence to be 
performed.  
b. Line up the individual sections. 
c. Select all and group. 
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Note:  Additional information can be added to the electropherograms by inserting 
text boxes.  I would suggested that once the formatting is completed on the text 
box, group it with the corresponding electropherogram. 
 
16. This finalized figure can be copied into another PowerPoint file (for oral or poster 
presentations) or converted to a PDF (for manuscript submission or Word documents 
in general). 
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Appendix B:  “Failed” Experiments 
 
 
 
As is the case with research, one typically encounters some bumps and obstacles along 
the way to completing a project. As noted in Chapters 2 and 6, a minimal number of 
microemulsion formulations turned out to be unsuccessful, namely the combinations of 
2% w/v S-DDCV with 1.2% v/v S-2-hexanol (plus 0.5% v/v ethyl acetate as the oil core) 
and R-DDCV with 1.65% S-2-hexanol and 0.88% diethyl R-tartrate.  In addition to these 
minor setbacks, a significant amount of time was spent on the utility of step-gradient 
analysis for chiral EKC using highly sulfated gamma cyclodextrin (HS-γ-CD).  
Unfortunately, this project did not come to fruition because some aspects of the data 
could not be fully explained due, in part, to the lack of a marker compound for the chiral 
selector.  The main findings of this incomplete project are reported in this appendix. 
 
Highly sulfated gamma cyclodextrin (HS-γ-CD) was employed in step-gradient analyses 
with suppressed electroosmotic flow in negative polarity mode on a commercial CE 
instrument.  The percentage of HS-γ-CD was increased throughout the run via vial 
switching.  Parameters that were investigated included applied voltage, number of steps, 
magnitude of HS-γ-CD increase, and the timing of vial changes.  The effects of running 
in constant voltage versus constant power were also examined.  Separations of chiral 
pharmaceutical compounds were successfully performed with step-gradients that 
included two or three steps.  A large improvement in efficiency was observed for some 
compounds compared to analysis with only one concentration of cyclodextrin. 
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B.1 Instrumental Parameters 
All experiments were performed on a Hewlett-Packard 3DCE instrument, model 
G1600AX, equipped with a UV diode array detector (Agilent Technologies, Waldbronn, 
Germany).  Fused silica capillaries (50 µm i.d. x 365 µm o.d.) were used (Polymicro 
Technologies, Phoenix, AZ, USA). The total capillary length was 32 cm and the effective 
length (inlet to detector) was 23.6 cm.  The capillary cassette was maintained at 25°C and 
the autosampler was at ambient conditions.  Injections were performed hydrodynamically 
at 25 mbar for two seconds.  Polarity was negative for EKC experiments and positive for 
capillary zone electrophoresis (CZE) experiments.  Applied voltages varied from 5 kV to 
16.5 kV depending on the BGE for constant voltage experiments.  Runs that were 
performed in constant power mode used applied powers ranging from 0.6 W to 0.9 W.  
The voltage ramp at the onset of each separation was 0.3 minutes.  Vial change times 
varied depending on the analyte, HS-γ-CD concentrations, and number of steps 
performed.  The detection wavelength used for analysis was 200 nm with the additional 
wavelengths of 215 and 230 nm being recorded. 
 
B.2 Preparation of Electrolyte and Sample Solutions  
A 25 mM phosphate buffer, pH 2.5, was prepared by adding the appropriate amount of o-
phosphoric acid to a given volume of HPLC grade water, adjusting the pH to 2.5 using 
1.0 M LiOH and 0.1 M LiOH, and diluting to the proper volume. A stock HS-γ-CD 
solution was prepared by weighing out a calculated amount and dissolving in phosphate 
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buffer to achieve a concentration of 5% w/v HS-γ-CD.  Aliquots of this solution were 
diluted with phosphate buffer to obtain solutions of 1%, 2%, and 3% w/v HS-γ-CD. 
 
Each analyte was weighed and dissolved in phosphate buffer at a concentration of 1 
mg/mL.  A negligible amount of methanol was added to some samples to aid in 
solubility.   Nitromethane was used as the t0 marker and was dissolved in phosphate 
buffer. 
 
B.3 EKC Analyses 
B.3.1 Constant CD Concentration EKC 
The analytes were separated using a constant concentration of HS-γ-CD.  In the constant 
BGE analyses, CD concentrations of 1% (w/v), 3% (w/v), and 5% (w/v) CD were 
utilized.  The separations of atenolol with 1% and 5% HS-γ-CD are shown in Figure B.1.  
For the compounds investigated, 5% HS-γ-CD gave the best efficiencies.  The 
efficiencies and resolutions obtained with 5% CD in negative polarity mode and an 
applied voltage of 10 kV are shown in Table B.1.  These values were calculated using 
statistical moments to minimize the error from underestimation of peak variance and for 
better accuracy.
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Figure B.1. Analysis of atenolol with constant HS-γ-CD concentration.  a)  1% HS-γ-CD, 
-16.5 kV and b) 5% HS-γ-CD, -10 kV.  Detection wavelength, 200 nm; capillary 
dimensions of 50 µm i.d. x 365 µm o.d., total capillary length of 32 cm and an effective 
length of 23.6 cm.  Injections were performed hydrodynamically at 25 mbar for two 
seconds.
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Table B.1.  Efficiencies and resolutions obtained with 5% HS-γ-CD. 
 
 
 
Compound N1 N2 Rs 
Atenolol 72900 75400 3.3 
Synephrine 20800 26000 1.5 
Octopamine 19900 22400 4.4 
Metoprolol 42400 43900 3.1 
Arterenol 22200 23500 3.3 
Norphenylephrine 45400 48300 4.6 
Alprenolol 30700 33800 3.2 
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B.3.2 Step-Gradient EKC 
Step-gradient analyses were performed using commercial CE instruments.  The method 
was set up so that at a specified time, the inlet and outlet vials were changed to the next 
concentration of CD.  The voltage was controlled by the instrument and was temporarily 
discontinued during the vial switching.  Various step-gradient experiments were run 
including:  1-5%; 3-5%; 0.5-1-3%; 1-2-3%; and 1-3-5% (all w/v %).  Results obtained 
for 0.5-1-3% and 1-3-5% did not show much potential and were not pursued.  The other 
gradients listed produced successful separations. 
 
The first successful step-gradient was obtained for atenolol.  A 1-5% HS-γ-CD step-
gradient was performed with a vial change at ten minutes.  The resolution obtained for 
the peaks was slightly higher than that obtained with only 5% HS-γ-CD (3.3 versus 3.4) 
and the efficiencies dramatically increased.  The retention times were increased by 
approximately six minutes.  Figure B.2 shows the separation of atenolol obtained with a 
step-gradient of 1-5% HS-γ-CD.  The applied voltage used for the gradient run was the 
same as that for the 5% CD separation, however the same range of power was not 
observed for the step-gradient run.  The power was between 0.3 and 0.4 W for the 1-5% 
CD gradient compared to a range of 0.9 to 1.0 W with 5% HS-γ-CD.  The differences in 
power are shown in Figure B.3. 
 
The 1-5% HS-γ-CD step-gradient was utilized to separate the other chiral pharmaceutical 
compounds.  The efficiencies obtained for each set of enantiomers with step-gradients are 
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Figure B.2.  Step-gradient analysis of atenolol.  1% to 5% HS-γ-CD, -10 kV, with the vial 
change at 10 minutes.  Other conditions as in Figure B.1. 
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Figure B.3.  Comparison of power for constant CD analyses versus step-gradient 
analysis.  1% HS-γ-CD at -16.5 kV, 5% HS-γ-CD at -10 kV, and 1-5% HS-γ-CD at -10 
kV, with the vial change at 10 minutes.  Other conditions as in Figure B.1. 
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shown in Table B.2 in addition to resolution.  The various step-gradients were performed 
with differing vial change times and applied voltage/power in an attempt to improve the 
separation.  For atenolol, a large increase in efficiency was observed for the 1-5% 
gradient only.  The other gradients performed gave approximately the same efficiencies 
and resolutions as with the 5% constant CD analysis.  The other compounds investigated 
showed decreases in efficiency with the step-gradients tested, see Figure B.4 for 
representative electropherograms.  Further optimization in applied voltage and vial 
change times could not alleviate this decrease.  Norphenylephrine and alprenolol 
experienced the largest decreases in efficiencies.  A larger decrease in efficiency was 
observed for the first enantiomer of synephrine.  Metoprolol showed an increase in 
efficiency for the second peak with the 1-5% gradient. 
 
B.4 Parameters in Step-Gradient EKC 
As with any type of chromatographic separation, there are numerous parameters to vary 
and optimize with step-gradient EKC.  For the purposes of this investigation, the identity, 
concentration, and pH of the buffer were not varied.  Also, the chiral selector HS-γ-CD 
was utilized for all of the experiments, with only the concentration being changed.  The 
initial step-gradient experiments were performed without any conductivity matching 
between the subsequent BGE’s as a means of checking the plausibility of the approach.  
Follow-up studies utilized conductivity matched solutions, but did not provide acceptable 
separations.  It was hypothesized that the addition of sodium chloride for increasing 
conductivity was interfering with the chiral separations.
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Table B.2.  Efficiencies and resolutions obtained with HS-γ-CD step-gradients. 
 
 
 
HS-γ-CD: 1-5% 3-5% 1-2-3%a) 
 Compound N1 N2 Rs N1 N2 Rs N1 N2 Rs 
 Atenolol 123600b) 144600 b) 3.4 b) 73100 c) 67400 c) 3.3 c) 71800 74100 2.8 
 Synephrine  11700 b)  21100 b) 1.2 b) 12800 c) 17400 c) 1.3 c) 12200 17200 1.3 
 Octopamine   2400 b)  14000 b) 3.4 b)   9200 c) 13400 c) 3.4 c) 10900 12400 3.3 
 Metoprolol  37400 d)  60900 d) 2.3 d) 38300 e) 39500 e) 2.4 e) 27600 36500 1.8 
 Arterenol  10300 d)  14200 d) 1.6 d) 13500 e) 17300 e) 2.1 e) 11000 11500 2.0 
 Norphenylephrine   1800 d)   5900 d) 1.3 d)  9200 e) 10700 e) 1.9 e) 9600 11200 1.7 
 Alprenolol   3300 b)   3200 b) 1.5 b) 13200 e) 13000 e) 1.9 e) 2900 2700 1.5 
 
a) Applied voltage of –9 kV, vial changes at 3 and 6 minutes 
b) Applied voltage of –10 kV, vial change at 10 minutes 
c) Applied power of 0.6 W, vial change at 5 minutes 
d) Applied voltage of –14 kV, vial change at 4 minutes 
e) Applied voltage of –10 kV, vial change at 2.5 minutes 
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Figure B.4.  Examples of step-gradient analyses of other compounds.  a) Arterenol, 3-5% 
gradient, -10 kV, vial change at 2.5 minutes, b)  Metoprolol, 1-5% gradient, -10 kV, vial 
change at 10 minutes, c)  Alprenolol, 3-5% gradient, -10 kV, vial change at 2.5 minutes.  
Other conditions as in Figure B.1.
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One of the options in setting up a CE method is running in constant voltage, constant 
power, or constant current mode.  The effects of using constant voltage versus constant 
power modes were briefly examined.  No significant benefits were found to running in 
constant power over constant voltage mode as shown in Figure B.5.  
 
The factors that had the most impact on the separations were applied voltage and vial 
change time(s).  Typically, applied voltages are chosen to stay within the linear region of 
an Ohm’s Law plot to reduce Joule heating.  It was found for the CD systems being used 
that running above a Joule heat level of 1.5 W/m did not negatively impact the results.  
The vial change time played a large role in the quality of the separation as shown in 
Figure B.6.  For compounds that were strongly to moderately complexed with the CD 
(short retention times), the vial change time had a greater impact.  It was observed that 
the greater the spacing between vial switches and peak elution, the better the peak shape.  
It is imperative that a change in vials does not occur during detection of a peak.  The brief 
discontinuation of voltage while the inlet and outlet vials change causes a dip in the peak 
and also dramatically affects peak shape.  Large variations in efficiencies were obtained 
depending on the step time.  
 
Another option in step-gradient elution is to change only the inlet vial instead of both the 
inlet and outlet vials.  In the case of the HS-γ-CD step-gradient, an additional variation 
would be to use the phosphate buffer without CD as the outlet throughout the run.  This 
would shorten the duration of time the voltage was interrupted for a vial change.  It 
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Figure B.5.  Comparison of atenolol separations in constant voltage and constant power 
modes.  (a)  Constant Voltage, -14.6 kV, vial change at 10 minutes, (b)  Constant Power, 
0.9 W, vial change at 10 minutes.  Other conditions as in Figure B.1.
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Figure B.6.  Effect of vial change timing on atenolol step-gradient analysis.  1-5% HS-γ-
CD gradient, constant power mode, 0.9 W.  (a)  10 minute vial change,  (b)  5 minute vial 
change. Other conditions as in Figure B.1.
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would also reduce the amount of solution containing CD being used, which decreases 
operating costs.  The feasibility of this approach was briefly investigated without success. 
 
B.5 Investigation into Atenolol Efficiency Increase 
Atenolol displayed a dramatic increase in efficiency with a 1-5% HS-γ-CD step-gradient, 
an applied voltage of –10 kV, and vial change time of 10 minutes.  In relation to the other 
compounds in this study, atenolol has the largest retention time for this gradient. 
Preliminary step-gradient studies were conducted with other analytes with some showing 
longer retention times than atenolol but without the same focusing effect.  In order to 
determine the root cause of the focusing for atenolol, CZE experiments were conducted 
for mobility calculations.   A correlation did not exist between the migration orders in 
CZE and EKC experiments due to the differences in analyte/HS-γ-CD complexation.  It 
was observed that atenolol had one of the lowest electrophoretic mobilities in the CZE 
experiments and the longest retention time in the step-gradient experiments.  The 
retention factors for the analytes have not been calculated due to the difficulty in finding 
a suitable CD marker compound.  It has been reported in the literature that PTS can be 
used as a reference marker for CD separations, although preliminary experiments with 
this marker did not provide the desired information.   
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Appendix C:  Microemulsion Particle Size Data 
 
 
Microemulsion  
 
Surfactant 
 
Cosurfactant 
 
Oil 
Average Particle Size a)b) 
(nm) 
Chapter 4:  Achiral Cosurfactants 
R-DDCV 1-hexanol Ethyl acetate 6.8 ± 0.3 
R-DDCV 2-hexanol Ethyl acetate 5.1 ± 0.2 
R-DDCV 1-pentanol Ethyl acetate 5.3 ± 0.3 
R-DDCV 2-pentanol Ethyl acetate 5.5 ± 0.2 
R-DDCV 1-butanol Ethyl acetate 5.8 ± 0.2 
R-DDCV cyclopentanol Ethyl acetate 5.6 ± 0.3 
R-DDCV cyclohexanol Ethyl acetate 4.7 ± 0.2 
Chapter 5:  Dual-Chirality Systems with Dibutyl Tartrate 
R-DDCV 2-hexanol (±) Dibutyl tartrate 6.0 ± 0.2 
R-DDCV 2-hexanol Dibutyl L-tartrate 6.1 ± 0.3 
S-DDCV 2-hexanol Dibutyl L-tartrate 6.0 ± 0.3 
R-DDCV 2-hexanol Dibutyl D-tartrate 5.9 ± 0.2 
S-DDCV 2-hexanol Dibutyl D-tartrate 6.3 ± 0.3 
(±) DDCV 2-hexanol Dibutyl L-tartrate 6.5 ± 0.3 
Chapter 6:  Dual-Chirality Systems with Diethyl Tartrate 
R-DDCV 2-hexanol (±) Diethyl tartrate 5.8 ± 0.3 
R-DDCV 2-hexanol Diethyl L-tartrate 5.9 ± 0.4 
S-DDCV 2-hexanol Diethyl L-tartrate 6.1 ± 0.3 
R-DDCV 2-hexanol Diethyl D-tartrate 5.2 ± 0.3 
S-DDCV 2-hexanol Diethyl D-tartrate 5.2 ± 0.2 
(±) DDCV 2-hexanol Diethyl L-tartrate 5.7 ± 0.3 
Chapter 7:  Additional Dual-Chirality Systems with Diethyl Tartrate 
(±) DDCV S-2-hexanol Diethyl L-tartrate 5.2 ± 0.3 
(±) DDCV S-2-hexanol Diethyl D-tartrate 4.9 ± 0.3 
R-DDCV S-2-hexanol (±) Diethyl tartrate 5.2 ± 0.2 
S-DDCV S-2-hexanol (±) Diethyl tartrate 5.6 ± 0.3 
Chapter 7:  Triple-Chirality Systems with Diethyl Tartrate 
R-DDCV S-2-hexanol Diethyl L-tartrate 5.5 ± 0.2 
S-DDCV S-2-hexanol Diethyl L-tartrate 5.3 ± 0.3 
R-DDCV S-2-hexanol Diethyl D-tartrate 5.4 ± 0.2 
S-DDCV S-2-hexanol Diethyl D-tartrate 5.2 ± 0.2 
 
a) Particle size measurements performed using a Horiba LB-500 dynamic light 
scattering particle size analyzer at 25°C with a refractive index setting of 1.340.   
b) 100 measurements were taken for each analysis with a minimum of 6 analyses 
performed on each microemulsion. 
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Appendix D:  Comparison of Enantioselectivity, Gibb’s Free Energy Change, 
Methylene Selectivity, and Elution Range Results Using R- and S-DDCV Single-
Chirality Microemulsions 
 
 
 
Parameter: 
R-DDCV 
Microemulsiona) 
S-DDCV 
Microemulsiona) 
% 
Difference 
Enantioselectivity 
Atenolol 1.024 ± 0.001 1.023 ± 0.001 0.10% 
Ephedrineb) 1.077 ± 0.002 1.079 ± 0.002 0.19% 
Metoprololb) 1.055 ± 0.001 1.056 ± 0.001 0.09% 
N-methyl ephedrine 1.079 ± 0.001 1.080 ± 0.001 0.13% 
Pseudoephedrineb) 1.140 ± 0.001 1.144 ± 0.002 0.35% 
Synephrineb) 1.053 ± 0.002 1.056 ± 0.005 0.28% 
Gibb’s Free Energy Change (kJ/mol) 
Atenolol -0.059 -0.056 4.3% 
Ephedrine -0.184 -0.188 2.4% 
Metoprolol -0.133 -0.135 1.7% 
N-methyl ephedrine -0.188 -0.191 1.7% 
Pseudoephedrine -0.325 -0.333 2.6% 
Synephrine -0.128 -0.135 5.2% 
Methylene Selectivity 2.569 ± 0.010 2.626 ± 0.011 2.2% 
Elution Rangec) 5.1 ± 1.5 4.0 ± 0.7 28% 
 
 
a) Microemulsion composition:  2.0% w/v DDCV, 1.65% v/v racemic 2-hexanol, 
and 0.5% v/v ethyl acetate in 50 mM phosphate buffer pH 7.0.  Separation 
conditions:  32 cm total capillary length, 23.6 cm effective capillary length, 50 
µm inner capillary diameter, 11.5 kV (applied voltage), hydrodynamic injection 
using a pressure of 25 mbar for 2 s, chiral enantiomer detection at 215 nm, and 
alkylphenone detection at 236 nm. 
b) Statistically different at 95% confidence level. 
c) Elution range determined using the PSP marker octanophenone.  It is important to 
note that the large variation is due, in part, to the condition of the capillary inner 
surface, which can change dramatically with each subsequent usage.  
Additionally, the first run attempted with S-DDCV required an additional 
conditioning sequence due to an excessively low EOF, thereby decreasing the 
elution range when the run was performed.  
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Appendix E:  Calculateda) and Observed Resolution Values 
 
 
 
Chapter 3:  Dual-Chirality Systems with S-2-Hexanol 
 RSX SSX  
 Calculated Observed Calculated Observed   
N-methyl ephedrine 1.73 1.72 2.35 2.37   
Pseudoephedrine 3.32 2.98 3.84 3.69   
Chapter 4:  Achiral Cosurfactants 
 1-Butanol 1-Pentanol 2-Pentanol 
 Calculated Observed Calculated Observed Calculated Observed 
Atenolol 1.06 0.92 0.70 0.67 0.79 0.72 
Ephedrine 2.66 2.42 2.59 2.36 2.49 2.34 
Metoprolol 1.82 1.62 1.75 1.65 1.84 1.71 
N-methyl ephedrine 2.41 2.21 2.31 2.12 2.27 2.07 
Pseudoephedrine 4.64 4.32 4.45 4.10 4.57 4.36 
Synephrine 1.47 1.34 1.16 1.05 1.16 1.02 
 1-Hexanol 2-Hexanol  
 Calculated Observed Calculated Observed   
Atenolol 0.62 0.57 0.75 0.73   
Ephedrine 2.48 2.34 2.46 2.48   
Metoprolol 1.71 1.72 1.97 1.97   
N-methyl ephedrine 2.37 2.29 2.21 2.10   
Pseudoephedrine 4.30 3.68 3.80 3.45   
Synephrine 1.25 1.10 1.28 1.21   
 Cyclopentanol Cyclohexanol  
 Calculated Observed Calculated Observed   
Atenolol 1.09 0.93 0.77 0.73   
Ephedrine 2.86 2.36 2.54 2.50   
Metoprolol 1.91 1.74 1.73 1.87   
N-methyl ephedrine 2.51 2.29 2.27 2.32   
Pseudoephedrine 4.24 3.61 3.83 3.67   
Synephrine 1.48 1.38 1.21 1.17   
Chapter 5:  Dual-Chirality Systems with Dibutyl Tartrate 
 RXX RXR RXS 
 Calculated Observed Calculated Observed Calculated Observed 
Atenololb) NR NR NR NR NR NR 
Ephedrine 1.97 1.84 1.93 1.81 2.26 2.15 
Metoprolol 1.17 1.10 1.31 1.24 1.34 1.30 
N-methyl ephedrine 2.07 1.94 1.99 1.85 2.34 2.21 
Pseudoephedrine 3.17 2.97 2.99 2.73 3.38 3.19 
Synephrine 0.75 0.72 0.63 0.59 0.72 0.69 
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 SXR SXS  
 Calculated Observed Calculated Observed   
Atenololf) NR NR NR NR   
Ephedrine 2.05 1.91 1.87 1.73   
Metoprolol 1.07 1.00 1.31 1.25   
N-methyl ephedrine 2.14 1.96 1.83 1.70   
Pseudoephedrine 3.17 2.95 3.07 2.84   
Synephrine 0.58 0.54 0.76 0.72   
Chapter 6:  Dual-Chirality Systems with Diethyl Tartrate 
 RXX RXR RXS 
 Calculated Observed Calculated Observed Calculated Observed 
Atenolol 0.64 0.59 0.62 0.61 0.57 0.53 
Ephedrine 2.32 2.23 2.65 2.26 2.31 2.04 
Metoprolol 1.74 1.60 2.06 1.63 1.90 1.76 
N-methyl ephedrine 2.35 2.17 2.57 2.17 2.43 2.16 
Pseudoephedrine 3.81 3.48 3.98 3.57 3.88 3.56 
Synephrine 1.04 0.94 1.14 0.98 1.13 1.03 
 SXR SXS  
 Calculated Observed Calculated Observed   
Atenolol 0.65 0.62 0.67 0.65   
Ephedrine 2.27 2.24 2.39 2.20   
Metoprolol 1.58 1.65 2.09 2.00   
N-methyl ephedrine 2.17 2.24 2.38 2.18   
Pseudoephedrine 3.85 3.56 3.95 3.53   
Synephrine 0.93 0.95 1.30 1.15   
Chapter 7:  Dual- and Triple-Chirality Systems with Diethyl Tartrate 
 RSX SSX  
 Calculated Observed Calculated Observed   
Atenolol 0.76 0.82 0.64 0.68   
Ephedrine 2.67 2.45 2.41 2.12   
Metoprolol 2.25 2.16 2.04 1.87   
N-methyl ephedrine 2.71 2.46 2.36 2.07   
Pseudoephedrine 4.55 4.06 4.05 3.71   
Synephrine 1.47 1.32 1.14 1.02   
 RSS SSR SSS 
 Calculated Observed Calculated Observed Calculated Observed 
Atenolol 0.64 0.61 0.65 0.64 0.64 0.60 
Ephedrine 2.32 2.14 2.47 2.28 2.29 2.27 
Metoprolol 2.13 2.03 2.09 1.94 2.10 1.89 
N-methyl ephedrine 2.44 2.23 2.61 2.42 2.29 2.15 
Pseudoephedrine 4.55 4.11 4.13 3.62 3.94 3.54 
Synephrine 1.32 1.23 1.29 1.19 1.16 1.03 
 
a) Resolution calculated with equation 1.6. 
b) Atenolol enantiomers were not resolved (NR).   
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